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Main thesis abstract 
 
Gestational diabetes mellitus (GDM) is a transient intolerance to carbohydrates affecting an 
increasing number of pregnant women worldwide in parallel with obesity. The condition is 
associated with adverse pregnancy outcomes, including long-term effects on the offspring through 
metabolic programming and epigenetic changes in utero.  GDM promotes a vicious cycle of metabolic 
diseases for future generations. Medical Nutrition Therapy is currently the cornerstone of GDM 
managements. The conflicting clinical evidence (and low quality overall for that evidence) has led to 
the lack of expert consensus. Establishing an effective and safe diet for management of GDM is an 
urgent priority. 
Lower carbohydrate (LC) diets have been growing in popularity as a means of lowering blood glucose 
levels (BGL) and have been endorsed by prestigious endocrine societies for GDM management. Aside 
from reducing BGL, LC diets increase the formation of ketones through increased fat catabolism 
(mainly as beta-hydroxybutyrate, BHB), particularly when the glucagon to insulin ratio is high. In 
pregnancy, ketone formation is exaggerated due to a shift in maternal metabolism. Therefore, the 
independent metabolic impact of LC diets is superimposed on gestational metabolism. High 3rd 
trimester serum BHB levels have been inversely correlated with child’s intelligence at 2-5 years old, 
but the quality of evidence is poor.  In the present thesis, the aim was to investigate the current 
literature on LC diets and generate evidence of their safety in GDM. 
In Chapter 1, our literature review indicated conflicting evidence in relation to LC diets promoting 
weight loss, lowering blood glucose and insulin levels, and improving cholesterol and triglyceride 
concentrations in non-pregnant populations. This may be traced to heterogeneity in daily targets of 
carbohydrate and differences in both study duration and study design. However, evidence on safety 
of LC diets in GDM populations was lacking, highlighting the need for further research.  
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To bring clarity, we conducted a systematic review and meta-analysis of prospective observational 
studies in which information on dietary intake and physical activity (PA) levels were collected during 
preconception or early pregnancy (Chapter 2). We found that frequent intake of potato and high 
protein intake (% energy) derived from animal sources suggested a higher risk of GDM, whereas the 
Mediterranean diet (MedDiet), Dietary Approaches to Stop Hypertension (DASH) diet and a higher 
Alternate Healthy Eating Index (AHEI) score resulted in 15-38% reduced risk.  In addition, 
engagement in >90 min/week in leisure time PA reduced the odds of GDM by 46%. Therefore, 
modifiable lifestyle factors such as diet and PA could play a critical role in disease prevention and 
provide direction for lifestyle management of GDM.   
To address the gap in knowledge on safety of LC diets, we conducted the MAMI 1 study 
(Macronutrient Adjustment in Mothers to Improve GDM). This was a 6-week pilot, 2-arm randomised 
controlled trial (RCT) comparing the effects of a Modestly Lower Carbohydrate diet (MLC, 135 g/day 
carbohydrate) and Routine Care diet (RC, 180-200 g/day carbohydrate) on blood BHB levels, and 
pregnancy outcomes. In total, 45 women were recruited and 33 completed the full protocol. The 
results suggested no differences in BHB levels (MLC 0.1 ± 0.0 mmol/L vs RC 0.1 ± 0.0 mmol/L; P = 
0.308), glycaemia (MLC 6.1 ± 0.1 mmol/L vs RC 6.0 ± 0.1 mmol/L, P = 0.307) or insulin dose (MLC 14.6 
± 1.8 units vs RC 21.2 ± 3.9 units, P = 0.126) between the study groups. Analysis of 3-day food records 
confirmed that carbohydrate intake was lower in the intervention arm, (mean ± SEM, carbohydrate 
MLC 165 ± 7 g vs RC 190 ± 9 g, P = 0.042). However, we also observed significantly lower energy (MLC 
7040 ± 240 kJ vs RC 8230 ± 320 kJ, P = 0.006), lower protein (85 vs 103 g/day, P = 0.006), and lower 
micronutrient intake (including iron and iodine) in the MLC group.  
The most surprising finding was a statistically smaller infant head circumference in the MLC group 
(MLC 33.9 ± 0.1 cm vs RC 34.9 ± 0.3 cm; P = 0.046), which remained significant after adjustment for 
gestational weight gain (GWG), gestational age at delivery and infant sex (P = 0.043). Head 
circumference ranged from the 10th to 25th percentile in the MLC group and between 25th to 50th 
 v 
percentile for the RC diet group.  Because head circumference is a proxy for brain volume and 
development, this finding suggests the need for caution on LC dietary advice in GDM.   
Due to the slow rate of recruitment in MAMI 1, we conducted a cross-sectional observational study 
(MAMI 2) to assess whether dietary carbohydrate consumption in the previous 12 hours (including 
dinner, supper and breakfast) was correlated with morning urine and blood ketones levels, or with 
pregnancy outcomes in women with GDM.  Of the total number of women recruited (n = 160), only 
14% were positive for ketonuria.  Blood BHB levels and urinary ketones were highly correlated (rS = 
0.717, P <0.001), but there was no correlation between ketonuria and carbohydrate intake.  
Compared to the highest tertile of carbohydrate intake (% energy), the lowest tertile had a 2-fold 
increased odds of higher blood ketone levels(OR = 2.14, 95% CI: 0.98 – 4.64, P = 0.055, adjusted for 
pre-pregnancy BMI, energy intake and GWG), although not statistically significant.  
Collectively, the studies in this thesis suggest the need for larger, appropriately-powered studies to 
determine the safety and risks associated with recommending even modestly lower carbohydrate 
intake in the management of GDM.  Although ketonaemia may not be of concern, total energy and 
micronutrient intake may be compromised, with unintended and potentially adverse effects on 
offspring. Dietary recommendations in GDM should not be based on intuition and anecdotal 
evidence, but rather robust scientific evidence that guarantees improved outcomes for the mother 
and her offspring. 
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Chapter 1, Part 1 
Low carbohydrate diets 
 
1.1  Introduction 
The concept of a lower carbohydrate (LC) diet is not a new one. The first reported recommendation 
was by William Banting in 1869 for weight loss (5). Since then, like the swing of a pendulum, the LC 
diet has gone in and out of fashion as exemplified by the emergence of Atkins (6), ketogenic (7) and 
Palaeolithic diets (8), with weight loss as the primary goal. Aside from weight loss, particularly in 
obesity, LC diets have shown favourable effects on diabetes management (9, 10). In this chapter, we 
examine 1) the scientific evidence behind LC diets and 2) its applicability in pregnancy, particularly in 
gestational diabetes mellitus (GDM). 
 
 
Figure 1.1. Chapter 1 overview.  
PART 1 - LC diets
• Defining LC diets, growing popularity and suggested health benefits
• Side effects of LC diets
• Carbohydrates and ketone metabolism
• Ketones monitoring and factors influencing their levels
PART 2 - GDM and LC diets 
• Defining GDM
• GDM diagnosis, prevalence and risk factors
• Metabolic differences between a healthy and GDM pregnancy
• Maternal lipid metabolism and accelerated starvation
• GDM monitoring & management 
• Ketonaemia in pregnancy, are there any concerns?
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1.2  LC diet definitions  
Defining a LC is a challenge, primarily due to inconsistencies in daily carbohydrate targets. Among 
the popular diets, the Atkins’ diet recommends <20 g/day or <100 g/day, depending on the diet 
phase, while the ketogenic diet specifies <50 g/day (11).  Dr Bernstein’s diabetes solution diet aims 
for 30 g/day (11). More recently, Hashimoto and colleagues stratified LC diets into either very-low 
(<50 g/day, carbohydrates comprising ~10% of total energy intake) or mild (~200 g/day, 
carbohydrates comprising ~40% of total energy intake) carbohydrate content (12).  On the other 
hand, Wheeler et al. categorised carbohydrate diets based on 4 levels of carbohydrate restriction 
(13). A summary of diet stratification based on carbohydrate content is shown in Table 1.1.  
Low levels of carbohydrate intake contrast with national dietary guidelines in Australia (14) and 
United States (15), which recommend that carbohydrates comprise 45-65% of total energy intake 
(16). The acceptable macronutrient distribution ranges were established by Institute of Medicine’s 
(IOM) Food and Nutrition Board on the basis that carbohydrate intake >65% total energy with a 
reciprocal fall in fat intake (<20%) decreased the risk of coronary heart disease (16), whereas low 
carbohydrate intake followed by compensatory increases in fat (>45% total energy intake) were 
associated with higher risk of obesity (17).  
Table 1.1 Diet stratification based on carbohydrate content in grams and percent (%) energy 
of total daily intake.    
 
Carbohydrate diets Grams/day % Energy 
Very Low 21 – 70 11   
• Atkins  - - 
- Phase 1 <20 11 - 
- Phase 2 80 – 100 11  - 
• Dr Bernstein’s 30 - 
• Ketogenic <50 11 10 12 
• Joslin Diet - 25 18 
Modestly Low - 30 – 40 13 
Moderate 200 13 40 – 65 11 
High - >65 13 
1 Wheeler et al. 2010 (13); 2 Fields et al. 2016 (11); 3 Hashimoto et al. 2016 (12); Osler et al. 1923 (18) 
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1.3  Current popularity of LC diets 
The re-emergence of LC diets is driven in-part by the obesity epidemic (19).  Currently, it is estimated 
that 375 million women and 266 million men across the globe are obese (BMI ≥30), a 5- to 8-fold 
increase since 1975, respectively (20). When geographic location is considered, it becomes clearer 
that certain populations are more predisposed to overweight and obesity than others.  The 
prevalence of female obesity in some developing Caribbean and Middle Eastern countries has 
reached 40-50% and exceeded 50% on several Polynesian and Micronesian islands (20).  
The rates of overweight and obesity in developed countries are also high, with almost two-thirds of 
adults classed as either overweight or obese in Australia (21) and United States (22). One-third of 
women of a childbearing age are above the normal weight threshold (23, 24) and the numbers are 
expected to rise further (25).  In fact, by 2030, it is anticipated that 3 billion or 40% of the total world 
population will be either overweight or obese (26, 27). Obesity is also the strongest risk factor for 
chronic diseases such as type 2 diabetes (T2DM) (20), GDM (28, 29), cardiovascular disease (CVD) 
(30) and cancer (31), which show the same upward trend over time.  
The potential causes of obesity and concurrent metabolic diseases include diet, physical activity and 
the environment in which we live. Mechanisation has considerably reduced our physical activity 
levels and consequently energy expenditure in the last five decades (32). Even incidental activity such 
as walking to our local supermarkets have become a rarity. In an urban setting, the size of our 
supermarkets was reported to have a positive relationship with obesity (33). Certainly, our busy 
lifestyles may have led to less opportunity to shop and cook food from basic ingredients.  The 
purchase of processed and pre-prepared foods with longer shelf-life are therefore favoured over 
perishable options (33).  
Many individuals pursuing weight loss diets have regained the weight within months or years (34). 
This suggests that obesity is under complex biological control (34) and not merely an imbalance of 
energy intake and expenditure (35). Nonetheless, there is an understandable desire to achieve rapid 
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weight loss (19), leading to a booming weight loss industry.  Currently, it is estimated that $64 billion 
was spent on weight loss products in United States alone (11), almost doubling since 1999 (36). The 
number and availability of specific low carbohydrate products in supermarkets has increased over 
the years (37, 38), with estimated sales up 500% in 2004 when compared to sales in 2001 (39). It 
comes as no surprise that 12 million copies of Atkins’ diet books have been sold across the globe, 
making it an all-time best-selling diet book (40).  
The popularity of LC diets and their products can also be attributed to the marketing tactics employed 
by manufacturers. The presence of nutrition claims such as “sugar free”, “no added sugar”, "carb 
smart” or “carb conscious” could potentially mislead consumers to believe that the product is 
healthful (38, 41), while the fat, added sugar and overall energy content could be relatively high (41, 
42). In recent times, the low carbohydrate products are targeted at a wider weight-conscious 
population where women are greater consumers (42, 43), not merely people pursuing LC diets (41). 
People with diabetes are more likely to be conscious of low carbohydrate nutrition claims (43) 
because they are taught that carbohydrate is the main macronutrient that affects postprandial 
glycaemia (44). Educating individuals to actively check claims and read nutrition information panels 
before deciding to purchase a product is one approach to overcoming marketing tactics (42).  
 
1.4  Benefits and mechanisms of LC diets 
Since the 1970s, LC diets such as the Atkins diet have claimed to be effective in mobilising lipids 
within adipose cells via fatty acid oxidation to provide accelerated weight loss (19, 45). Rapid initial 
weight loss may be attributed to depletion of glycogen stores, loss of water associated with the 
glycogen structure (46, 47) or a reduction in the overall energy intake (19, 36, 48-51). The 
mechanisms behind LC diets have now been the subject of intense investigation, with increased 
interest in insulin dynamics and glucose homeostasis as well as in blood lipid changes.  LC diets have 
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also been studied in the context of mood, epilepsy, cancer and sports performance where other 
mechanisms may be relevant (51-54).  
 
1.4.1  Weight loss 
Several randomised controlled trials (RCTs) have demonstrated that LC diets promote greater weight 
loss when compared to diets of higher carbohydrate content (36, 48, 49, 55-58). A systematic review 
and meta-analysis by Bueno and colleagues, consisting of 13 studies and 1400 overweight or obese 
patients, suggested that LC diets resulted in ~1 kg (weighted mean difference kg = -0.91, 95% CI: -
1.65, -0.17, P = 0.02) greater weight loss than low fat/high carbohydrate diets (59). A meta-regression 
analysis of intervention studies lasting >4 weeks indicated a mean difference of 1.6–1.7 kg.  The best 
weight loss results occurred when the diet contained <41% energy from carbohydrates (60). 
However, the weight loss effects of LC diets may be short term (3-6 months) (10, 48, 51, 61), and are 
often accompanied by weight regain at 12 months (50, 56). Greater dietary adherence to LC diets 
may help explain why the results initially appear more favourable (50, 59), although long term 
adherence may be difficult (45). However, majority of the studies did not account for quality of 
carbohydrates consumed.    
LC diets usually induce a state of ketosis, i.e. the presence of elevated ketone levels (See 1.7 Ketones) 
which are commonly believed to inhibit appetite. A systematic review by Gibson and colleagues of 
26 studies provided convincing evidence of appetite reduction when following LC diets, despite a 
period of severe energy restriction (9).  These authors also suggested that the threshold level of 
ketones (specifically beta-hydroxybutyrate, BHB) required to reduce appetite could be 0.5 mmol/L, 
as higher levels of ketosis did not provide any additional benefit (9). In contrast, Foster and 
colleagues reported no relationship between ketosis and weight loss (48), but appetite was not 
assessed.  
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Other mechanisms may contribute, including decreases in the hormone ghrelin and increases in 
leptin concentrations which together reduce appetite, and thereby leading to lower energy intake  
(9, 46, 51). Greater satiety on LC diets may also be related to increases in dietary protein intake and 
greater thermogenesis, leading to higher energy expenditure (62).  
Unfortunately, a comprehensive systematic review consisting of 107 articles on LC diets suggested 
that there were no significant differences in weight loss between different levels of carbohydrate 
intake (19). When protein-sparing, modified fast diets (low energy, high protein and low 
carbohydrate diets) were compared to low and very low-calorie diets, there were no observed 
differences in weight loss (63). Similarly, in the context of T2DM, a systematic review by Snorgaard 
et al. reported that LC diets did not provide any added benefit to weight loss when compared to 
other higher carbohydrate diets (61), although, once again, carbohydrate quality was not considered. 
Certainly, heterogeneity with respect to daily carbohydrate targets and levels of energy restriction 
(vs ad libitum), as well as study duration and design were evident in majority of the systematic 
reviews.  The relationship between LC diets and weight loss is therefore inconclusive at present.  
 
1.4.2  Blood insulin levels and glycaemia 
Since carbohydrates have a direct effect on glycaemia (44), limiting carbohydrate intake should 
theoretically lead to reductions in serum glucose levels. According to a 2-year RCT by Shai et al., LC 
diets reduced glycated haemoglobin (HbA1c, a measure of average glucose levels, mean ± SD = 0.9 ± 
0.8%, P = 0.05) (55), but did not contribute to improvements in fasting blood glucose levels. Of 5 
systematic reviews and a meta-analysis on LC diets in a population of either higher BMI or T2DM (10, 
19, 59, 61, 64, 65), 1 reported short term improvements in fasting glucose concentrations (-0.06 
mmol/L [95% CI-1.67 to -0.44]) (64) and 2 indicated a small reduction in HbA1c levels (-0.21 [95% CI 
8 
 
- 0.24 to -0.18] or -0.34% [95% CI -0.63 to -0.06]) (61, 64). Protein-sparing, modified fast diets 
produced a greater reduction in both fasting plasma glucose as well HbA1c levels when compared to 
low and very-low calorie diets which contain carbohydrate (63).  
The conflicting effects of LC diets on glycaemia were observed in a recent systematic review of diet 
in type 1 diabetes mellitus (T1DM). The review of 9 studies noted differences in study design and 
sample size (66). The significant heterogeneity among studies and lack of HbA1c reporting led to the 
conclusion that the benefits of LC diets on improving glycaemia cannot be established at present.  As 
HbA1c is a superior indicator of glycaemic control than fasting glucose, future studies should 
specifically report HbA1c as well as other cardiovascular risk markers to ascertain the benefits of LC 
diets, particularly in populations with diabetes.  
Fasting insulin levels may also be relevant when they reflect improvements in insulin resistance 
rather than impairments in beta-cell function. Santos and colleagues reported a significant decrease 
in fasting insulin following a period of LC diet consumption (-2.24 µIU/L) (64). While findings from an 
observational study suggested that a lower fasting insulin in middle-aged and elderly non-diabetic 
people may be an indicator of reduced  insulin resistance and risk of metabolic syndrome (67), in the 
context of  LC diets, the lowering effect of fasting insulin could potentially reflect beta-cell 
dysfunction (68). Moreover, a systematic review Bravata et al. (19) and a meta-analysis by Bueno et 
al. (59) reported no differences in insulin concentrations, even when the degree of weight loss was 
taken into consideration (19). For these reasons, the controversy surrounding LC diets remains. 
 
1.4.3  LC diets and blood lipids  
The majority of the systematic reviews on LC diets versus low-fat diets report an improvement in 
certain risk factors for CVD, i.e. an increase in serum high-density-lipoprotein cholesterol (HDL-C) 
(0.04 to 0.12 mmol/L) and a decrease in triglyceride (TAG) concentrations (-0.17 to -0.8 mmol/L) (10, 
9 
 
59, 64, 65). The rise in HDL-C could partially be attributed to the replacement of carbohydrates with 
dietary fats (69), although careful consideration should be employed when selecting fat type due to 
their differing effects on metabolism. For instance, higher intake of saturated fatty acid acts 
unfavourably towards HbA1c and insulin sensitivity when compared to higher intake of 
polyunsaturated fatty acids (70). 
The effect of LC diets on HDL-C and TAG could be beneficial for overall health, since higher HDL-C 
cholesterol was reported to be protective against onset of coronary artery disease (71), while higher 
serum TAG was associated with an increased risk of CVD (72). Interestingly, 1 mmol/L reduction in 
TAG was reported to decrease CVD death risk by 23% (73). Other diets, such as the Mediterranean 
and some low-fat/high-carbohydrate diets, have also promoted a positive change in HDL-C 
concentrations. While LC diets had a superior effect in the short term (55),  there were no long term 
benefits (17-24 months) (59, 65).  
Unfortunately, RCTs have demonstrated that LC diets have been associated with an increase in low-
density-lipoprotein cholesterol (LDL-C) concentrations at 6 months (0.14-0.17 mmol/L) and 12 
months (0.20-0.37 mmol/L) (10, 65). Elevated LDL-C concentrations in LC/high-fat diets may be 
related to lower insulin levels (at least in the short term) and abundance of free fatty acids  (74). 
Considering that high LDL-C concentration is associated with risk of CVD-related (73) and all-cause 
mortality (75), the rise in LDL-C following LC diets is a concern. In particular, higher saturated fat 
intake is associated with a rise in LDL-C (59, 69), prompting the need for closer monitoring of type of 
fat following periods of carbohydrate restriction. Interestingly, many LC diet studies distinguished 
between different dietary fats (e.g. saturated, polyunsaturated and monosaturated fats) in their 
analyses (64), but failed to compare the effects of different carbohydrates, that are well known to 
have differing effects on the metabolism (see 1.6 Carbohydrates).  
In their systematic review consisting of 94 LC dietary interventions reporting data for 3268 
participants, Bravata and colleagues reported no changes in serum LDL-C levels but noted that 
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reductions in LDL-C were associated with weight loss, energy restrictions and longer study 
participation (19). Again, evidence of heterogeneity among included studies prevented conclusive 
statements in favour of LC diets, especially in patients with lifelong metabolic syndrome who are 
already at an increased risk of hypertension, elevated LDL-C and obesity (76).  
 
1.4.4  Mood 
The relationship between dieting and negative effects on mood is well established (77, 78). In fact, 
Quehl et al. suggested that there was an association between depressive symptoms and  a lower 
healthy diet score (β = -0.016, 95% CI: -0.029 to -0.003, P = 0.017) in young female students (79). 
According to a recent systematic review of the psychological and social outcomes of weight loss diets, 
there are no added benefits in following a LC diet when compared to other weight loss diets. In 
addition, they reported that any observed psychosocial benefit from weight loss diets is independent 
of their macronutrient composition (52). 
 
1.4.5  Treatment of epilepsy and cancer 
Epilepsy is a medical condition affecting the brain, characterised by unexpected seizures (80). Almost 
a century ago, LC diets were recommended for the treatment of seizures, but gradually became less 
popular following the emergence of anticonvulsant medications (54). In recent years, drug-resistance 
as well as avoidance of undesirable medication side effects prompted the resurfacing of LC diets for 
the treatment of epilepsy (54).  The hypothesised mechanism of action comes from the formation of 
ketone bodies following carbohydrate restriction, which are believed to have anticonvulsant 
properties, reducing neuronal excitability and subsequent seizure incidence (51). According to a 
Cochrane review, seizure incidence was reduced up to 85% after 3 months following a LC diet 
composed of 4:1 fat to protein ratio (81). However, as anticipated, the diet was associated with 
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adverse effects including gastro-intestinal disturbances, resulting in participant withdrawals from the 
study (81).  
Following their success in reduction of tumour size in mice and tumour progression in humans, LC 
diets have also been prescribed for the treatment of certain cancers (51).  LC diets are thought to 
‘deprive’ cancer cells of glucose, subsequently reducing their rapid replication (82). Although LC diets 
were reported to improve the response to chemotherapy, a systematic review concluded that the 
effects cannot be generalised due to heterogeneity in study design, type and location of cancers (82).  
 
1.4.6  Sports performance  
The conventional dietary message for athletes is to consume a diet consisting of ~40-60% energy 
derived from carbohydrates (83). However, LC diets have been prescribed to older athletes in the 
hope of overcoming progressive insulin resistance with increasing weight and oxidative stress. 
Following LC diets, endurance athletes often exhibit metabolic adaptations, such as ketosis where 
they utilise an abundance of fat stores to fuel their performance without necessitating consumption 
of carbohydrates.  Emerging evidence suggests that ketones may fuel most of the brain’s energy 
demands when carbohydrate intake is limited and promote better muscle recovery following 
exercise (53).  This subject remains controversial and is likely a long way from resolution.  
 
1.5  Side effects of LC diets 
Multiple side effects have been associated with LC diets. Elevated blood and urine ketone 
concentrations as well as compensatory increases in protein content of the diet following 
carbohydrate restriction, were reported to drive an impairment in insulin sensitivity, liver and renal 
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function, and hyperdyslipidaemia in children and adults (19). Long-term exposure to ketogenic/LC 
diets may also cause kidney damage and development of kidney stones in children (84). The 
propensity for kidney stone formation as well as bone loss has been observed within 6-weeks of 
following a LC diet containing high protein content in a healthy population (85). However, modestly 
higher protein diets (~25% energy intake) have not had adverse effects on estimated glomerular 
filtration rate in adults with pre-diabetes (86).    
LC diets invariably increase the intake of protein and fat, saturated fatand cholesterol, all factors long 
associated with the risk of CVD (87).  A 12-month RCT by Wycherley et al. demonstrated that a LC 
diet vs low fat/high carbohydrate diet decreased flow mediated dilatation in overweight and obese 
subjects (3.7 ± 0.5% vs 5.5 ± 0.7%, respectively). This suggested that the long-term LC diet pattern 
may be unsafe due to unfavourable changes in the endothelial function (88). Recent studies have 
shown a U-shape relationship between carbohydrate intake and risk of mortality, with low (<40% 
energy) and high carbohydrate intakes (>70% energy) both associated with increased risk of death 
(pooled hazard ratio 1.20, 95% CI: 1.09–1.32 vs 1.23, 95% CI: 1.11–1.36, respectively) (89). 
Interestingly, when carbohydrates were substituted with protein and fat of animal origin, the risk 
increased, but decreased when these macronutrients were derived from plant-based sources 
(pooled hazard ratio 1.18, 95% CI: 1.08–1.29 vs 0.82, 95% CI: 0.78–0.87, respectively) (89).  
Among the more symptomatic adverse effects, LC diets have been associated with constipation, 
fatigue (19, 36), headaches, halitosis and diarrhoea (36). Salt and water depletion following a rapid 
weight loss, may also drive feelings of general weakness, hypotension and constipation (19). Since 
the LC diet usually involves lower consumption of fruits, starchy vegetables and wholegrain cereals 
(all are sources of fibre for the large bowel microbial flora), the occurrence of constipation is not 
surprising (87).  This constellation of symptoms is likely to lead to low long-term compliance (49, 51).  
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1.6  Carbohydrates  
Carbohydrates are a heterogenous class of nutrients ranging from simple sugars to starches and 
dietary fibre. Carbohydrate foods include fruit, starchy vegetables, refined grains, wholegrains, dairy 
products, table sugar and sugar-sweetened beverages. Due to their differing properties, they also 
have varying effects in the human body and overall metabolism. Fermentable carbohydrates 
increase the odds of dental caries through increases in oral acidity (90). However, no such effect was 
observed with higher quartiles of dietary fibre intake (90, 91). Based on comprehensive meta-
analyses and systematic reviews, higher intake of sugar-sweetened beverages and refined cereals 
has been associated with weight increase and higher risk of T2DM, while higher consumption of 
foods naturally high in dietary fibre, such as wholegrain cereals, fruits and vegetables, is protective 
(92).  
Jenkins and colleagues pioneered the glycaemic index (GI) concept - a method of categorising 
carbohydrates with respect to their propensity to raise blood glucose levels when compared to the 
same amount of carbohydrate in the reference food (93). As depicted in Figure 1.2, low GI foods 
produce lower glycaemic fluctuations, a desirable trait for individuals with impairments in 
carbohydrate metabolism. Other favourable effects associated with low GI diets include 
improvements in inflammatory markers (C-reactive protein), fasting insulin and TAGs, glucose 
tolerance and a reduced risk of developing T2DM, breast cancer and gallbladder disease (94-96). 
 
 
Figure 1.2 Incremental area under the curve 
of low and high glycaemic index foods (Image 
sourced from GlycemicIndex.com).  
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Dietary fibre was reported to improve insulin sensitivity and slow down absorption of glucose 
independently of a food’s GI value (97). A study examining the effects of 3 cereal-containing meals 
consumed at dinner-time, such as white bread, pasta (low GI, low fibre) and barley (low GI, high 
fibre), demonstrated that a high fibre meal resulted in greater glucose tolerance at breakfast the 
following morning (95), possibly via ‘second-meal’ phenomenon – i.e. presence of a late glycemic 
response. Aside from positive effects on glycaemia, dietary fibre positively interacted with certain 
gut microbiota (Lactobacillus and Bifidobacterium) to reduce inflammation, lower LDL-C as well as 
the risk of certain cancers, onset of T2DM and CVD (98).  
The link between dietary fibre and gut health was further emphasised in a study examining the 
effects of a high-protein, animal-based diet vs a high-fibre, plant-based diet.  Within a day, as the 
contents reached the colon, Bilophila wadsworthia and Prevotella microorganisms increased sharply 
in the stools of individuals following animal vs plant-based diets, respectively (99).  Bilophila has been 
previously associated with inflammation, dysfunction of the intestinal barrier and dysmetabolism of 
bile acid (100), while Prevotella improved glucose metabolism (101). Diets with low fibre content 
(including many LC diets) were reported to reduce the stool concentration of short chain fatty acids, 
which play an important role in maintaining the immune system, appetite and glucose homeostasis 
(102).  
Given that high fibre diets are generally high in carbohydrates, this raises questions about 
carbohydrate types when drawing conclusions with respect to health benefits and detriments of LC 
diets. One meta-analysis compared the effects of LC diets to high carbohydrate diets and exclusively 
removed studies with high fibre to remove its confounding effects from the analysis (103). Although 
the majority of metabolic parameters were comparable, fasting insulin and triglycerides were higher 
and HDL-C lower, in the high carbohydrate diet groups (103). However, it is likely that a higher fibre 
version of the high carbohydrate diets could have ameliorated these effects. While it cannot be 
denied that refined carbohydrates increase the risk of certain chronic diseases such as diabetes (104), 
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GI and dietary fibre content of a diet should never be neglected as carbohydrate quality plays a 
greater role in population health than quantity (105). Figure 1.3 summarises the effects of multiple 
dietary components on insulin sensitivity.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Dietary manipulation and effects on insulin sensitivity and resistance (Modified from 
Weickert et al. 2012) (3). BCAA – branched chain fatty acid; GI – glycaemic index; 
MUFA – monounsaturated fatty acid; SFA – saturated fatty acid; TFA – trans fatty 
acid.  
 
1.7  Ketone bodies 
Ketone bodies are a by-product of the breakdown of fat as a fuel source.  They are produced in the 
liver as acetoacetate (AcAc), BHB (most abundant, 75% ketones produced) and acetone (least 
abundant) (106-108). When the glucagon to insulin ratio is high, ketogenesis is initiated in 
mitochondria of hepatic cells. Free fatty acid oxidation (FAO) and subsequent formation of AcAc, 
shifts the equilibrium towards BHB formation via a NAD+/NADH- coupled reaction (Figure 1.4) (4, 107, 
109). BHB is a 4-carbon compound that moves out of the cell via solute carrier 16A (SLC16A), en route 
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to extrahepatic tissues (4, 110). Upon entry into the extrahepatic cells using the same carrier, BHB 
migrates to mitochondria where ketolysis ensues. In a multi-step process, BHB is broken down to 
Acetyl Coenzyme A (Acetyl CoA), which enters the tricarboxylic acid cycle to undergo terminal 
oxidation (4). 
 
 
Figure 1.4  Hepatic production of ketones through ketogenesis and ketolysis in extrahepatic 
tissues. (Figure amended from Cotter et al. 2013, (4); AcAc – Acetoacetate: CoA –
Coenzyme A; BHB – Beta hydroxybutyrate; FAO – Fatty acid oxidation; TCA – 
Tricarboxylic acid). 
 
Only 1-4% of ketone bodies are synthesised from non-fatty acid sources, such as glucose metabolism 
and amino acid (particularly leucine) catabolism (4). Others have suggested that between 15-20% of 
the carbon structure could be obtained from amino acids, with estimated overall ketone body 
production ~115-180 g/day (110). Following a meal, the ratio between BHB:AcAc is normally 1, but 
can rise to 6 in instances of a prolonged fast (106). Serum concentrations of BHB can vary across 
populations due to age, fasting duration and differences in basal metabolic rates (106). Normal levels 
of BHB are usually <0.5 mmol/L, while hyperketonaemia is defined as 0.5-3.0 mmol/L (some suggest 
>1 mmol/L) and ketoacidosis as >3 mmol/L.  Ketoacidosis is seen in uncontrolled type 1 diabetes and 
requires medical intervention (106, 107). Collectively, ketone bodies including BHB and AcAc are 20% 
more energy efficient than glucose and can fuel approximately half of the basal energy usage (106, 
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110, 111). However, the only organ not capable of metabolising ketone bodies for energy is the liver 
(112). 
Compared to smaller animals, humans have a slower basal metabolic rate enabling them to produce 
and utilise greater amounts of ketone bodies. Ketotic sheep and dogs can oxidise only 50% of ketone 
bodies to carbon dioxide, while humans can oxidise a greater proportion, possibly due to a larger 
brain or larger adipose tissue stores in the case of obese subjects (113).  The human brain accounts 
for only ~2% of total body weight, but consumes up to 20% of total energy intake (114). Although 
preference lies in utilisation of glucose, the brain can also oxidise ketone bodies for energy (114). 
Ketogenesis is often halted or dampened by the action of insulin which acts on Foxa2 to supress 
transcription of Hmgcs2 (4, 115). 
 
1.8  What influences ketone levels?  
Under normal circumstances, low levels of ketone bodies are produced (106, 116) but the process is 
accelerated during periods of starvation, or consumption of LC diets, high-fat diets or calorie 
restricted diets. Higher levels of ketones are produced during prolonged exercise, pregnancy and 
uncontrolled metabolic disease states, such as T1DM, T2DM, cortisol deficiency and growth hormone 
deficiency (106, 110, 117).  
Obese humans can live ~2 months during starvation, provided they have access to water (118). Given 
that hepatic stores of glycogen amount to ~70 g in a non-fasted state, they would be consumed 
within 18-24 hours of fasting if gluconeogenesis and mobilisation of free fatty acids were not initiated 
(109).  After several days of fasting, blood glucose levels often stabilise and the brain obtains most 
of its energy requirements from BHB and AcAc (which equates to 100-145 g/day of glucose under 
normal circumstances) as they pass through the blood brain barrier (118). Amazingly, during 
prolonged starvation, the body spares the use of muscle protein for energy to ensure survival of the 
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host, accompanied by a decline in insulin concentration so that the production of ketone bodies is 
not supressed (118). Much like starvation, LC diets reduce the availability of glucose, through 
intentional restriction of carbohydrate foods. Although nutritional ketosis ensues, BHB 
concentrations are much lower than those observed in individuals experiencing diabetic ketoacidosis 
(119). BHB and AcAc gradually become the main source of energy in LC diets (120).  
Diabetic ketoacidosis is a life-threatening condition characterised by a decline in blood’s pH value 
due to a rise in metabolic acidosis. This is more common in individuals with recent diagnosis of T1DM 
and therefore complete insulin deficiency or uncontrolled T2DM (110, 121). In uncontrolled T2DM, 
hyperinsulinaemia contributes to cytoplasmic localisation and inactivation of a mitochondrial Foxa2 
transcription factor (responsible for inhibiting the production of BHB), resulting in hepatic 
accumulation of lipids that leads to higher BHB production, thereby furthering insulin resistance 
(115).  
A healthy pregnancy is associated with a progressive rise in fasting free fatty acids (122), followed by 
significant increases in BHB concentrations in the 3rd trimester due to greater insulin resistance (109, 
123). In addition, there is an exaggerated 3-fold increase in maternal ketone levels when breakfast 
is omitted (124). This manifestation is termed “accelerated starvation” (124), which preserves 
glucose for fetal needs, while providing BHB for maternal use (109). During a therapeutic abortion, 
84 hours of fasting resulted in a 30-fold rise (~4.2 mmol/L) in BHB levels, far more pronounced than 
in fasted non-pregnant women (109). While glucose is the preferred source of energy for maternal 
brain function and fetal development, ketones can cross the placenta without affecting fetal 
secretion of insulin (107, 110, 125, 126). Newborns have a slightly higher rate of ketone production 
initiated by the high fat content of maternal milk, although this is deemed normal in the absence of 
ketonuria (106). The presence of ketonuria, however, is indicative of a disturbed metabolism (106). 
Children also have a greater propensity for hyperketonaemia following 24-hours of fasting, due to 
their low stores of hepatic glycogen (106, 107).  
19 
 
Ketones can also be consumed from exogenous sources.  In the absence of carbohydrate and energy 
restriction, synthetic (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone ester (KE) dampened muscle 
glycolysis despite periods of intense physical activity (116). Another KE (R-3-hydroxybutyrate-R-1,3-
butanediol monoester) was recently reported to increase resting energy expenditure and markers of 
adipose tissue thermogenesis in obese mice fed a high-fat diet (127). This led to less weight gain and 
lower fat mass compared with pair-fed controls. 
 
1.9  Measurement of ketones 
At present, body ketone levels can be established by a means of urinalysis or blood (capillary or 
venous) and breath samples (Figure 1.5). Urinalysis involves immersing a reagent strip (dipstick) into 
a “mid-stream” urine sample for a microscopic assessment (128) of ketones. Blood ketones in the 
form of BHB can be measured using hand-held monitors and accompanying ketone test strips 
requiring a small sample of blood (~0.6 µL). These strips were previously validated and show a high 
degree of reliability and reproducibility (129). 
 
 
 
 
 
 
Figure 1.5  Multi-parameter urine dipstick test (left) and dual blood and ketone monitor (right).  
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Blood ketones assessed by the hand-held monitors have been reported as superior to ketone 
urinalysis, particularly in diagnosing ketoacidosis (130). In fact, ketonuria may be high before blood 
ketones begin to rise (131). Ketone urinalysis may produce false positive results, particularly when 
dealing with highly pigmented urine samples (132), whereas some medications (sulphydril (108) or 
levodopa medications (132)), as well as strip air exposure may lead to false-negative results (108). 
Nitroprusside-type test strips cannot detect urinary BHB (108), as they have been designed to 
establish the presence of the other major ketone body, AcAc (132). Certainly, urinalysis is qualitative, 
meaning that a change in strip colour may be subject to misinterpretation by the observer (133). On 
the other hand, capillary assessment of ketones is expensive.  
Breath ketone tests have recently been gaining popularity, as it is a non-invasive alternative in 
assessing body ketone concentrations (134). Unlike a hand-held monitor, which determines 
concentrations of BHB, the breath test assesses acetone as it is a volatile compound that can easily 
be exhaled in air (134). Under normal living conditions, acetone is present in breath and its 
concentrations have been correlated with fasting blood glucose, serum and urine ketones, LDL-C, 
creatinine, and blood urea nitrogen (134). Therefore, breath acetone concentrations are deemed as 
a reliable method for diagnosing and monitoring diabetic ketosis. The common procedure is to 
exhale alveolar air into a collection bag, which will be subsequently analysed by gas chromatography 
(135). However, should a participant fail to provide their alveolar air, this could lead to false negative 
results. Other reported limitations include high cost, difficulty in storing bags of gas samples and 
variability in acetone due to ethnicity, gender, age, dietary intake, weight and medication use (136). 
In recent years, portable acetone breathalysers were developed and have suggested precision up to 
100 parts per billion by volume (137).  
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Chapter 1, Part 2 
Understanding pregnancies and gestational diabetes 
 
1.10  Normal pregnancy vs GDM  
Pregnancy is a transient period in a woman’s life accompanied by a plethora of hormonal changes 
that correspond with crucial developmental stages in the fetus. In the 1st trimester, fasting blood 
glucose levels show a temporary decrease (~10%), even though the embryo is still too small to 
require glucose as a fuel (122, 138, 139). However, obese pregnant women often experience either 
no decline or a rise that is attributed to higher insulin resistance (140). In early pregnancy, maternal 
metabolism is anabolic, promoting accumulation of adipose tissue (141), with little or no change in 
insulin secretion (142). As pregnancy progresses, particularly in the 2nd and 3rd trimester, the 
metabolism milieu shifts towards catabolism, increasing lipolysis and ultimately contributing to  
insulin resistance (141). This mechanism appears to be further amplified in women with GDM (143). 
In the 3rd trimester of a healthy pregnancy, studies have reported a further, though modest decline 
in fasting blood glucose levels (123, 139), which often increases in GDM (144).   
Glucose is an important source of energy for the developing fetus, and readily crosses the placenta 
(145, 146). The fetus is entirely dependent on maternal circulatory glucose concentrations as fetal 
gluconeogenesis is low (147).  Fetal glucose levels are ~15-20% lower than maternal (138) or 
equivalent to 0.5-1.1 mmol/L (109), providing a distinct concentration gradient for glucose to cross 
the placenta via facilitated diffusion. Since maternal insulin cannot cross the placenta (145), elevated 
maternal blood glucose concentrations force the fetus to produce sufficient insulin (145) to 
normalise glucose levels. Indeed, infants of women with uncontrolled diabetes are at higher risk of 
hyperinsulinism (138), fetal overgrowth and subsequently hypoglycaemia at birth (148).  
As pregnancy progresses and the placenta grows, the levels of human placental lactogen, 
cortisol(138, 149), glucagon (149, 150), prolactin and maternal progesterone rise, antagonising the 
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normal actions of insulin (138).  By the 3rd trimester, insulin sensitivity can be reduced by 50-70%, 
when compared to non-pregnant women (151). To maintain blood glucose in the normal range, 
maternal pancreatic beta-cells undergo hypertrophy to achieve a greater beta-to-alpha cell ratio 
(152) and greater insulin than glucagon secretion (122, 138, 152).  Higher insulin-to-glucagon ratio 
directs more nutrients towards the growing fetus (150), but some women experience marked 
hyperglycaemia possibly due to insulin resistance, often resulting in a diagnosis of GDM (138).  
In humans, FFA also serve as a fuel source for fetal brain development and fat deposition (147), 
although this is largely dictated by maternal glucose concentrations (153). Compared to glucose, the 
transfer of TAG is more difficult and often requires TAG lipases to break it down to simple FFA, which 
are then delivered to the fetus via transporter proteins (147). Serum cholesterol and TAG can rise 
25-50% and 200-400%, respectively (154), with oestrogen and insulin resistance driving this increase 
(155). High glucose concentrations observed in women with GDM (all on insulin therapy) lead to a 
~30% decline in FAO, accompanied by a 3-fold higher TAG concentration when compared to healthy 
controls (156). This is thought to contribute to fetal macrosomia (147).  
 
1.11  Diagnosis of GDM  
GDM is a transient form of diabetes characterised by glucose intolerance observed for the first time 
in pregnancy [145].  In developed nations, pregnant women are routinely screened for GDM, usually 
at 24-28 weeks gestation (157). In 2008, the HAPO (Hyperglycaemia in Pregnancy Outcomes) study 
provided firm evidence that there were adverse maternal and fetal outcomes associated with 
glucose levels lower than previously appreciated, even outside of diabetes (158). As a result, the 
International Association of Diabetes and Pregnancy Study Groups (IADPSG) proposed new 
diagnostic criteria for GDM which was based on a fetal growth outcome. Following a fasting 75 g oral 
glucose tolerance test (OGTT), any one of the following are deemed sufficient for GDM diagnosis: 
fasting BGL ≥5.1 mmol/L, 1-hour BGL hour ≥10.0 mmol/L and 2-hour BGL ≥8.5 mmol/L (159). 
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Although the Australasian Diabetes in Pregnancy Society (ADIPS) adopted the diagnostic guidelines, 
they may not be consistently used in clinical practice. Some centres still prefer to use older criteria 
(ADIPS: fasting BGL ≥5.5 mmol/L or the 2-hour ≥ 8.0 mmol/L (160)) or other criteria for GDM 
diagnosis (Table 1.2). Although minor variations in diagnosis are justified to reflect Australian local 
conditions, the progression towards an international diagnostic method is recommended (160).  
A recent survey conducted among health practitioners and members of the Society for Maternal–
Fetal Medicine in the United States suggested that 90% use a 2-step diagnostic test (i.e. 50 g glucose 
challenge and 100 g OGTT) and ~80% used the Carpenter-Coustan criteria for the 3-hour OGTT (161).  
With respect to the cut-off point for the 50 g glucose challenge test, it varied between 130-140 mg/dL 
(equivalent to ~7.2-7.8 mmol/L) (161). Therefore, both Australia and United States demonstrate 
inconsistency with regards to diagnostic criteria used to ascertain GDM status.   
 
Table 1.2  Guidelines used in diagnosis of gestational diabetes mellitus (sourced from World 
Health Organization, WHO 2013, (1)). Glucose concentration is given in mmol/L.  
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1.12  Concerns and consequences of a GDM pregnancy 
Exposure to a hyperglycaemic environment during fetal development has long been hypothesised to 
be associated with fetal macrosomia (162). According to the Barker hypothesis of “fetal origins of 
adult disease”, not only does the uterine environment influence fetal growth and development, but 
also plays a role in “programming” long-term health, largely through epigenetic changes (163-166).  
The Dutch famine birth cohort demonstrated that food shortages during pregnancy increased the 
risk of T2DM, obesity and coronary heart disease in the offspring later in life, particularly if 
undernutrition occurred during early gestation (164).  
Evidence from the HAPO study demonstrated that healthy pregnant women with moderately 
elevated glycaemia not only had a higher risk of developing pre-eclampsia, higher induction of labour 
rates and caesarean section delivery, but also a higher risk of neonatal complications including 
shoulder dystocia, neonatal macrosomia and hypoglycaemia  (158). The maternal risk of progressing 
to T2DM in later life was as high as 70% (167, 168), with infants also likely to develop the disease in 
early  adulthood (169), along with obesity in childhood (170), especially if they were born large-for-
gestational age (170, 171). Maternal obesity and excessive gestational weight gain (GWG) were 
reported to be independent factors that predicted undesirable pregnancy outcomes in T1DM, T2DM 
and GDM (172, 173). The concept of intrauterine environment influencing offspring health long-term 
was further corroborated by others.  McLean et al. demonstrated that female offspring of GDM 
women were twice as likely to develop GDM themselves, compared with female offspring of fathers 
with diabetes (174). According to a recent study, GDM altered the expression of 26 microRNA (micro 
Ribonucleic Acid) signatures in the feto-placental endothelial cells in a sex specific manner (22 in 
females and 4 in males), suggesting greater metabolic derangements in female than male neonates 
(175).  
The prevalence of GDM continues to rise due to advanced maternal age and obesity, as well as 
adoption of the new diagnostic criteria as suggested by the IADPSG (160, 176, 177). While the 
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proportions have reached ~30% in some populations (160, 178), there is some evidence of 
improvement. In fact, several studies to date have demonstrated that lifestyle changes have the 
potential to improve GDM pregnancy outcomes (179).  A recent meta-demonstratedfor the first time 
that nutrition modification (across different types) does reduce offspring birthweight, as well as 
maternal fasting and postprandial glucose concentrations (180) (See section 1.13).  
 
1.13  GDM monitoring and management 
Medical nutrition therapy (MNT) is the first line of treatment for women recently diagnosed with 
GDM, with specific focus on monitoring quality and quantity of carbohydrate intake, in conjunction 
with prescribing more physical activity. The ADIPS guidelines suggested the following target BGLs for 
GDM: fasting ≤5.0 mmol/L, 1-hour postprandial ≤7.4 mmol/L and 2-hour postprandial ≤6.7 mmol/L 
(181). When lifestyle approaches are insufficient, women are often started on insulin or other 
hyperglycaemic lowering agents (182).   
At present, it was acknowledged that women should consume a minimum 175g carbohydrate/day 
(183), but there is no established consensus on the most effective dietary strategy for the 
management of GDM (184, 185). One probable reason is that lower carbohydrate intake is often 
accompanied by an increase in fat, which is worrisome as exemplified by animal models (186) and 
some human studies regarding a positive association between maternal lipids and offspring growth 
(187). The lack of agreement provides fuel for apprehension and confusion among pregnant women. 
The American Endocrine Society and the American College of Obstetricians and Gynaecologists 
recommend a lower carbohydrate diet with ~30-45% energy derived from carbohydrates, with 
glucose management as the primary goal (188, 189). However, only a handful of studies have 
investigated the effects of LC diets in a GDM population, often with mixed findings regarding 
maternal glucose levels and pregnancy outcomes (44, 190, 191).  
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According to a Cochrane review and meta-analysis, the combined effect of various lifestyle 
interventions compared to a control/standard care group resulted in reductions in risk of postnatal 
depression, large-for-gestational age infants and neonatal fat mass (180, 192). More specifically, one 
review by Viana and colleagues suggested that a low GI diet was associated with favourable 
outcomes including less frequent insulin use and lower infant birthweight (193). This demonstrates 
that lifestyle interventions may be able to dampen the effect of intrauterine stressors commonly 
associated with GDM pregnancies (e.g. hyperglycaemia) and therefore improve pregnancy 
outcomes.  
 
 
1.14  LC diets and ketonaemia in pregnancy 
In the 1980s, Churchill and colleagues were among the first to suggest a correlation between 
ketonuria in mothers with diabetes and lower intelligence quotient of their offspring in a 
retrospective observational study (194). Unfortunately, the association disappeared when the data 
were later adjusted for multiple factors including psychomotor development (e.g. Down Syndrome) 
(195).  
It was not until a study published in the prestigious New England Journal of Medicine in 1991 (196), 
that ketone bodies gained another wave of attention. Pregnant women with pre-gestational diabetes 
(n = 89), GDM (n = 99) and a healthy pregnant control group (n = 25) were included with the aim of 
collecting several metabolic parameters, such as serum BHB and glucose concentration between 2nd-
3rd trimester. After adjustment for multiple confounding variables (e.g. socioeconomic status, 
diabetes status and ethnicity), Rizzo and colleagues reported a strong inverse correlation between 
3rd trimester maternal BHB concentrations within all 3 groups (196) and child’s intelligence at 2-5 
years old. What was more concerning was that BHB serum concentrations (range = 0.14-0.18 
mmol/L) were well below the threshold for ketonaemia (<0.5 mmol/L) and the effect of BHB on 
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children’s intelligence was observed even in the healthy pregnant women. Similarly, a meta-analysis 
consisting of 12 observational cohort studies  suggested that infants born to mothers with diabetes 
(GDM and pregestational) had lower mental and psychomotor development scores than infants born 
to healthy mothers. However, dietary intake and BHB concentrations were not assessed and the 
studies were reasonably heterogenous (197). In the limited number of studies available on 
carbohydrate reduction in GDM, only urinary ketone levels (44, 190, 191) have been assessed. The 
popularity of LC diets for the management of GDM makes it more important than ever to resolve the 
controversy surrounding serum BHB and pregnancy outcomes. 
To date, several animal models have investigated the effects of LC, high-fat diets on pregnancy 
outcomes.  One study suggested that a ketogenic diet during gestation in mice resulted in changes 
in embryonic organ growth including the brain, which was smaller at 13.5 days gestation but larger 
at 17.5 days gestation when compared to a standard high carbohydrate diet (198). Another study in 
a different mouse model reported that LC, high-fat diets resulted in greater production and activity 
of arginase enzyme in the lung, contributing to obesity in the offspring, without causing an 
impairment of the glucose metabolism (199). Because both animal models indicated negative effects 
of LC diets on the offspring, more studies in human pregnancy are required, particularly in 
metabolically-challenged populations such as GDM.  
 
1.15  Conclusion  
At present, there is a lack of consensus surrounding the use of LC diets in pregnancy, despite an 
urgent need to establish the most effective treatment strategy for women with GDM.  The increasing 
incidence of GDM together with the popularity of LC diets has resulted in the need for a greater 
understanding of the safety and potential health consequences for the mother and her offspring. 
The following chapters of this thesis address in turn the lifestyle risk factors associated with GDM 
(Chapter 2), a pilot RCT called MAMI 1 (Macronutrient Adjustments in Mothers to Improve GDM) 
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examining the effects of a LC diet in GDM management and pregnancy outcomes (Chapter 3), and a 
cross-sectional observational study (MAMI 2) investigating the relationship between recent 
carbohydrate intake and random blood ketone concentrations in women with GDM (Chapter 4).  
Given the new findings, the final chapter suggests future directions for research on diet in GDM 
(Chapter 5). 
 
 
 
 
 
 
 
 
 
Chapter 2 
___________________________________________________ 
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Associations of diet and 
physical activity with risk for 
gestational diabetes mellitus: A 
systematic review and meta-
analysis 
 
 
 
 
Note: Chapter 2 was published in Nutrients Journal, May 2018. While the content remained the 
same, the chapter was reformatted to match the rest of this thesis.  
Citation: 
Mijatovic-Vukas, J.; Capling, L.; Cheng, S.; Stamatakis, E.; Louie, J.; Cheung, N.W.; Markovic, T.; Ross, G.; Senior, 
A.; Brand-Miller, J.C.; Flood, V.M. Associations of diet and physical activity with risk for gestational diabetes 
mellitus: A systematic review and meta-analysis. Nutrients 2018, 10, 698.  
Abstract 
Rising rates of gestational diabetes mellitus (GDM) and related complications have prompted calls 
to identify potentially modifiable risk factors that are associated with gestational diabetes mellitus 
(GDM). We systematically reviewed the scientific literature for observational studies examining 
specific dietary and/or physical activity (PA) factors and risk of GDM. Our search included PubMed, 
Medline, CINAHL/EBSCO, Science Direct and EMBASE, and identified 1167 articles, of which 40 met 
our inclusion criteria (e.g., singleton pregnancy, reported diet or PA data during pre-
30 
 
pregnancy/early pregnancy and GDM as an outcome measure). Studies were assessed for quality 
using a modified Quality Criteria Checklist from American Dietetic Association. Of the final 40 
studies, 72% obtained a positive quality rating and 28% were rated neutral. The final analysis 
incorporated data on 30,871 pregnant women. Dietary studies were categorised into either 
caffeine, carbohydrate, fat, protein, calcium, fast food and recognized dietary patterns. Diets such 
as Mediterranean Diet (MedDiet), Dietary Approaches to Stop Hypertension (DASH) diet and 
Alternate Healthy Eating Index diet (AHEI) were associated with 15–38% reduced relative risk of 
GDM. In contrast, frequent consumption of potato, meat/processed meats, and protein (% energy) 
derived from animal sources was associated with an increased risk of GDM. Compared to no PA, 
any pre-pregnancy or early pregnancy PA was associated with 30% and 21% reduced odds of GDM, 
respectively. Engaging in >90 min/week of leisure time PA before pregnancy was associated with 
46% decreased odds of GDM. We conclude that diets resembling MedDiet/DASH diet as well as 
higher PA levels before or in early pregnancy were associated with lower risks or odds of GDM 
respectively. The systematic review was registered at PROSPERO (www.crd.york.ac.uk/PROSPERO) 
as CRD42016027795. 
 
 
 
2.1  Introduction 
Gestational diabetes mellitus (GDM) is defined as diabetes or glucose intolerance occurring for the 
first time in pregnancy (200). Although diagnostic criteria vary, GDM affects approximately 15-20% 
(201) of pregnancies, reaching 30% (178, 202) in some parts of the world. The World Health 
Organization’s (WHO) new diagnostic criteria explain some, but not all, of the recent rise in 
prevalence (178). Delayed age of motherhood, obesity and migration of higher risk population 
groups to regions of lower risk also contribute to increasing prevalence of GDM (203). Women with 
GDM have up to 70% chance of progressing to type 2 diabetes mellitus (T2DM) within 28 years post-
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partum (167). GDM also increases the risk of macrosomia, hypoglycaemia (204) and epigenetic 
changes in the infant, resulting in a new generation susceptible to obesity and type 2 diabetes later 
in life (205).  
Current treatment options include changes in lifestyle, e.g. more physical activity (PA) and improved 
diet quality through MNT (192). MNT aims to achieve and maintain euglycaemia through 
consumption of appropriate meal portions, distribution of carbohydrates (206) and consumption of 
foods with a lower GI (178, 192). A recently published Cochrane review and meta-analysis of RCTs 
demonstrated that provision of more intensive health care such as additional dietary counseling and 
exercise, lead to an improved glycated hemoglobin (HbA1c), lower incidence of large-for-gestational-
age (LGA) infants, decreased weight gain in pregnancy and lower rate of depression in mothers three 
months post-partum, compared to standard care (192). However, when lifestyle approaches alone 
are not sufficient, insulin or other anti-hyperglycaemic pharmacological therapies are often 
prescribed (178, 192). 
The increasing prevalence of GDM has prompted calls to identify key lifestyle factors that either 
prevent or promote onset of the disease. The Finnish Gestational Diabetes Prevention Study (RADIEL) 
study suggested that the risk of GDM can be reduced by approximately 40% by following a physically 
active lifestyle and a diet enriched with fruits, vegetables and wholegrain cereals as per Nordic 
Nutrition Recommendations (207). While higher fruit and vegetable intake has also been reported 
to reduce all-cause mortality, particularly cardiovascular mortality in a general population (208), 
other dietary patterns, habits and components may be relevant risk factors for GDM. 
PA has long been prescribed to patients with diabetes due to improvements in glycaemia and insulin 
sensitivity (209). It has been proposed that PA achieves these benefits by promoting an increase in 
skeletal muscle glucose uptake in resistance training or increase mitochondrial density and 
expression of glucose transporter proteins that are evident in aerobic exercises (209, 210). Women 
are currently advised to take part in 150-300 min/week in moderate-intensity aerobic PA both during 
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pregnancy and after delivery (211) as there is a strong inverse association between PA and excessive 
weight gain in pregnancy, postpartum depression as well as GDM (212). However, despite the 
benefits, only 23-29% of pregnant women meet the recommendations (212). Women generally 
decrease their incidental PA as pregnancy progresses (213) and spend the majority of their day being 
sedentary (up to 60%), as shown by motion sensor data from the US (214).    
The aim of the present study was to undertake a systematic literature search of observational studies 
investigating the associations between diet and PA aspects before and in early pregnancy that are 
associated with risk of GDM. In addition, we conducted a meta-analysis on PA studies to examine the 
associations of specific types or duration of PA with GDM risk.  
 
 
 
 
 
2.2  Materials and Methods  
2.2.1  Eligibility Criteria 
Longitudinal and cohort studies containing information on diet and PA either prior to or at the 
commencement of a singleton human pregnancy were included. Although GDM was the main 
outcome measure, studies that reported other outcomes (e.g. pre-eclampsia, macrosomia and 
large/small for gestational age offspring) were also included. Studies were excluded if they were 
published in a language other than English, subjects had diabetes mellitus in pregnancy diagnosed at 
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the start of the pregnancy, or an underlying medical condition that affected digestion and absorption 
of nutrients (e.g. sleeve gastrectomy or gastric bypass surgery).  
 
2.2.2  Information Sources and Search 
This systematic review was registered at PROSPERO (www.crd.york.ac.uk/PROSPERO) as 
CRD42016027795. A systematic literature search was undertaken initially 22nd October 2015 and was 
later updated 2nd February 2017 by three independent researchers (J.M-V., L.C. and S.C.). The search 
was conducted using Medline, PubMed, Science Direct, EMBASE and Cumulative Index to Nursing 
and Allied Health Literature (CINAHL) databases with interest in studies that reported on the 
relationship between diet and/or PA during pre-pregnancy or early pregnancy and risk of GDM. 
Additionally, we hand searched reference lists to obtain more studies. For a complete list of search 
terms, please refer to Table 2.1. A time frame 1985-2017 was selected as it reflected the current 
context of high prevalence of GDM as well as to capture good quality cohort and longitudinal studies.  
 
 
2.2.3  Quality Assessment and Data Extraction 
To determine study quality, studies were assessed independently (J.M-V., L.C., S.C.) using a modified 
version of the Quality Criteria Checklist found in the American Dietetic Association (ADA) Evidence 
Manual (2). Information about confounding variables and adjusted data was also collected from 
included studies to highlight study strengths or weaknesses. We assigned either a positive, neutral 
or a negative value for studies that were of excellent, good and poor quality respectively. Study 
characteristics were extracted into a pre-determined table that collected information including 
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author, year of publication, participant number, study selection criteria, data collection methods, 
GDM diagnostic criteria as well as results and how they were deduced. Data were cross-checked by 
co-author (V.F.) for any errors and discrepancies. 
 
2.2.4  Statistical Analysis 
Our primary outcome measure was onset of GDM. We quantified study results using odds ratios 
(OR), which along with their sample variances, were calculated using the escalc function in metafor 
R package (Maastricht University, Maastricht, Netherlands) (215). A positive effect size suggests that 
the odds of GDM are higher in group A (active) than B (inactive). Where results were reported as 
stratified across groups a combined effect-size was calculated following Borenstein and colleagues 
(216). Where results were reported in text as relative risk (RR), we used the following equation from 
Deeks and Altman (217) to convert values reported to OR, where pc is the typical event rate without 
treatment: 
                                                                                                               
 
For analysis, odds ratios were log transformed (i.e. lnOR), and in places we back-transform overall 
lnOR for interpretation by raising e (exponential) to the power of the lnOR.   
We analyzed effect sizes using a random-effects meta-analysis (REMA) model, implemented in the R 
package metafor. Statistical heterogeneity was quantified via the heterogeneity statistic, I² - a type 
of intra-class correlation (218). I² corresponds to the percentage of among effect sizes variance, that 
cannot be attributed to sampling. An I² value determined variability of results between different 
studies as either low (25%), moderate (50%) or high (75%). We were unable to perform a meta-
OR = RR (1 – pc) 
 1 – pcRR 
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analysis on dietary studies as they were too diverse in the aspects of the diet they report on. 
Therefore, we report on meta-analyses conducted on PA studies only.  
We assessed the risk of publication bias across studies by developing a funnel plot with lnOR scale 
and inverse standard error as x and y-axis respectively. We also used a regtest function in metafor 
to determine funnel plot asymmetry. It should be noted that tests of funnel plot asymmetry can be 
unreliable indicators of publication bias where the number of effect sizes is small (<10) and/or there 
is substantial heterogeneity. Thus, in the main text, we only present and interpret results from 
publication bias tests where the number of effect sizes was greater than 10. Statistical significance 
of the overall effect of PA was inferred when the p-value was <0.05 and 95% Confidence Intervals 
(CI) did not contain 0.  
 
2.3  Results 
2.3.1  Studies Identified  
We extracted 1166 articles from the database searches, and one article was identified through hand-
search. After screening and assessing for eligibility, we identified 40 journal articles which met 
inclusion criteria (Figure 2.1). Of these 40 articles, 23 reported data only on dietary intake, 15 only 
on PA and two articles reported on both dietary intake and PA. Twenty-nine studies (72%) obtained 
a positive quality rating and 11 (28%) were rated neutral (Table 2.1). All the articles reported findings 
from prospective cohort studies of which there were multiple publications from four major studies 
including Nurses’ Health Study II (n = 14) (219-232), Omega (n = 7) (233-239), Australian Longitudinal 
Study on Women's Health (n = 4) (240-243) and Project Viva (n = 2) (244, 245). The most common 
reasons for exclusion of publications were unavailability of full texts, no relevant data collected 
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necessary for the present review and late recruitment of study participants, consequently capturing 
dietary and PA information that were not reflective of the pre-pregnancy or early pregnancy period. 
 
 
Figure 2.1.  PRISMA flow diagram of screening, selection process and inclusion of 
studies. 
 
2.3.2  General Characteristics of Studies  
The review captured data on 30,871 pregnancies of which 1980 (7%) developed GDM. The studies 
provided information on women from multiple populations including 26 American (219-239, 244-
248), five Australian (240-243, 249), two Hispanic American (250, 251) and one each for the 
following: Iranian (252), Danish (253), Canadian (254), Pakistani (255), Norwegian (256), Spanish 
(257), and multi-centre Mediterranean Study (Algeria, France, Greece, Italy, Lebanon, Malta, 
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Morocco, Serbia, Syria and Tunisia) (258). The number of participants per study ranged from 97 to 
71,239 and were published between 1997-2016, with an age range of 16-48 years as reported in 27 
studies. Of 22 studies that reported retention rate, 14 had ≥80% (233, 235, 239, 242, 244, 245, 247, 
249, 251, 253, 255-258), 7 had 50-79% (236-238, 243, 246, 250, 254), and only one <50% (242).  
The reported GDM diagnostic methods included a 100g (n = 12) (233, 235, 236, 238, 244, 245, 248, 
250-252, 255, 259), 75g (n = 5) (242, 243, 249, 256, 258), 50g (n = 1) (246), a combination of these (n 
= 2) (254, 257) OGTT or were extrapolated from medical records (n = 20) (219-232, 234, 239-241, 
247, 253, 260). Multiple diagnostic criteria were used to ascertain GDM status and included 1.) 1997 
American Diabetes Association (ADA) criteria (n = 2; fasting ≥105 mg/dL, 1-hr ≥190 mg/dL, 2-hr ≥165 
mg/dL, 3-hr ≥145 mg/dL) (234, 235), 2.) 2004 ADA criteria (n = 10; fasting ≥95 mg/dL, 1-hr ≥180 
mg/dL, 2-hr ≥155 mg/dL, 3-hr ≥140 mg/dL) (236-238, 244, 245, 250-252, 255, 257), 3.) 2010 
International Association of the Diabetes and Pregnancy Study Group (IADPSG) criteria (n = 3; fasting 
≥5.1 mmol/L, 1-hr ≥10.0 mmol/L, 2-hr ≥8.5 mmol/L) (249, 256, 258), 4.) 1998 Australasian Diabetes 
in Pregnancy Society (ADIPS) criteria (n = 3; fasting ≥5.6 mmol/L  and/or 2-hr ≥8.0 mmol/L) (241-243) 
or were not reported (n = 22) (219-233, 239, 240, 246-248, 253, 254). Thirty-six studies reported on 
pre-pregnancy body mass index (BMI), of which 20 were within the normal range (219-225, 228-231, 
234, 236-238, 244, 252, 256, 257), one overweight (246), one obese (140) and 14 were categorised 
into multiple groups (227, 232, 235, 242, 243, 245, 247, 248, 250, 251, 253-255, 258) rather than 
providing an overall average. Twenty-two publications reported data from the pre-pregnancy period 
(219, 221-233, 236, 237, 240-242, 246, 257), ten focused on early pregnancy (234, 243, 245, 247-
249, 252, 253, 255, 258), seven on both (235, 238, 244, 250, 251, 254, 256) and one was unclear 
(239). Refer to Table 2.2 for more information on study characteristics.        
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Table 2.1 Modified quality assessment & risk of bias form obtained from the Evidence Analysis Manual: Steps in the academy 
evidence analysis process (2). 
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Adeney et al. 2007 (233) Y Y * Y Y X Y Y Y Y Y Neutral 
Badon et al. 2016 (234) Y Y NA NA Y N Y Y Not E Y Y Neutral 
Bao et al. 2013 (219) Y Y NA NA Y Y Y Y Y Y Y Positive 
Bao et al. 2014a (220) Y Y NA NA Y Y Y Y Y Y Y Positive 
Bao et al. 2014b (221) Y Y NA NA Y Y Y Y Y Y Y Positive 
Bao et al. 2016 (222) Y Y NA NA Y Y Y Y Y Y Y Positive 
Baptiste-Robert et al. 2011 
(246) 
Y Y Y NA Y Y Y Y Not E Y Y Positive 
Behboudi-Gandevani et al. 
2013 (252) 
Y * X X Y Y Y Y Not E Y * Neutral 
Bowers et al. 2011 (223) Y Y NA NA Y Y Y Y Y Y Y Positive 
Bowers et al. 2012 (224) Y Y NA NA Y Y Y Y Y Y Y Positive 
Chasan-Taber et al. 2008 
(251) 
Y Y Y Y Y Y Y Y Not E Y Y Positive 
Chasan-Taber et al. 2014 
(250) 
Y Y Y Y Y Y Y Y Not E Y Y Positive 
Chen et al. 2009 (225) Y Y NA NA Y Y Y Y Not E Y Y Neutral 
Chen et al. 2012 (226) Y Y NA NA Y Y Y Y Not E Y Y Neutral 
Currie et al. 2014 (254) Y Y Y Y Y Y Y Y Not E Y Y Positive 
Dempsey et al. 2004 (235) Y Y Y Y Y X Y Y Not E Y Y Positive 
Dominguez et al. 2014 (257) Y Y Y X Y Y Y Y Y Y * Neutral 
Dye et al. 1997 (247) Y Y Y Y Y X Y Y Not E Y Y Positive 
Gresham et al. 2016 (240) Y Y Y * Y Y Y Y Y Y Y Positive 
Harrison et al. 2012 (249) Y X Y Y Y Y Y Y Not E Y Y Positive 
Hinkle et al. 2015 (253) Y Y Y Y Y * * Y Not E Y * Neutral 
Iqbal et al. 2007 (255) Y Y Y Y Y Y Y Y Not E Y Y Positive 
Karamanos et al. 2014 (258) Y Y Y X Y Y Y Y Y Y Y Positive 
Morkrid et al. 2007 (256) Y Y Y Y Y Y Y Y Not E Y Y Positive 
39 
 
 
A
u
th
o
r,
 Y
ea
r 
R
es
ea
rc
h
 q
u
es
ti
o
n
 
cl
ea
rl
y 
st
at
ed
 
P
ar
ti
ci
p
an
ts
 
re
p
re
se
n
ta
ti
ve
 o
f 
a 
G
D
M
 p
o
p
u
la
ti
o
n
 
R
es
p
o
n
se
 R
at
e
 
A
tt
ri
ti
o
n
 R
at
e
 
Ex
p
o
su
re
 le
ve
l 
d
es
cr
ib
ed
 
D
ie
t 
o
r 
P
A
 
as
se
ss
m
en
t 
to
o
ls
 
va
lid
at
ed
 
M
et
h
o
d
 o
f 
G
D
M
 
d
ia
gn
o
si
s 
st
at
ed
 
A
p
p
ro
p
ri
at
e 
st
at
is
ti
ca
l a
n
al
ys
is
 
C
o
n
fo
u
n
d
in
g 
fa
ct
o
rs
 
ad
ju
st
ed
 
D
is
cu
ss
io
n
 o
f 
fi
n
d
in
gs
, b
ia
s(
es
) 
&
 
st
u
d
y 
lim
it
at
io
n
s 
id
en
ti
fi
ed
 &
 
d
is
cu
ss
ed
 
Fu
n
d
in
g 
o
r 
sp
o
n
so
rs
h
ip
 b
ia
s 
u
n
lik
el
y 
Q
u
al
it
y 
R
at
in
g 
Oken et al. 2006 (244) Y Y Y Y Y Y Y Y Not E  Y Y Positive 
Osorio-Yanez et al. 2016 
(236) 
Y Y Y Y Y Y Y Y Y Y Y Positive 
Putnam et al. 2013 (248) Y Y Y X Y Y Y Y Not E Y Y Positive 
Qiu et al. 2011a (237) Y Y Y Y Y Y Y Y Y Y Y Positive 
Qiu et al. 2011b (238) Y Y X Y Y Y Y Y Y Y Y Positive 
Radesky et al. 2008 (245) Y Y Y Y Y Y Y Y Not E Y * Neutral 
Rudra et al. 2006 (239) Y Y Y X Y Y Y Y Not E Y Y Neutral 
Schoenacker et al. 2015 
(242) 
Y Y Y Y Y Y Y Y Y Y Y Positive 
Schoenacker et al. 2016 
(241) 
Y Y Y Y Y Y Y Y Y Y Y Positive 
Solomon et al. 1997 (227) Y Y Y X Y X Y Y Not E Y Y Neutral 
Tobias et al. 2012 (228) Y Y NA NA Y Y Y Y Y Y Y Positive 
Van der Ploeg et al. 2011 
(243) 
Y Y Y X Y Y Y Y Not E Y Y Neutral 
Zhang et al. 2006a (229) Y Y NA NA Y Y Y Y Y Y Y Positive 
Zhang et al. 2006b (230) Y Y NA NA Y Y Y Y Y Y Y Positive 
Zhang et al. 2006c (231) Y Y NA NA Y Y Y Y Y Y Y Positive 
Zhang et al. 2014 (232) Y Y NA NA Y Y Y Y Y Y Y Positive 
Key: Y = Yes; N = No; NA = Not Available; * = Unclear            
Abbreviations: E – Energy; GDM - Gestational Diabetes Mellitus; PA - Physical Activity 
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Table 2.2 – Characteristics of observational studies.    
 
 
DIET & PHYSICAL ACTIVITY (PA) 
Source Aim & Study population 
Selection 
Criteria 
Diet 
Assessment 
Method 
Physical 
Activity 
Assessment 
Method 
Diagnostic 
Method for 
GDM 
Statistical Analysis 
& Adjusted factors 
Selected Main Findings (RR, 
OR etc.) 
Quality Rating, 
Retention 
Baptiste-Robert 
et al. 2011 (246) 
To determine pre-
pregnancy PA & dietary 
intake in early pregnancy 
& its effect on glucose 
tolerance test.  
n = 152 
Age: 30.1 (SD = 5.2) 
Country: United States 
Study: Parity, 
Inflammation & DM 
Inclusion: <14 
weeks 
gestation, 
no history of 
DM, consent to 
participate.   
Validated 
Rapid Food 
Screener  
Interview 
questionnai
re (not 
validated) 
 
50g, 1-hr 
GCT, 
Medical 
records   
Multiple logistic 
regressions 
Adjustments: race, 
age, parity, 
gestational weight 
gain & BMI. 
 
68% less likely to have a 1-hr 
GCT response >140 mg/dL 
with a leisure score of ≥2.75 
when compared to <2.75 [RR 
= 0.32, 95% CI: 0.12-0.86, P 
<0.05]. No association 
between dietary intake & 
response to 1-hr GCT 
response. 
Positive,  
64.4% 
 
 
 
 
 
Zhang et al. 2014 
(232) 
To examine the effect of 
lifestyle characteristics on 
risk of GDM. 
n women = 14 437  
n pregnancies = 20 136 
Age: 24-44 
Country: United States 
Study: NHS II 
 
Inclusion: No 
history of GDM, 
T2DM, CVD & 
cancer.  
Exclusion: 
Pregnancies 
after GDM. 
Validated 
FFQ.  
 
 
Validated 
physical 
activity 
questionnai
re  
(not in a 
pregnant 
population)
.  
Medical 
records  
Multivariable log 
binomial models 
with generalized 
estimating 
equations 
Adjustments: age, 
parity, family history 
of DM, history of 
infertility, race/ 
ethnicity, alcohol 
intake, 
questionnaire period 
& total EI.  
Adhering to any 4 low risk 
lifestyle factors (AHEI-2010, 
PA, BMI, Smoking) before 
pregnancy, risk of GDM was 
lower by 83% when compared 
to those that did not adhere 
to any [RR = 0.17, 95% CI: 
0.12-0.25]. Highest quintile of 
PA (≥210min/week) vs lowest 
(<30min/week) reduced the 
risk of GDM by 22% [RR = 
0.78, 95% CI: 0.64-0.94].  
Positive,  
NA%  
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DIET ONLY 
Source 
Aim & Study 
Population 
Selection Criteria 
Diet 
Assessment 
Method 
Diagnostic 
method for 
GDM 
Statistical Analysis & Adjusted 
factors 
Selected Main Findings (RR, OR 
etc.) 
Quality 
Rating, 
Retention 
Adeney et al. 
2007 (233) 
To examine the 
relationship between 
coffee consumption & 
the risk of GDM. 
n = 1744  
Age: 32.1 (0.1) yrs 
Country: United 
States  
Study: Omega 
Inclusion: <16 weeks 
gestation, knowledge of 
English language. 
Exclusion: <18 yrs, non-
term pregnancy, did 
not plan to deliver at 
the research hospitals. 
121-item 
semi-
quantitative 
FFQ (not 
validated). 
 
 
100g, 3-hr 
OGTT, 
Medical 
records  
Generalized linear model using a 
log-link function 
Adjusted factors: age, race, BMI, 
parity, smoking, alcohol use before 
pregnancy, smoking during 
pregnancy & chronic hypertension.   
Moderate pre-pregnancy 
caffeinated coffee intake 
significantly reduced the risk of 
GDM by 52% when compared 
with non-consumers [RR = 0.48, 
95% CI: 0.28-0.82]. 
 
Neutral,  
87.2% 
 
 
 
Bao et al. 2013 
(219) 
To examine the 
association between 
dietary protein & 
GDM.  
n women = 15 294 
n pregnancies = 21 
457 
Age: 25-44 years 
Country: United 
States 
Study: NHS II 
Inclusion: singleton 
pregnancy, >6 months 
long, years 1991-2001. 
Exclusion: Previous 
GDM, T2DM, cancer, 
CVD prior to pregnancy, 
FFQ not delivered or 
incomplete with 
unrealistic values.  
Semi-
quantitative 
FFQ 
(validated) 
Medical 
records 
Multivariate logistic regression using 
generalized estimating equations 
Adjustments: age, parity, 
race/ethnicity, family history DM, 
smoking, alcohol intake, PA, total EI, 
intakes of 
saturated/monounsaturated/ 
trans/polyunsaturated fatty acids, 
dietary cholesterol, glycemic load, 
dietary fiber, mutual adjustment for 
animal protein & vegetable protein & 
BMI. 
Animal protein intake 
significantly increased GDM risk 
by 49% [RR = 1.49, 95% CI: 1.03-
2.17], whereas vegetable protein 
intake significantly reduced the 
risk of GDM by 31% [RR = 0.69, 
95% CI: 0.50-0.97].  
Positive,  
NA% 
Bao et al. 2014a 
(221) 
To examine the 
association between 
pre-pregnancy fried 
food consumption & 
risk of incident GDM. 
n women = 15 027 
n pregnancies = 21 
079 
Age: 25-44 
Country: United 
States  
Study: NHS II 
Inclusion: No history of 
GDM, T2DM, 
cardiovascular disease 
& cancer. 
Exclusion: no pre-
pregnancy 
FFQ, an incomplete 
form or unrealistic EI 
(<600 or 
>3500kcal/day).   
 
Semi-
quantitative 
FFQ 
(validated) 
Medical 
records 
Generalized estimating equations 
with log-binomials models  
Adjustments: age, parity, race/ 
ethnicity, family history of DM, 
smoking, PA, total EI, diet quality 
(AHEI-2010 score) & BMI. 
 
Frequent fried food intake 
especially away from home, was 
associated with a greater risk of 
GDM when comparing frequency 
of ≥7/week vs <1/week [RR = 
2.18, 95% CI: 1.53-3.09]. BMI 
adjustment resulted in 
attenuated but significant risk of 
GDM. 
Positive, 
NA% 
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DIET ONLY 
Source 
Aim & Study 
Population 
Selection Criteria 
Diet 
Assessment 
Method 
Diagnostic 
method for 
GDM 
Statistical Analysis & Adjusted 
factors 
Selected Main Findings (RR, OR 
etc.) 
Quality 
Rating, 
Retention 
Bao et al. 2014b 
(220) 
To examine the 
association of 3 pre- 
pregnancy low 
carbohydrate (CHO) 
diet patterns with risk 
of GDM. 
n women = 15 265 
n pregnancies = 21 
411 
Age: 25-44 
Country: United 
States  
Study: NHS II 
Inclusion: No history of 
GDM, T2DM, CVD or 
cancer. 
Exclusion: no pre-
pregnancy FFQ or an 
incomplete form with 
unrealistic EI (<600 or 
>3500kcal/day).   
Semi-
quantitative 
FFQ 
(validated) 
Medical 
records 
Log-binomials models with 
generalized estimating equation  
Adjustments: age, parity, race/ 
ethnicity, family history of DM, 
smoking, alcohol intake, PA, BMI & 
total EI.  
 
Low CHO diet high in animal 
protein increases the risk of GDM 
by 36% [RR = 1.36, 95% CI: 1.13-
1.64, P-trend = 0.003], however 
opposite is true for high 
vegetable protein & fat, reducing 
GDM by 16% [RR = 0.84, 95% CI: 
0.69-1.03, P-trend = 0.08]. 
Overall low CHO diet is 
associated with an increased risk 
of GDM [RR = 1.27, 95% CI: 1.06-
1.51, P-trend = 0.03]. 
Positive,  
NA% 
Bao et al. 2016 
(222) 
To examine the 
association between 
pre-pregnancy potato 
consumption & risk of 
GDM. 
n = 21 693 
Age: 24-44  
Country: United 
States 
Study: NHS II 
Inclusion: No history of 
GDM, T2DM, CVD or 
cancer. 
Exclusion: no pre-
pregnancy FFQ or an 
incomplete form with 
unrealistic EI (<600 or 
>3500kcal/day).   
FFQ 
(validated) 
Medical 
records 
Log-binomials models with 
generalized estimating equation. 
Adjustments: age, parity, race, family 
history of DM, smoking, PA, EI & 
AHEI-2010 score.   
Consuming ≥5 servings/week of 
potatoes compared to <1 
serving/week significantly 
increases the risk of GDM by 62% 
[RR = 1.62, 95% CI: 1.24-2.13, P 
<0.001].  
Positive, 
NA 
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DIET ONLY 
Source 
Aim & Study 
Population 
Selection Criteria 
Diet 
Assessment 
Method 
Diagnostic 
method for 
GDM 
Statistical Analysis & Adjusted 
factors 
Selected Main Findings (RR, OR 
etc.) 
Quality 
Rating, 
Retention 
Behboudi-
Gandevani et al. 
2013 (252) 
To investigate the 
association between 
maternal iron/zinc 
serum levels & 
women’s nutritional 
intake in early 
pregnancy with GDM. 
n = 1 033 
Age: 27.57 (SD = 4.84) 
Country: Iran 
 
Inclusion: singleton 
pregnancy, 20-35 yrs, 
14–20 weeks gestation, 
attending prenatal 
clinics in specified 
hospitals.  
Exclusion: disease of 
glucose metabolism 
(T1DM/T2DM), 
abortions, infections, 
chronic illness, or 
medical treatments. 
 
 
 
Semi-
quantitative 
FFQ 
(validated) 
 
100g, 3-hr 
OGTT (2004 
American 
Diabetes 
Association 
criteria)  
 
Mann–Whitney, chi-square & 
multiple logistic regression tests   
Adjustments: age, BMI, education, 
parity, passive smoking, history of 
GDM & family DM, serum zinc/iron & 
hemoglobin levels, & deficient 
zinc/iron intakes in early pregnancy. 
Higher early pregnancy maternal 
serum iron levels increased risk 
of GDM [mean (SD) = 143.8 (48.7) 
versus 112.5 (83.5) μg/dL in GDM 
and non-GDM women 
respectively, P <0.0001]. No 
significant difference in zinc 
levels & iron/zinc nutritional 
intake between these groups [OR 
= 1.006, 95% CI: 1.002-1.009, P = 
0.001]. 
Neutral, 
NA% 
Bowers et al. 
2011 (223) 
To determine if pre-
pregnancy dietary & 
supplemental iron 
intakes are associated 
with risk of GDM. 
n = 13 475 
Age: 22-44 
Country: United 
States  
Study: NHS II 
Inclusion: 22-44 yrs, 
singleton pregnancy, no 
history of GDM/T1DM/ 
T2DM, CVD or cancer. 
Exclusion: no pre-
pregnancy FFQ, 
incomplete form, 
unrealistic EI (<600 or 
>3500kcal/day), peri-
menopausal at 
baseline, missing 
information on age/iron 
intake.  
133-item 
semi-
quantitative 
FFQ 
(validated) 
 
 
 
Medical 
records 
Pooled logistic regression, restricted 
cubic spline regressions  
Adjustments: Age, parity, BMI, PA, 
glycemic index, cereal fiber, 
polyunsaturated fatty acids, smoking 
status, alcohol, total calories, & 
family history of DM. 
Dietary heme iron is positively 
associated with GDM risk when 
comparing highest vs lowest 
quintile [RR = 1.58, 95% CI 1.21-
2.08]. Every 0.5mg/day increase 
in heme iron intake increases risk 
of GDM by 22% [RR = 1.22, 95% 
CI 1.10-1.36].  
Positive,  
NA%  
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DIET ONLY 
Source 
Aim & Study 
Population 
Selection Criteria 
Diet 
Assessment 
Method 
Diagnostic 
method for 
GDM 
Statistical Analysis & Adjusted 
factors 
Selected Main Findings (RR, OR 
etc.) 
Quality 
Rating, 
Retention 
Bowers et al. 
2012 (224) 
To determine 
whether the total 
amount, type 
& source of pre-
pregnancy dietary 
fats is related to risk 
of GDM. 
n = 13 475 
Age: 22-44 
Country: United 
States  
Study: NHS II 
Inclusion: age 22-44 
yrs, singleton 
pregnancy >6 months 
(1991-2001).  
Exclusion: unrealistic 
total EI (<500 or 
3500kcal/ day), DM, 
GDM, CVD, cancer, or 
missing information on 
age/iron intake or peri-
menopausal at 
baseline.  
133-item 
semi-
quantitative 
FFQ 
(validated) 
 
 
Medical 
records 
Pooled logistic regression  
Adjustments: age, parity, current 
smoking, BMI, PA, family history of 
DM, smoking, alcohol, race, & total 
EI, cereal fiber, dietary cholesterol, 
glycemic load & mutual adjustment 
for the specific fatty acids or source 
of fats. 
 
Higher animal fat & cholesterol 
intakes increased GDM risk by 
88% [RR = 1.88, 95% CI: 1.36-
2.60, P=0.05] and 45% [RR = 1.45, 
95% CI: 1.11-1.89, P = 0.04] 
respectively, when comparing 
highest vs lowest quintile.  
Positive,  
NA% 
Chen et al. 2009 
(225) 
To examine the 
association between 
regular pre-gravid 
sugar sweetened 
beverage (SSB) 
consumption & the 
risk of GDM.  
n = 13 475 
Age: 24-44 
Country: United 
States  
Study: NHS II 
Exclusion: Incomplete 
FFQ in 1991, >70 items 
left blank (FFQ), 
unrealistic total EI, 
multiple gestation, no 
PA data in 1991, history 
of DM, GDM, cancer or 
CVD.   
 
133-item 
semi-
quantitative 
FFQ 
(validated) 
 
 
Medical 
records 
 
Cox proportional hazards models & 
multivariate adjustments  
Adjustments: age & parity.  
 
Higher SSB significantly increased 
the risk of GDM by 23% when 
comparing ≥5 servings/week vs 
<1/month [RR = 1.23, 95% CI 
1.05-1.45, P-value = 0.005]. 
When SSB intake was treated as a 
continuous variable, each 
serving/day increment was 
associated with a 23% increase in 
GDM risk [RR = 1.23, 95% CI: 
1.05-1.43, P-value = 0.01]. 
 
 
Neutral, 
NA% 
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DIET ONLY 
Source 
Aim & Study 
Population 
Selection Criteria 
Diet 
Assessment 
Method 
Diagnostic 
method for 
GDM 
Statistical Analysis & Adjusted 
factors 
Selected Main Findings (RR, OR 
etc.) 
Quality 
Rating, 
Retention 
Chen et al. 2012 
(226) 
To examine the 
association of pre-
pregnancy habitual 
consumption of fruits 
& fruit juices & GDM 
risk. 
n = 13 475 
Age: 22-44 
Country: United 
States  
Study: NHS II 
Inclusion: women that 
did not have DM & 
major chronic diseases 
at baseline. 
133-item 
semi-
quantitative 
FFQ 
(validated)  
Medical 
records 
 
Cox proportional hazards models & 
restricted cubic spline regressions 
Adjustments: age, parity, race, 
smoking, alcohol intake, PA, family 
history of DM, BMI, & dietary factors 
(cereal fiber, processed meat/red 
meat, SSB & fruit juice or apple). 
Higher consumption of whole 
fruits 
is not associated with an 
increased GDM risk, when 
comparing highest vs lowest 
quintile [RR = 0.93, 95% CI: 0.76-
1.16]. The association of fruit 
juices with GDM risk appears to 
be nonlinear, with lowest risk 
reported in women with 
moderate fruit juice 
consumption.  
Neutral 
NA% 
Dominguez et 
al. 2014 (257) 
To investigate the 
incidence of GDM 
according to the 
consumption of fast 
food in a cohort of 
university graduates. 
n = 3 048 
Country: Spain 
Study: Seguimiento 
Universidad de 
Navarra (SUN)  
Inclusion: Graduates 
from the University of 
Navarra & other 
Spanish universities, 
registered nurses & 
other health 
professionals from 
different Spanish 
provinces. 
Exclusion: Extremely 
low/ high total EI, had 
previous GDM or DM.  
Semi-
quantitative 
FFQ 
(validated)  
50g or 100g 
OGTT (2004 
American 
Diabetes 
Association 
criteria) 
Non-conditional regression models  
Adjustments: age, total EI, smoking, 
PA, family history of DM, 
cardiovascular disease/ 
hypertension, parity, adherence to 
MedDiet pattern score, alcohol 
intake, fiber intake, and SSB intake 
and BMI. 
 
 
Fast food consumption was 
significantly associated with an 
86% higher risk of incident GDM 
when compared to the lowest 
category of fast food 
consumption [OR = 1.86, 95% CI: 
1.13-3.06].  
Neutral 
97.2% 
46 
 
 
 
 
 
DIET ONLY 
Source 
Aim & Study 
Population 
Selection Criteria 
Diet 
Assessment 
Method 
Diagnostic 
method for 
GDM 
Statistical Analysis & Adjusted 
factors 
Selected Main Findings (RR, OR 
etc.) 
Quality 
Rating, 
Retention 
Gresham et al. 
2016 (240) 
To assess whether 
diet quality before or 
during pregnancy 
predicts adverse 
pregnancy & birth 
outcomes in 
Australian women. 
n = 1 907 
Age: 20.8 (SD 1.4) 
Country: Australia 
Study: Australian 
Longitudinal Study on 
Women’s Health 
Exclusion: not classified 
as pre-conception or 
pregnant when 
completing the FFQ, 
multiple birth, 
incomplete FFQ.  
 
74-item FFQ 
(validated) 
Self-report Multiple logistic regressions  
Adjustments: level of education, age, 
weight, area of residence, smoking 
status, parity, and level of exercise. 
 
When comparing highest to 
lowest quintile, diet quality was 
not associated with GDM [OR = 
1.7, 95% CI: 0.7-4.0].  
Positive,  
NA% 
Hinkle et al. 
2014 (253) 
To examine the 
relation between first 
trimester coffee & tea 
intake & the risk of 
GDM. 
n = 71 239 
Age: 16-48 yrs 
Country: Denmark 
Study: Danish 
National Birth Cohort 
Inclusion: first singleton 
pregnancy. 
Exclusion: pre-existing 
DM, data of relevant 
covariates missing. 
Interview Self-report & 
medical 
records 
Chi-square statistics for bivariate 
analyses & modified Poisson 
regression 
Adjustments: age, parity, smoking 
status, cola intake, BMI, SES.  
Suggested a protective, but non-
significant association with 
increasing coffee [≥8 vs 0 
cups/day RR = 0.89, 95% CI: 0.64-
1.25] and tea intake [≥8 vs 0 
cups/day RR = 0.77, 95% CI: 0.55-
1.08].  
 
 
Neutral, 
82.4% 
47 
 
 
 
 
DIET ONLY 
Source 
Aim & Study 
Population 
Selection Criteria 
Diet 
Assessment 
Method 
Diagnostic 
method for 
GDM 
Statistical Analysis & Adjusted 
factors 
Selected Main Findings (RR, OR 
etc.) 
Quality 
Rating, 
Retention 
Karamanos et 
al. 2014 (258) 
To investigate the 
association of 
MedDiet with the 
incidence of GDM in 
Mediterranean 
regions.  
n = 1 003 
Country: Algeria, 
France, Greece, Italy, 
Lebanon, Malta, 
Morocco, Serbia, 
Syria & Tunisia).  
Inclusion: women with 
oral glucose tolerance 
test results, women 
with/without a history 
of GDM. 
Exclusion: history of 
T1DM or T2DM.  
Questionnai
re 
(validated) 
&   MedDiet 
Index. 
75g, 1 & 2-hr 
OGTT (2010 
International 
Association in 
Diabetes and 
Pregnancy 
Study Group 
criteria) 
Binary logistic regression  
Adjustments: age, BMI, family 
history of DM, gestational weight 
gain, EI. 
GDM incidence was lower in 
subjects with better MedDiet 
adherence, 8.0% vs 12.3% [OR = 
0.62, 95% CI 0.40-0.95, P = 0.030] 
by American Diabetic Association 
2010 and 24.3% vs 32.8% [OR = 
0.66, 95% CI: 0.50-0.87, P = 
0.004] according to International 
Association of Diabetes & 
Pregnancy Study Group 2012 
criteria.  
Positive 
93.2% 
Osorio-Yáñez et 
al. 2016 (236) 
To examine the 
association between 
dietary Calcium 
intake and risk of 
GDM. 
n = 3 414 
Age: 32.8 
Country: United 
States 
Study: Omega 
 
 
 
 
Inclusion: >18 yrs, <20 
weeks gestation, spoke 
& read English, 
delivered at specified 
hospitals. 
Exclusion: history of 
DM/GDM, multi-
gestation, pregnancy 
<20 weeks, iron 
deficiency anaemia, 
incomplete FFQ, 
unrealistic levels of 
total EI (<500 kcal/day 
or >3500 kcal/ day).  
121-item 
FFQ 
(validated) 
100g, 3-hr 
OGTT (2004 
American 
Diabetic 
Association 
criteria) 
Generalized linear models with log-
link function, log Poisson regression 
model and robust standard errors. 
Adjustments: total energy, age, 
race/ethnicity, education, smoking 
status, BMI, prenatal vitamin use, PA, 
family history of DM, alcohol, coffee, 
SSB, red & processed meats, fatty 
fish, total fiber intake & dietary 
covariates (vitamin D & Mg). 
Higher dietary Calcium intake 
compared to lower was 
inversely (though not statistically) 
associated with GDM risk [RR = 
0.57, 95% CI: 0.27-1.21). Calcium 
intake ≥795 mg/day resulted in a 
42% reduction in GDM risk when 
(<795 mg/day) [R = 0.58, 95% CI: 
0.38-0.90, P-value = 0.02). 
Positive, 
74.2% 
48 
 
DIET ONLY 
Source 
Aim & Study 
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Statistical Analysis & Adjusted 
factors 
Selected Main Findings (RR, OR 
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Qiu et al. 2011a 
(237) 
To investigate the 
association of egg 
intake and dietary 
cholesterol & GDM 
risk in a cohort study. 
n = 3 158 
Age (mean): 32.7 yrs 
Country: United 
States 
Study: Omega 
Inclusion: pre-natal 
care <20 weeks, >18 
yrs, spoke/read English, 
to deliver at either of 2 
study hospitals. 
Exclusion: DM, multi-
gestation, incomplete 
or unrealistic dietary 
intake (<500 or 
>3500kcal/day). 
121-item 
semi-
quantitative 
FFQ 
(validated) 
 
 
100g, 3-hr 
OGTT (2004 
American 
Diabetic 
Association 
criteria)  
Multivariable models, generalized 
linear models using a log-link 
function 
Adjustments: EI, age, race/ethnicity, 
parity, PA, pre-pregnancy BMI, 
dietary fiber, vitamin C, intake red & 
processed meats, saturated fat 
intake.  
Higher eggs and cholesterol 
intake during the pre-pregnancy 
and early pregnancy period were 
associated with a greater GDM 
risk [RR (≥10 eggs/week) = 2.52, 
95% CI: 1.11-5.72; RR (294 vs 
<151 mg/day cholesterol) = 2.35, 
95% CI: 1.35-4.09 respectively]. 
 
Positive, 
79% 
 
Qiu et al. 2011b 
(238) 
To examine the 
associations of 
dietary heme & non-
heme iron with the 
risk of GDM. 
n = 3 158 
Age: 32.7 yrs 
Country: United 
States 
Study: Omega 
Inclusion: pre-natal 
care <20 weeks, >18 
yrs, spoke/read English, 
to deliver at either of 2 
selected hospitals. 
Exclusion: DM, multi-
gestation, incomplete 
or excessive dietary 
intake (<500 or 
>3500kcal/day). 
121-item 
semi-
quantitative 
FFQ 
(validated)  
 
100g, 3-hr 
OGTT (2004 
American 
Diabetic 
Association 
criteria)  
Generalized linear models using a 
log-link function 
Adjustments: EI, age, race/ethnicity, 
parity, PA, pre-pregnancy BMI, 
dietary fiber, vitamin C. 
Higher heme iron intake is 
associated with an increased 
GDM risk [RR = 1.57, 95% CI 
0.95–2.61] when comparing 
highest to quartile. Women who 
reported very high heme iron 
intake (≥1.52 mg/ day) had a 
2.26-fold increased risk (95% CI 
1.09–4.69) of GDM compared 
with women reporting lower 
levels. 
Positive,  
79% 
Radesky et al. 
2008 (245) 
To report results from 
an analysis of diet 
quality & risk of 
abnormal glucose 
tolerance among a 
cohort of women.  
n = 1 733 
Age: 32.2 (4.9) yrs 
Country: United 
States  
Study: Project Viva 
 
Inclusion: <20 weeks, 
singleton pregnancy, 
complete study forms 
in English.  
Exclusion: missing or 
incomplete oral glucose 
tolerance test & diet, 
history of T2DM or 
T2DM, or polycystic 
ovarian syndrome.  
Self-
administere
d Semi-
quantitative 
FFQ 
(validated)  
100g, 3-hr 
OGTT (2004 
American 
Diabetes 
Association 
criteria) 
 
Multinomial regression  
Adjustments: age, pre-pregnancy 
BMI, race/ ethnicity, family history of 
DM, history of GDM. 
Alpha-linolenic acid was 
associated with increased risk for 
GDM [OR = 1.29, 95% CI: 1.04-
1.60) for each 300 mg/day after 
adjustment for confounders & 
other fats. Overall women with 
GDM had higher average n-3 
fatty acid intake, lower n-6/n-3 
ratio, and slightly higher 
polyunsaturated fat intake than 
normo-glycaemic women. 
Neutral, 
81.4%  
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Schoenacker et 
al. 2015 (242) 
To examine the 
associations between 
pre-pregnancy dietary 
patterns & risk of 
GDM. 
n = 3 853 
n pregnancies = 6626 
Age: 28 (1.4) yrs 
Country: Australia 
Study: Australian 
Longitudinal Study on 
Women’s Health 
Inclusion: Australian 
women without pre-
existing DM. 
Exclusion: T2DM or 
T2DM, pregnant with 
their first child in 2003, 
did not report a live 
birth at consecutive 
surveys in 
2006/2009/2012, 
missing data, had GDM, 
unrealistic EI (<2093 or 
>14654kJ/d).  
Questionnai
re 
(validated)  
 
 
75g, 1-hr 
OGTT;   
Self-report 
(1998 
Australasian 
Diabetes in 
Pregnancy 
Society 
criteria) 
 
Generalized estimating equation, 
Log-binomial models or Log-Poisson 
Adjustments: age, EI, parity, 
hypertensive disorders of pregnancy, 
highest education, smoking status, 
PA, BMI, polycystic ovarian 
syndrome. 
No association between fruit & 
low-fat dairy or cooked 
vegetables with GDM risk. 
Mediterranean-style diet 
associated with 15% lower GDM 
risk [RR = 0.85, 95% CI: 0.76-
0.98]. Each SD increase in score 
of the meats, snacks & sweets 
pattern was associated with 41% 
higher GDM risk [RR = 0.59, 95% 
CI:1.03-1.91]. This association 
was no longer statistically 
significant after additional 
adjustment including BMI [RR = 
1.35, 95% CI: 0.98-1.81]. 
Positive, 
42.4% 
Schoenacker et 
al. 2016 (241) 
To determine how 
much pre-pregnancy 
BMI mediates the 
association between 
a pre-pregnancy 
MedDiet & 
development of 
GDM. 
n = 3 378 
Country: Australia 
Study: Australian 
Longitudinal Study on 
Women’s Health 
 
Inclusion: not pregnant 
at baseline and who 
reported ≥1 live birth 
during the 9-y follow-
up. 
Exclusion: women in 
rural or remote areas.  
 
FFQ 
(validated) 
Self-report 
(1998 
Australasian 
Diabetes in 
Pregnancy 
Society 
criteria) 
 
Linear or logistic regression  
Adjustments: education, parity, 
polycystic ovarian syndrome, EI and 
PA. 
BMI contributes 32% to the total 
effects and relationship between 
pre-pregnancy MedDiet and odds 
of GDM [OR = 1.35, 95% CI: 1.02-
1.60].  
Positive,  
84.5% 
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Tobias et al. 
2012 (228) 
To assess usual pre-
pregnancy adherence 
to well-known dietary 
patterns & GDM risk. 
n = 15 254 
Age: 24-44 
Country: United 
States 
Study: NHS II 
Inclusion: singleton 
pregnancy, no GDM 
history, no history of 
DM/cancer/ CVD event. 
Exclusion: pregnancies 
after GDM, pre-
pregnancy FFQ, left >70 
FFQ items blank, or 
reported unrealistic 
total EI (<500 or 
3500kcal/ day). 
Semi-
quantitative 
FFQ 
(validated) 
Medical 
records 
 
Multi-variable marginal logistic 
using Generalized estimating 
equation 
Adjustments: age, EI, race/ethnicity, 
PA, BMI, family history of DM, 
gravidity, smoking status. 
Comparing high to low dietary 
adherence, the risk of GDM was 
24% lower with the alternate 
MedDiet score [RR = 0.76, 95% 
CI: 0.60, 0.95, P-value = 0.004], 
34% lower with the Dietary 
Approaches to Stop Hypertension 
(DASH) score [RR = 0.66, 95% CI 
0.53, 0.82, P-trend = 0.0005], & 
46% lower with the AHEI score 
[RR = 0.54, 95% CI: 0.43- 0.68, P-
trend <0.0001]. 
Positive,  
NA% 
 
Zhang et al. 
2006a (229) 
To examine whether 
pre-gravid dietary 
fiber consumption 
from cereal, fruit, & 
vegetable sources & 
dietary glycemic load 
was related to GDM. 
n = 13 110 
Age: 24-44 
Country: United 
States 
Study: NHS II 
Inclusion: pregnant 
women. 
Exclusion: did not 
complete FFQ in 1991, 
incomplete FFQ, dietary 
intake was unrealistic 
total EI (500 kcal/day or 
3,500 kcal/day), 
multiple gestation or 
history DM/cancer/CVD 
or GDM. 
133-item 
Semi-
quantitative 
FFQ 
(validated) 
Medical 
records 
 
Cox proportional hazards analysis 
Adjustments: parity, age, BMI, 
smoking status, race/ ethnicity, PA, 
family history of DM & dietary 
variables (total fat expressed as % 
energy), cereal fiber, fruit & 
vegetable fiber, alcohol 
consumption, EI & glycaemic load. 
Dietary total fiber & cereal & fruit 
fiber were strongly inversely 
associated with GDM risk. Each 
10g/day increment in total fiber 
intake was associated with 26% 
(RR = 0.74, 95% CI: 0.51-0.91) 
reduction in risk. Each 5g/day 
increment in cereal or fruit fiber 
was associated with a 23% (9 –
36) or 26% (5– 42) reduction 
respectively. 
 
Positive,  
NA%  
 
Zhang et al. 
2006b (230) 
To examine whether 
dietary patterns are 
related to risk of 
GDM.  
n = 13 110 
Age: 24-44 
Country: United 
States 
Study: NHS II 
Inclusion: pregnant 
women 
Exclusion: did not 
complete FFQ in 1991, 
> 9 items blank in FFQ,   
unrealistic total EI (500 
kcal/day or 3,500 
kcal/day), multiple 
gestation. 
133-item 
semi-
quantitative 
FFQ 
(validated) 
Medical 
records 
 
Cox proportional hazards analysis  
Adjustments: parity, age, BMI, 
smoking status, race/ ethnicity, PA, 
family history of diabetes & dietary 
variables including total fat (% 
energy), cereal fiber, alcohol intake, 
total EI & glycaemic load. 
Comparing the highest with the 
lowest quintile of the Western 
pattern scores, RR = 1.63 (95% CI: 
1.20–2.21, P = 0.001) & 
conversely comparing the lowest 
with the highest quintile of the 
prudent pattern scores, RR = 1.39 
(95% CI: 1.08–1.80, P = 0.018).  
Positive, 
NA% 
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Badon et al. 
2016 (234) 
To investigate the 
associations of Leisure 
Time Physical Activity 
(PA) before and during 
pregnancy with GDM risk. 
n = 3 449 
Age: 32.6 (SD 4.4) 
Country: United States 
Study: Omega  
 
Inclusion: >18 yrs, 
speak & read in English 
language, prenatal care 
<20 weeks gestation, 
deliver at allocated 
hospitals. 
Exclusion: Pre-
pregnancy or early 
pregnancy PA of ≥35 
metabolic equivalents 
(MET-hrs/week), 
missing data on PA, had 
prior T1/T2DM.  
Questionnaire 
(Invalidated) 
 
100-g, 3-hr 
OGTT (1997 
American 
Diabetic 
Association 
criteria) 
   
 
Multivariable Poisson regression 
Adjustments: age, race, education, 
marital status, nulliparity, pre-
pregnancy BMI category, gestational 
weight gain, smoking during 
pregnancy, alcohol use during 
pregnancy & year of study 
enrollment. 
Leisure time PA during both 
pre-pregnancy and early 
pregnancy was associated with 
a 46% reduced risk of GDM [RR 
= 0.54, 95% CI: 0.32-0.89] when 
compared with inactivity.  
Neutral,  
NA 
Chasan-Taber 
et al. 2008 
(251) 
To determine whether PA 
during pregnancy reduces 
the risk of GDM in 
Hispanic women. 
n = 1006, (710 for mid-
pregnancy data) 
Age: 16-40 yrs 
Country: United States 
 
Inclusion: age 16-40 
yrs, <24 weeks 
gestation.  
Exclusion: Non-
Hispanic, T2DM, 
hypertension, heart 
disease, chronic renal 
disease, medications 
that influence glucose 
tolerance, multi-
gestation & previous 
participation in the 
study. 
 
 
 
 
 
 
 
Kaiser PA 
Survey & 
Pregnancy PA 
Questionnaire 
(validated in a 
pregnant 
population)  
 
 
100g, 3-hr 
OGTT (2004 
American 
Diabetic 
Association 
criteria), 
medical 
records 
Logistic regression  
Adjustments: age & BMI. 
Higher levels of household/ 
caregiving activity in early (OR = 
0.2, 95% CI: 0.1-0.8, P-trend = 
0.03) & mid-pregnancy (OR = 
0.2, 95% CI: 0.1-0.8, P-trend = 
0.004) were associated with a 
reduced risk of GDM. Higher 
level of total PA was also 
associated with reduced odds 
of GDM (OR = 0.4, 95% CI: 0.1-
1.2, P-trend = 0.06). 
Positive, 
81.7% 
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Chasan-Taber 
et al. 2014 
(250) 
To examine the 
relationship between PA 
during pre, early & mid 
pregnancy & risk of 
abnormal glucose 
tolerance & GDM. 
n = 1241 
Age: 16-40 yrs 
Country: United States 
Study: Proyecto Buena 
Salud 
Inclusion: born in the 
Caribbean Islands or 
had a parent or ≥2 
grand-parents born in 
the Caribbean Islands.  
Exclusion: history of 
DM/hypertension/heart 
or renal disease, <16 or 
>40 yrs old, multi- 
gestation or 
medications that 
influence glucose 
tolerance. 
Pregnancy PA 
Questionnaire 
(validated in 
pregnant 
women) 
100g, 3-hr 
OGTT (2004 
American 
Diabetic 
Association 
criteria); 
medical 
records 
Logistic regression  
Adjustments: age, BMI, gestational 
weight gain, education level, 
generation in the United States.  
Women in the top quartile of 
moderate intensity PA in early 
pregnancy had a 52% 
decreased risk of abnormal 
glucose result when compared 
to the lowest quartile [OR = 
0.48, 95% CI: 0.27-0.88, P-trend 
= 0.03] 
Positive, 
76.3% 
Currie et al. 
2014 (254) 
To examine if physical 
activity in the year pre- 
pregnancy & in the first 
half of pregnancy is 
associated with maternal 
& neonatal outcomes. 
n = 1 749 
Age: 31 (mean) 
Country: Canada 
Exclusion: >20 weeks 
gestation, pre-existing 
DM, early pregnancy 
loss or pregnancy 
termination, any 
missing information, 
contraindications to PA 
present before 20 
weeks gestation. 
Kaiser PA 
Survey 
(validated in 
pregnant 
women) 
50g, 1-hr 
GCT or 100g 
1 & 2-hr 
OGTT, 
Medical 
records 
Logistic regression 
Adjustments: age, pre-pregnancy 
BMI, education, parity, & history of 
GDM. 
Relative to the lowest tertile of 
pre-pregnancy household PA, 
women in the middle & the 
highest tertiles were at 
decreased risk of GDM [OR = 
0.29, 95% CI: 0.12 – 0.74 & OR 
= 0.33, 95% CI: 0.12 - 0.88] 
respectively, albeit statistically 
insignificant.  
Positive, 
79.5% 
Dempsey et 
al. 2004 (235) 
To examine the 
relationship between 
recreational PA before & 
during pregnancy & risk 
of GDM. 
n = 909 
Country: United States 
Study: Omega  
Inclusion: <16 weeks 
gestation 
Exclusion: <18 yrs, did 
not speak/read English, 
did not carry to term, if 
they did not plan to 
deliver at the selected 
hospitals.  
Questionnaire 
(Invalidated) 
 
100-g, 3-hr 
OGTT (1997 
American 
Diabetes 
Association 
criteria), 
Medical 
records 
Generalized linear models using a 
log-link function 
Adjustments: maternal age, race, 
parity, & pre-pregnancy BMI. 
Compared with those who 
were inactive, women who 
participated in any recreational 
PA in the pre-pregnancy period, 
had a 56 % GDM risk reduction 
(RR = 0.44, 95% CI: 0.21 - 0.91). 
Women who engaged in PA 
before & during pregnancy had 
a 69% GDM reduced risk (RR = 
0.31, 95% CI: 0.12, 0.79). 
Positive, 
90.9% 
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Dye et al. 
1997 (247) 
To determine whether 
exercise has a preventive 
role in the development 
of GDM in women living 
in central New York State 
on a population-based 
birth registry. 
n = 12 799 
Country: United States 
 
 
Inclusion: women that 
delivered a livebirth 
within the New York 
State between 
1/10/1995-31/07/1996. 
Exclusion: conditions 
that affect exercise (e.g. 
heart disease, multi-
gestation, incompetent 
cervix, previous 
preterm delivery & low 
birth weight infant & 
chronic hypertension).   
 
Personal 
interview 
Medical 
records 
Chi-square statistics, Logistic 
regression 
Adjustments: age, race, parity, pre-
pregnancy BMI, gestational weight 
gain & insurance coverage.  
When stratified by pre-
pregnancy BMI category, 
exercise was associated with 
reduced rates of GDM only 
among women with a BMI >33 
[OR = 1.9, 95% CI: 1.2-3.1]. 
Positive, 
89.1% 
Iqbal et al. 
2007 (255) 
To identify lifestyle 
predictors of GDM in 
South Asian women.  
n = 611 
Age: 29.4 (4.7) 
Country: Canada 
 
Inclusion: women of 
South Asian origin, ≤18 
weeks of gestation & 
did not have known 
diabetes. 
Exclusion: missing data, 
terminating a 
pregnancy, refusing 
oral glucose tolerance 
test.  
Interviewer 
administered 
Monitoring 
Trends & 
Determinants 
of 
Cardiovascula
r Disease 
(Monica) 
Optional 
Study of PA, 
(Validated)  
 
 
 
 
 
 
100g, 3-hr 
OGTT (2004 
American 
Diabetic 
Association 
criteria) 
Logistic regression  
Adjustments: age, family history of 
DM, education, height, parity BMI, 
PA level (kcal/day) & rate of weight 
gain/week.  
Increase in PA (100 kcal), 
decreased the risk of GDM by 
11% [OR = 0.89, 95% CI: 0.79-
0.99]. 
Positive, 
81.6% 
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Morkrid et al. 
2007 (256) 
To assess the association 
between objectively 
recorded PA in early 
gestation & GDM 
identified at multiethnic 
cohort.  
n = 759 
Age: 29.9 (4.4) 
Country: Norway 
Study: Stork Groruddalen 
Study 
Inclusion: lived in one 
of the selected districts, 
to give birth in one of 
the 2 selected 
hospitals, <20 weeks 
gestation, could speak 
one of the 9 listed 
languages & to provide 
written consent.   
Exclusion: known 
diabetes or other 
diseases requiring 
frequent hospital visits.  
Questionnaire 
(validated) 
75g, 2-hr 
OGTT 
(amended 
2010 
Internationa
l Association 
of Diabetes 
& 
Pregnancy 
Study Group 
criteria) 
 
 
 
Logistic regression 
Adjustments: ethnic origin, weeks 
gestation, age, parity, & pre-
pregnancy BMI. 
 
 
Significant associations 
between the following 3 
components GDM risk: 
objectively recorded steps/day 
in early gestation [OR = 0.79, 
95% CI: 0.65 –0.97], self-
reported regular PA before 
pregnancy [OR = 0.66, 95% CI 
0.46-0.94] & self-reported 
aerobic PA ≥ 150 min/week 3 
months before pregnancy [OR = 
0.69, 95% CI: 0.49-0.97].  
Positive, 
92.2% 
Oken et al. 
2006 (244) 
To examine the 
associations of PA & 
television viewing before 
& during pregnancy, with 
risk for GDM & abnormal 
glucose tolerance. 
n = 1 805 
Age: 32.1 (5.0) 
Country: United States 
Study:  Project Viva 
 
 
 
 
 
 
 
Exclusion: history of 
T1DM or type 2 
diabetes no 
measurement of 
blood glucose levels 
during pregnancy, no 
data on PA or TV 
viewing, no records of 
pre-pregnancy BMI.   
Questionnaire
; modified 
from the 
leisure time 
activity 
section of the 
PA Scale for 
the Elderly 
(validated on 
an elderly 
population).  
 
 
 
 
 
 
 
100g, 3-hr 
OGTT (2004 
American 
Diabetic 
Association 
criteria) 
Logistic regression Adjustments: age, 
race/ethnicity, pre-pregnancy BMI, 
history of GDM in a previous 
pregnancy, & mother’s history of 
DM. 
Vigorous activity during the 
year before pregnancy reduced 
the risk of GDM by 44% [OR = 
0.56, 95% CI: 0.33-0.95]. 
Vigorous activity before 
pregnancy & light-to-moderate 
or vigorous activity during 
pregnancy appeared to reduce 
the risk of GDM [OR = 0.49, 
95% CI: 0.24-1.01]. 
Positive, 
84.8% 
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Putnam et al. 
2013 (248) 
To determine association 
between daily physical 
activity & pregnancy & 
neonatal outcomes in 
stay at home military 
wives. 
n = 190 
Age: 28.3 (5.5) 
Country: United States 
 
Inclusion: unemployed, 
married to an active-
duty or reserve service 
member, aims to 
complete prenatal care 
& delivery within the 
specified medical 
facility.  
Exclusion: preexisting 
hypertension/ DM or 
thrombophilia, multiple 
gestation, or history of 
preterm delivery.  
 
Validated 
questionnaire 
describing 
their 
domestic PA 
on a typical 
day during 
the previous 4 
weeks (1st 
trimester).  
 
100g, 3-hr 
OGTT, no 
further 
information 
Logistic regression Adjustments: 
maternal BMI at first visit & delivery, 
number of children at home, 
gravidity, & parity. 
Highest incidence rate of GDM 
occurred in the group with the 
least average daily energy 
expenditure (P = 0.025). 
Positive, 
NA% 
Rudra et al. 
2006 (239) 
To examine the relation 
between perceived 
exertion & GDM within 
sub-groups of women 
categorize by energy 
expenditure.  
n = 897 
Country: United States 
Study: Omega 
 
 
Inclusion: women who 
initiated prenatal care 
before 16 weeks 
gestation. 
Exclusion: <18 yrs, did 
not speak/read English, 
did not plan to carry 
the pregnancy to term, 
or did not plan to 
deliver at either of the 
specified hospitals. 
Stanford 7-
Day PA Recall 
& the 
Minnesot 
Leisure-Time 
PA 
Questionnaire
, (validated 
among men & 
non-pregnant 
women). 
Medical 
records 
 
Logistic regression models 
Adjustments: age, race/ethnicity pre- 
pregnancy hypertension, nulliparity, 
& pre-pregnancy BMI.  
Women reporting strenuous & 
very strenuous maximal 
exertion had 37% [OR = 0.63, 
95% CI: 0.31-1.29] & 43% [OR = 
0.57, 95% CI: 0.24-1.37] lower 
risk of GDM respectively, when 
compared with negligible-
moderate exertion. Women 
reporting ≥15.0 MET-
hours/week experienced 86% 
GDM risk reduction when 
compared to inactive women 
[OR = 0.14, 95% CI: 0.05-0.38].  
 
 
 
 
 
 
Neutral, 
89.7% 
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Solomon et al. 
1997 (227) 
To assess whether 
recognized determinants 
of NIDDM may also be 
markers for increased risk 
of GDM. 
n = 14 613 
Age: 25-42 yrs 
Country: United States 
Study: NHS II 
Inclusion: no history of 
GDM or diabetes, 
singleton pregnancy 
between 1990 & 1994, 
pregnancy lasting >6 
months. 
Exclusion: multiple 
pregnancy. 
PA (1989) - 
assessed as 
average MET 
expenditures. 
In 1991 - 
women were 
questioned 
about the 
number of 
times /week 
they engaged 
in PA to 
perspire 
heavily. 
 
Medical 
records 
Logistic regression 
Adjustments: age, BMI & parity.  
No association between total 
MET score in 1989 & 
subsequent GDM risk. GDM risk 
appeared slightly lower with 
frequent participation in 
vigorous PA, albeit statistically 
insignificant [RR(≥4/week) = 
0.78, 95% CI: 0.47-1.29]. 
 
 
 
Neutral, 
NA% 
Van der Ploeg 
et al. 2011 
(243) 
To examine the 
relationships between 
PA, sedentary behavior & 
the development of GDM 
n = 3 529 
Age: 24-34 yrs 
Country: Australia 
Study: Australian 
Longitudinal Study on 
Women’s Health 
Inclusion: Women in 
Australia. 
Exclusion: T1DM, type 
2 diabetes were 
pregnant at the second 
survey, were pregnant 
with their first child at 
the third survey or did 
not have a live-birth 
between survey 2 & 3. 
Australian 
Longitudinal 
Study on 
Women’s 
Health 
modification 
of the 7-day 
recall Active 
Australia 
questionnaire, 
non-validated 
 
 
 
 
 
75 g, 2-hr 
OGTT, self-
reported 
(1998 
Australasian 
Diabetes in 
Pregnancy 
Society 
criteria).  
Generalized estimating equations 
Adjustments: EI, overweight & 
obesity, age, BMI, parity, age at birth 
of first child, country of birth, & 
education. 
Neither total PA nor sedentary 
behavior were associated with 
the risk of GDM. Analyses for 
self-reported vigorous PA 
showed no significant 
relationships with the 
development of GDM, with 
OR=1.23 [95% CI 0.83-1.81] & 
OR=0.95 [95% CI 0.62-1.46] for 
1–90 min/week & >90 
min/week, respectively. 
Neutral,  
S2: 82.0% 
S3: 75.3% 
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Zhang et al. 
2006c (231) 
To assess whether the 
amount, type, & intensity 
of pre-gravid PA & 
sedentary behaviors are 
associated with GDM risk. 
n = 21 765 
Age: 24-44 yrs 
Country: United States 
Study: NHS II 
 
Inclusion: singleton 
pregnancy lasting 6 
months or longer. 
Exclusion: history of 
GDM/diabetes/cancer 
or cardiovascular 
disease, were pregnant 
in 1989 questionnaire, 
no PA data, multiple 
gestation.  
 
Questionnaire 
(validated) 
Medical 
records 
Cox proportional hazards analysis 
Adjustments: parity, nulliparous 
women, age, smoking status, race or 
ethnicity, family history of diabetes & 
dietary variables (total fat, % energy, 
cereal fiber, alcohol, GI, total EI) & 
BMI. 
Highest quintile of vigorous PA 
significantly reduced the risk of 
GDM by 23%, when compared 
to the lowest quintile [RR=0.77, 
95% CI 0.69-0.94, P-
trend=0.002]. 
 
Positive 
69.8% 
Abbreviations: AHEI-2010 – Alternative Healthy Eating Index – 2010, BMI – Body mass index, CHO – Carbohydrates, CIs – confidence intervals, CVD – Cardiovascular Disease, DM – Diabetes Mellitus, EI – Energy Intake, FFQ – food frequency 
questionnaire, GCT – Glucose Challenge Test, GDM – gestational diabetes mellitus, GI – Glycemic index MedDiet – Mediterranean Diet, MET - metabolic equivalent, NA – Not Available, NHS I/II – Nurse’s Health Study I or II, NIDDM – non-insulin 
dependent diabetes mellitus, OGTT – Oral Glucose Tolerance Test, OR – odds ratio, PA – physical activity, RCT – randomised controlled trial, RR – relative risk, SD – Standard Deviation, SE – Standard Error, SES – socioeconomic status, SSB – Sugar 
sweetened beverage, T1/T2DM – Type 1 or Type 2 Diabetes Mellitus,  
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2.3.3   Diet Related Studies 
To account for the diversity of 25 dietary studies identified after inclusion, we categorised them into 
one of seven themes: carbohydrates, fat intake, protein, fast food intake, caffeine, calcium intake 
and commonly recognised dietary patterns. The predominating dietary collection method was a 
validated Food Frequency Questionnaire (FFQ) (n = 23) (219-226, 228-230, 236-238, 240-242, 252, 
257, 258). The remaining two studies used a rapid food screener (246) and an interview (253) to 
collect dietary data. Studies focusing on early pregnancy collected dietary data <22 weeks into 
pregnancy. When studies reporting on diet and PA were compared with respect to adjusted 
confounding variables (Figure 2.2), we observed that age, BMI and parity were most common in 
both. Only 70% of diet related and 10% PA studies adjusted for energy intake.  
 
Figure 2.2.  Confounding variables that were adjusted for in studies collecting information 
on dietary intake (white bars) and physical activity levels (blue bars). Age, BMI 
and parity were most commonly adjusted confounding variables in 
observational studies reporting on either diet or physical activity. 
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2.3.3.1  Carbohydrates (Fruit, Fiber, Beverages, Potato) 
Five studies reported on high carbohydrate foods, including fruit, fiber, potato and beverage intake 
and their respective associations to GDM risk (221, 222, 225, 226, 229). High pre-pregnancy fruit 
intake was not associated with an increase in GDM risk (RR high vs low intake = 0.93, 95% CI: 0.76 - 
1.16) (226), however fruit fiber (229) was reported to be protective (RR fruit fiber = 0.66, 95% CI: 
0.51 - 0.86). Although high compared to low apple intake suggested non-significant protection from 
GDM risk (RR apple = 0.81, 95% CI: 0.65 - 1.01), the overall trend across quintiles of apple 
consumption reached statistical significance (P-trend <0.05) (226). Protective effects were also 
evident when consumption of total dietary fiber and cereal fiber were examined (RR total fiber = 
0.67, 95% CI: 0.51 - 0.90; RR cereal fiber = 0.76, 95% CI: 0.59 -0.99) (229).  
Higher frequency of potato intake increased the risk of GDM (RR high vs low frequency intake = 1.62, 
95% CI: 1.24 - 2.13) (222). However, frequent consumers of potato tended to be current smokers, 
had higher BMI and lower diet quality as assessed by the Alternate Healthy Eating Index (AHEI) 2010 
score (222). In contrast, a study by Karamanos and colleagues found that women who went on to 
develop GDM consumed less potatoes and cereals than those that did not develop it (258). Replacing 
two servings of potatoes per week for other vegetables types, legumes or wholegrain foods resulted 
in a 9%, 10% and 17% GDM risk reduction, respectively (222). No significant association was observed 
between potato crisps or corn chips and GDM risk after adjustment of confounding variables 
including age, parity, race, family history of diabetes, smoking, PA, energy intake, diet quality and 
BMI (222). 
The relationship between 100% fruit juice consumption and GDM onset was nonlinear, with the 
lowest risk observed in women with moderate fruit juice intake (226). In contrast, higher sugar 
sweetened beverage (SSB) intake was associated with GDM risk (RR ≥5 week = 1.23, 95% CI: 1.05 - 
1.45, P-value = 0.005) (225). When different sub-types of SSB were taken into account, the strongest 
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association was observed for sugar sweetened cola (RR high vs low intake = 1.29, 95% CI: 1.07 - 1.55) 
but not for non-cola SSB (RR high vs low = 0.99, 95% CI: 0.78 - 1.25) (225).  
 
2.3.3.2  Fat Intake (i.e. Total, Monounsaturated Fatty Acids, 
Dietary Cholesterol, Egg Intake) 
Higher intake of animal, cholesterol and monounsaturated fatty acids (MUFA) were significantly 
associated with increased risk of GDM (224). When comparing highest to lowest quintile of animal 
fat intake (%EI), the risk increased by ~90% (RR = 1.88, 95% CI: 1.36 - 2.60) (224). Similarly, a 
comparison between the highest and lowest quintile of cholesterol intake elucidated a positive 
relationship with GDM risk (RR = 2.35, 95% CI: 1.35, 4.09). On the contrary, Baptise-Roberts and 
colleagues reported no association between either cholesterol or total fat intake with a high glucose 
response following a glucose challenge test (246).  
While no associations were observed between total omega-3 or total omega-6 fatty acids and risk of 
GDM in one study (224), another noted that women who developed GDM had a lower n-6/n-3 ratio, 
a higher intake of n-3 fatty acid and polyunsaturated fats than their non-GDM counterparts (245). 
Each 300 mg/day intake of alpha-linolenic acid, was associated with an increased risk for GDM, with 
an OR = 1.29 (95% CI: 1.04 - 1.60) (245). Karamanos and colleagues reported that olive oil was 
consumed in higher quantities in women who went on to develop GDM compared to those that did 
not (258), however no association analysis was presented (258). With regards to egg consumption, 
one study suggested that high intakes increased the risk of GDM by a 1.77 fold (237), while another 
found no such association (219). 
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2.3.4.3  Protein Intake (i.e. Meat, Iron, Heme) 
Bao and colleagues reported that an intake of protein from animal origin increased the risk of  GDM 
by ~50%, whereas an intake of protein sourced from vegetables was protective by 30% (219). 
Similarly, a low carbohydrate dietary pattern with high animal protein and animal content was 
associated with a 36% increase risk of GDM, whereas a low carbohydrate diet containing high intake 
of plant-sourced protein and fat was not associated with any increased risk (220). Replacing 5% 
energy of animal protein for protein of plant origin reduced GDM risk by 51% (219).  
Neither a high meat score before pregnancy calculated using The Rapid Food Screener (246) or a high 
red meat intake in early pregnancy (245) were able to predict GDM risk in the two studies. On the 
contrary, three studies concluded that women with a high pre-pregnancy red meat intake had 
between 1.4-2.0 times the risk of developing GDM (219, 230, 242). There are similar inconsistent 
findings for processed meat intake and GDM risk. Two studies reported a statistically significant 
increased risk for GDM, ranging between 48-68% during the pre-pregnancy period (219, 230), 
whereas the remaining study found no such association (245). A positive relationship was observed 
between higher pre-pregnancy iron or heme intake and GDM (223, 238). While Behboudi-Gandevani 
and collegues (252) observed no statistically significant differences in iron or zinc intake in women 
with or without GDM, women with GDM did have a statistically significant higher serum iron level in 
early pregnancy. 
 
2.3.3.4  Caffeine 
Two studies (233, 253) reported on caffeine intake and risk of GDM. Whilst both captured caffeine 
intake during the pre-pregnancy period, Hinckle and colleagues additionally looked at tea intake 
(253). Coffee consumption was reported to have a protective affect against GDM in one study [RR = 
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0.48 (95% CI: 0.28 - 0.82)] (233), but failed to reach a statistical significance in the other (RR ≥8 vs 0 
cups/day = 0.89, 95% CI: 0.64 - 1.25) (253). Consumption of decaffinated coffee was not associated 
with risk reduction (233). Increasing frequency of tea intake indicated a potential protective effect 
against GDM risk, albeit statistically insignificant (RR ≥8 vs 0 cups/day = 0.77, 95% CI: 0.55 - 1.0) (253).  
 
2.3.3.5  Fast Food Intake 
Increasing frequency of fast food intake prior to pregnancy was associated with a statistically 
significant increased risk (221) or incidence (257) of GDM. The reported RR for ≥7/week vs <1/week 
= 2.18, 95% CI: 1.53 - 3.09) (221) and Odds Ratio (OR) for highest vs lowest frequency intake = 1.86, 
95% CI: 1.13 - 3.06) (257). Women with greater fast food consumption were typically younger, 
current smokers, multiparous, less physically active and followed diets that were either less adherent 
to the Mediterranean Diet (MedDiet) pattern (257) or had an overall lower AHEI-2010 diet quality 
score (221).      
 
2.3.4.6  Calcium/Dairy Intake 
Total pre-pregnancy dairy intake was not associated with risk of GDM (219, 236). Habitual maternal 
intake of low-fat dairy suggested a non-significant inverse association with GDM risk (RR highest vs 
lowest quintile = 0.57, 95% CI: 0.32 - 1.02) (236), however the overall trend across quartiles of low-
fat dairy intake reached statistical significance (P-trend <0.05). Interestingly, Schoenacker and 
colleagues (2015) observed fruit and low-fat dairy as a dietary pattern but found no association with 
GDM risk (242). With respect to calcium intake, an inverse association with GDM risk was observed, 
albeit statistically insignificant (236). When quintiles were grouped into higher vs lower level of 
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intake, women who consumed ≥795 mg Calcium/day had a 42% GDM risk reduction when compared 
to those who had <795mg/day (236).  
 
2.3.4.7  Recognised Dietary Patterns 
MedDiet was the most consistently reported protective dietary pattern against GDM risk, reaching 
statistical significant in all four studies (228, 241, 242, 258). In a comprehensive review by Radd-
Vagenas, MedDiet is defined as a diet containing higher bread, cereal, legume, vegetable, fruit, fish 
and olive oil intake and smaller or limited intake of animal fat, meat and eggs (261). The extent of 
MedDiet protectiveness ranged from 15-38%. Although women with better MedDiet compliance had 
lower incidence of GDM than their non-compliant counterparts, Karamanos and colleagues reported 
that GDM incidence greatly differed when comparing ADA and IADPSG diagnostic criteria between 
the compliant groups (8% vs 24%, respectively) (258).  
Adherence to a diet with a high AHEI 2010 score was associated with a reduced risk of GDM by 19% 
(232) or 46% (228). When additional lifestyle factors were taken into account such as regular PA, 
normal BMI, non-smoker, the association with risk reduction was 83% (232). Similarly to the AHEI 
scoring system, some studies used an Australian Recommended Food Score (ARFS) (240) or Dietary 
Approaches to Stop Hypertension (DASH) score (228). A high ARFS was not associated with GDM risk 
(240), whereas a greater DASH diet compliance was associated with a 34% GDM risk reduction (228). 
With respect to Prudent and Western diets, there were some conflicting results. Whilst compliance 
to a Prudent or Western diet resulted in a negative and positive association with GDM risk 
respectively in one study (230), a second study observed no such relationships (245).   
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2.3.5   Physical Activity  
The relationship between PA and risk of GDM was examined by 17 publications, including the Nurse’s 
Health Study II (NHS II, n = 3), OMEGA Study (n = 3), Projecta VIVA (n = 1), the Australian Longitudinal 
Study on Women's Health (n = 1). Data collection methods included interviews (n = 2), questionnaires 
(n = 14, of which 12 were validated) and a self-report (n = 1, also validated). PA levels were captured 
during the pre-pregnancy (n = 10) and early pregnancy (n = 9) stages.  
Overall, PA was reported to be protective against GDM in 13 of 17 studies and the degree of 
protection generally increased with greater levels of PA. Eleven studies reported that PA before 
pregnancy was beneficially associated with reduced risk by 22-86% (231, 232, 234, 235, 239, 244, 
246, 251, 256), with only two studies not reaching statistical significance (227, 254). The degree of 
potential protection depended on type and duration of PA. Similarly, ten studies that assessed early 
pregnancy PA levels also reported a reduction in GDM risk with higher PA, ranging between 11-52%, 
however two studies not reaching statistical significance (235, 243). When both pre-pregnancy and 
early pregnancy PA levels were taken into account, there was an even lower risk of GDM observed 
(RR = 0.31, 95% CI: 0.12 - 0.79) (235).  
The most apparent associations between PA and GDM risk were observed in 13 studies reporting on 
Leisure Time PA (LTPA). Of these, ten reported a significant reduction in GDM risk (231, 232, 234, 
235, 239, 244, 246, 250, 255, 256). Two studies that examined LTPA volumes, suggested ≥150 
min/week (256) or ≥ 210 min/week (232) as being sufficient to reduce the risk of GDM. Higher leisure 
activity score (246) before pregnancy was associated with a 68% reduced risk of a high 1-hr glucose 
challenge test. In terms of intensity-weighted PA volume (Metabolic Equivalent (MET) hours/week), 
the beneficial association of PA in the year before pregnancy were observed at ≥ 15 (239) or ≥ 21 
MET hours/week (235). Solomon et al. (227) and Van der Ploeg et al. (243) suggested a lower GDM 
risk with higher frequency and volume of vigorous PA, but this association did not reach statistical 
significance. In contrast, one study (247) reported that LTPA was associated with reduced rates of 
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GDM only among women in the obese pre-pregnancy BMI category. Engaging in LTPA (234) before 
and during pregnanacy was associated with a 46% GDM risk reduction.  
The three studies that reported on total PA levels suggested that higher total PA volume (251, 256) 
or score (254) was associated with lower risk of GDM (251, 254, 256), although one did not reach 
significance (254) and another was borderline statistically significant (251). Two studies suggested 
that higher domestic (e.g. child and elderly caregiving, meal preparation, cleaning, shopping, 
gardening) PA levels were associated with lower risk of GDM (251, 254), although one did not reach 
statistical significance (254). Putman and colleagues observed that GDM risk was highest among 
women with the least average daily energy expenditure (≤2200 kcal) (248).  
 
2.3.5.1  Meta-analysis and Assessment of Bias  
Of 17 PA studies, 16 were suitable for meta-analyses (227, 231, 232, 234, 235, 239, 243, 244, 246-
248, 250, 251, 254-256) as they reported associations with sufficient statistical evidence. We were 
able to test a priori different indicators of PA and results were consistent. Engaging in any type of PA 
compared to none during the pre-pregnancy period was associated with approximately 30% reduced 
odds of GDM (OR = 0.70, 95% CI = 0.57 - 0.85; I² = 52% (medium), P-value = 0.0006), whereas engaging 
in any PA early in pregnancy suggested reduced odds of GDM by 21% (OR = 0.79, 95% CI = 0.64 - 
0.97, I² = 26% (low), P-value = 0.03) as evident in Figure 2.3. Taking part in any LTPA compared to 
none either before (OR = 0.65, 95% CI = 0.43 - 1.00; I² = 90% (high), P-value = 0.05) or during early 
pregnancy (OR = 0.69, 95% CI = 0.50 - 0.96; I² = 15% (low), P-value = 0.03) suggested a beneficial 
association with GDM (Figure 2.4), with the prior not achieving statistical level of significance. 
When comparing the studies reporting pre-pregnancy LTPA in MET.hr/week, our analysis suggested 
that >15 MET.hr/week was associated with 48% reduced odds of GDM (OR = 0.52, 95% CI = 0.27 - 
1.00; I² = 95%, P-value = 0.05) (Figure 2.5). Taking part in approximately >90 min/week in LTPA before 
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pregnancy was associated with 46% reduced odds of GDM (OR = 0.54, 95% CI = 0.34 - 0.87; I² = 70% 
(medium), P-value = 0.01) (Figure 2.6). It was not possible to perform a meta-analysis for the early 
pregnancy period for any LTPA indicator due to insufficient number of studies.  
Tests revealed a variable degree of heterogeneity ranging from 15-95%. Based on an almost 
symmetrical distribution of data points in funnel plots Figure 7A (n studies = 10, z = -1.52, p = 0.13) 
and 7B (n studies = 10, z = -0.65, p = 0.52), there was no evidence of publication bias. Remaining 
funnel plots are presented in supplementary materials section as they contained <10 studies in their 
analyses. This includes the following figures found in the Appendix section of this thesis Figure A1a 
(n studies = 9, z = -1.90, p = 0.06) with some symmetry present and Figure A1b (n studies = 6, z = -
2.96, p = 0.003) and Figure A1c (n studies = 4, z = -2.34, p = 0.02) suggesting presence of asymmetry 
and potentially publication bias.  The raw values of back-transformed natural log ORs are shown in 
the Appendix section of this thesis in Table A1.  
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3A.) 
 
3B.) 
Figure 2.3. Meta-analysis of participation in any physical activity (PA) versus none and odds of 
gestational diabetes (GDM). Estimates are expressed as odds ratios (OR) with their corresponding 
95% confidence intervals, however x-axis uses lnOR scale. A.) Engaging in any PA before pregnancy 
suggested 30% reduced odds of GDM (OR = 0.70, 95% CI = 0.57 - 0.85; I² = 52% (Medium), P-value = 
0.0006). B.) Engaging in any PA during early pregnancy suggested 21% lower odds of GDM (OR = 0.79, 
95% CI = 0.64 - 0.97, I² = 26% (low), P-value = 0.03). 
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4A.) 
 
4B.) 
Figure 2.4. Meta-analysis of participation in high versus low level of leisure time physical activity 
(LTPA) and odds of gestational diabetes (GDM). Estimates are expressed as odds ratios (OR) with their 
corresponding 95% confidence intervals, however x-axis uses lnOR scale. A.) Engaging in any LTPA 
before pregnancy suggested possible reduced odds of GDM (OR = 0.65, 95% CI = 0.43 - 1.00; I² = 90% 
(high), P-value = 0.05). B.) Engaging in any LTPA during early pregnancy suggests reduced odds of 
GDM (OR = 0.69, 95% CI = 0.50 - 0.96; I² = 15% (low), P-value = 0.03). 
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Figure 2.5. Meta-analysis of participation in high versus low level of leisure time physical activity 
(LTPA) before pregnancy in metabolic equivalents (MET.hr/week) and odds of gestational diabetes 
(GDM). Estimates are expressed as odds ratios (OR) with their corresponding 95% confidence 
intervals, however x-axis uses lnOR scale. Taking part in ~ >15 MET.hr/week suggested 52% reduced 
odds of GDM (OR = 0.52, 95% CI = 0.27 - 1.00; I² = 95%, P-value = 0.05). Due to insufficient number of 
studies reporting on LTPA in MET.hr/week in early pregnancy, a meta-analysis could not have been 
performed. 
 
 
Figure 2.6. Meta-analysis of high versus low level of leisure time physical activity (LTPA) before 
pregnancy reported in hr/week and odds of gestational diabetes (GDM). Estimates are expressed as 
odds ratios (OR) with their corresponding 95% confidence intervals, however x-axis uses lnOR scale. 
Longer hours (>90 min/week) of LTPA/week reduced the odds of GDM by 46% (OR = 0.54, 95% CI = 
0.34 - 0.87; I² = 70% (medium), P-value = 0.01). Due to insufficient number of studies reporting on 
LTPA in hr/week in early pregnancy, a meta-analysis could not have been performed. 
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           A.) 
 
B.) 
Figure 2.7. Assessing the risk of publication bias using funnel plots for different meta-analyses. A.) 
Any type pre-pregnancy physical activity (PA) versus none (n studies = 10, z = -1.52, p = 0.13). B.) Pre-
pregnancy leisure time PA (LTPA), comparing high versus none regardless of units reported (n studies 
= 10, z = -0.65, p = 0.52) Due to insufficient number of studies reporting on early pregnancy period, a 
funnel plot could not have been performed for some meta-analyses. 
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2.4  Discussion 
The present systematic review identified 40 studies reporting on the relationship between diet or PA 
and subsequent risk of GDM. It is the first review to examine a range of specific dietary factors and 
indicators of PA, with a view to shedding light on the relative importance of these crucial lifestyle 
health behavior factors. We identified more observational studies than previous reviews (262, 263), 
including those that additionally reported on PA levels, thereby providing a more comprehensive 
overview of lifestyle factors involved in the development of GDM. In addition, we visually depicted 
different types of confounding variables that were adjusted for in each individual study (Figure 2). 
While age, BMI and parity topped the list, we discovered that only one-in-three dietary studies 
adjusted for energy intake. This raises concerns about interpretation of data as many nutrients are 
associated with energy intake (264).  
 
2.4.1  Diet and GDM Risk 
Our present study investigated consumption of different types of beverages including fruit juice, SSB, 
coffee and tea intake in relation to GDM risk. While coffee consumption appeared to be protective 
against GDM in one study, SSB consumption resulted in a statistically significant positive association. 
There are now concerns over excessive SSB intake, particularly due to the reported association with 
obesity and risk of chronic diseases (265). At the population level, there has been a decline in the 
overall SSB intake in several countries (265-267) over the same time frame, but there may be 
segments of the population such as young adults who continue to consume SSB in high amounts 
(268). Added sugars from SSB are likely to be part of a poorer quality diet and lifestyle (269). In one 
study (225), women with higher intake of SSB tended to have a diet lower in total dietary fiber, fruits 
and vegetables prompting the need to focus on a dietary pattern and quality in understanding any 
associations with GDM risk. 
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In particular, several studies from our literature search indicate that a MedDiet may be protective 
and possibly reduce the risk of GDM by 15-38%. The protective association may extend to reducing 
future risk of type 2 diabetes (by 19-23%), increasing chance of remission (by 49%) (270) and 
protection against cardiovascular diseases with extra virgin olive oil and plant-based dietary 
components in the diet (261). There are however, drawbacks in defining what specifically constitutes 
a ‘traditional’ MedDiet due to variability among different regions of the Mediterranean. At present, 
a ‘traditional’ MedDiet is characterized by larger quantities of fruits, vegetables, legumes, nuts, 
unprocessed cereals and grains, extra virgin olive oil, moderate fish and wine and small amount of 
meat intake with low amounts of discretionary foods (261). High red or processed meat consumption 
before pregnancy was associated with an increased risk of GDM. In fact, two meta-analyses 
conducted in a healthy adult population found that processed meat intake was associated with a 
greater risk of coronary heart disease (42%) and type 2 diabetes (19-32%) (271, 272). The proposed 
mechanism of coronary heart disease and type 2 diabetes onset include excess sodium and oxidative 
stress due to high levels of iron and advanced glycation end products (272) but warrants further 
discussion. Given the traditional MedDiet is low in meat consumption, this could be one of the 
reasons why the diet persistently provides health benefits across different age groups and stages of 
life.  
The risk of GDM in an Australian population following a MedDiet was partly (32%) mediated by pre-
pregnancy BMI (241). While it cannot be denied that MedDiet provides multiple health benefits, the 
extent to which BMI explains the association with GDM comes as no surprise as obesity promotes 
insulin resistance (273). In fact, a study by Janssen et al. (274) reported significant changes in insulin 
and leptin levels in the first trimester of women with a high BMI that was comparable to that of 
women with a normal BMI in the third trimester. This has enormous implications not only for 
maternal metabolism but also for fetal growth trajectory (274).    
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2.4.2  Physical Activity and GDM 
The present meta-analysis suggested a protective association of PA (21-46%) from GDM when 
comparing any type of PA to none in either the pre-pregnancy or early pregnancy period. In a pooled 
data set from 6 studies, consisting of 661 137 men and women, Arem and colleagues (275) reported 
a similar protective association for all-cause mortality, which was steepest for comparisons between  
none (referent) and the equivalent of 150 min/week moderate-intensity LTPA (or 7.5 MET.hr/week). 
While current PA guidelines for pregnancy recommend 150 min/week (212, 276) of moderate or 75 
min/week vigorous intensity PA (277), the majority of adults still fail to meet the PA guidelines (278) 
Our meta-analysis, however, suggests a potentially lower odds of GDM (46%) at >90 min/week. 
Similarly, O’Donovan and colleagues reported that taking part in 1 or 2 sessions/week in moderate-
vigorous intensity PA resulted in CVD and all-cause mortality risk reduction regardless of an 
individual’s adherence to the current guidelines (279). Whilst the potential benefits of structured 
LTPA are undisputed, volumes of PA below the recommended levels and even light intensity PA may 
have measurable health benefits (280).   
We also observed that women who engaged in any type of PA compared to none in the year before 
pregnancy had potentially 10% lower odds of developing GDM than women who engaged in PA also 
compared to none during early pregnancy. The findings are further strengthened by presence of low-
medium level of heterogeneity, no evidence of publication bias and data collected by predominatly 
validated questionnaires. On the other hand, Cordero and colleagues (281) suggested that engaging 
in structured PA 150-180 min/week during pregnancy could reduce the risk of GDM up to 90% when 
compared to standard care in their RCT. While it can be argued that study design may have an effect 
on the strength of the results, it cannot be denied that increasing PA appears to have an inverse 
association with risk of GDM. Since pregnancy is a temporary phase in a woman’s life, accompanied 
by many physiological and physical changes, preconception period should be perceived as a window 
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of opportunity to adopt a healthier lifestyle. This could include incorporating more PA, achieving a 
healthy BMI and following a diet rich in plant-based food groups such as MedDiet to prevent 
undesirable pregnancy outcomes. 
 
2.4.3  Strengths and Limitations 
This study has strengths and limitations. Due to strict the selection criteria, a few larger population 
studies were excluded which may have limited the findings of this review. For example, the Coronary 
Artery Risk Development in Young Adults (CARDIA) study (282) (n = 1488) did not report on the 
relationship between diet or PA and risk of GDM, but rather differences in health behaviours 
between the pre-pregnancy period to several years after pregnancy. On the other hand, a study by 
Deierlein and colleagues (283) (n = 1437) did not report GDM as an outcome measure but used the 
term ‘hyperglycaemia’ instead. Studies that were included in other systematic reviews (263), such as 
Saldana et al. (284) and He et al. (285), were excluded in our review due to late study recruitment 
and subsequently collection of dietary data that was not reflective of the early pregnancy period. 
Since all included studies are observational, they are susceptible to the effects of bias, confounding, 
potential measurement error, and under/over reporting of dietary intake. In the meta-analysis of PA, 
we were able to minimize these effects by using a random-effects model in statistical analysis 
(assuming heterogeneity) and in all the reviewed studies we conducted independent assessment of 
study quality, including whether validation of data collection methods had occurred (Table 2.2). 
What adds strength to the present study is that different indicators of LTPA were tested a priori with 
consistent findings. However, caution should be applied when interpreting sub-analysis of LTPA 
studies, particularly as there are <10 data sets available to be able to determine with confidence 
whether asymmetry is real or a coincidental occurrence (286).   
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2.5  Conclusions  
Assuming that the associations we identified reflect causal relationships, our review suggests that a 
MedDiet and PA are promising interventions for the prevention of GDM. However, a greater degree 
of protection may occur when both lifestyle factors are incorporated before pregnancy and followed 
throughout pregnancy. Engaging in any PA even below the guidelines suggested a protective 
association with GDM risk. The finding in part raises the importance of individualized-patient care as 
the level of PA set in the current guidelines may be unachievable by some, however they could still 
potentially achieve similar health benefits at a lower PA threshold. There is an opportunity for future 
RCTs to further explore interventions with both PA and MedDiet pattern, especially in the pre-
conception period to ensure best outcomes throughout pregnancy.     
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Chapter 3 
___________________________________________________ 
 
 
 
 
A modestly lower carbohydrate 
diet for the management of 
gestational diabetes 
 
 
 
 
 
 
 
 
 
 
Abstract 
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Background: Individuals with diabetes are commonly instructed to monitor their carbohydrate 
intake for better blood glucose control. Diets with reduced carbohydrates have the potential to 
increase levels of ketones in blood, which are negatively associated with infant brain development. 
Currently, the safety and benefit of lower carbohydrate diets in managing gestational diabetes 
(GDM) remain unclear. 
Objective: To investigate blood ketone levels, risk of ketonaemia and pregnancy outcomes in women 
with GDM prescribed a Modestly Lower Carbohydrate (MLC) diet vs Routine Care (RC) diet.  
Method:  Women diagnosed with GDM were invited to participate in the MAMI 1 (Macronutrient 
Adjustments in Mothers to Improve GDM) study, a pilot, 2-arm randomised controlled trial 
conducted at Campbelltown and Royal Prince Alfred (RPA) Hospitals, Sydney, Australia. Using block 
randomisation, eligible participants were randomised to MLC diet (carbohydrate target 135 g/day) 
or RC (180-200 g/day). Blood ketones and 3-day food diaries were collected at baseline and after a 
6-week intervention. Dietary compliance and random blood ketone levels were assessed at clinic 
visits. Pregnancy outcomes were obtained from medical records. The trial was registered in the 
Australia and New Zealand Clinical Trials Register (ANZCTR): 12616000018415. 
Results: Forty-six women completed the study, 24 in MLC and 22 in RC. Carbohydrate and total 
energy intake were significantly lower in MLC vs RC (mean ± SEM, carbohydrate 165 ± 7 g vs 190 ± 9 
g; P = 0.042; energy, 7040 ± 240 kJ vs 8230 ± 320 kJ; P = 0.006, respectively). There were no detectable 
differences in blood ketones (MLC 0.1 ± 0.0 mmol/L vs RC 0.1 ± 0.0 mmol/L; P = 0.308) with mean 
levels well below the threshold of ketonaemia. Infant head circumference was significantly lower in 
the MLC group (MLC 33.9 ± 0.11 cm vs RC 34.9 ± 0.3 cm; P = 0.046), before and after adjustment for 
GWG, weeks gestation at delivery and infant sex (P = 0.043).  
Conclusion: A MLC diet provided sufficient carbohydrates to prevent ketonaemia but may also 
reduce overall energy and nutrient intake with a potentially negative impact on brain development. 
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3.1  Introduction  
Carbohydrates have played an important role in human evolution with marked changes in gene 
frequency related to starch and lactose intake (287). In early pregnancy, maternal BGLs typically fall 
despite increases in hepatic glucose production (139). In famine and prolonged fasting, maternal 
glucose is diverted to the fetus while the mother temporarily switches to fat metabolism to generate 
energy (150). Similarly, in a non-pregnant state, when macronutrients are consumed simultaneously, 
the body has greater selectivity towards glucose absorption (288) and carbohydrate oxidation (289) 
over other macronutrients. Aside from energy, carbohydrate foods are sources of vitamins, minerals 
and dietary fibre (290). National guidelines advise dietary intake of carbohydrate to be 45-65% of 
total energy intake (EI) (16), although estimates of actual consumption fall within a wider range of 
40-80% (287).  
Since 1961, global cereal production has increased 5-fold (291), concurrently with an increase in 
world population (292) and a 3-fold increase in the prevalence of obesity and type 2 diabetes mellitus 
(T2DM) (293). Carbohydrate is the main component of cereals and the primary determinant of 
postprandial glucose (44). In recent studies, limiting carbohydrate intake in people with T2DM has 
produced significant improvements in glycated haemoglobin A1c (HbA1c) and body mass index (BMI) 
(294). However, few studies have investigated the effects of a lower carbohydrate diet in treatment 
of GDM (44, 190, 191, 295-297). In some instances, there were improvements in postprandial 
glucose levels (190, 191, 295, 296), a reduction in insulin requirements (191) and lower risk for LGA 
infants (191).  One study reported no differences in any outcome (44).  
Currently there is no consensus on the most effective diet for management of GDM (185). This is 
concerning as GDM is associated with a plethora of negative pregnancy outcomes including 
macrosomia (298), caesarean section and pelvic trauma (299), and the incidence of GDM continues 
to rise (178, 299). MNT is the first line of treatment for GDM and focuses on carbohydrate quality, 
quantity and distribution throughout the day to achieve euglycaemia (300). While MNT does not 
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specify a daily carbohydrate target, although it is generally accepted that the minimum daily 
carbohydrate intake should be 175g (183), the American Endocrine Society and American College of 
Obstetrics and Gynaecologists advise women to follow a lower carbohydrate diet, where 
carbohydrates comprise ~35-45% (301) and 33-40% (189) of their total EI, respectively. Typically, 
carbohydrate restriction reduces the ratio of glucagon to insulin, thereby promoting oxidation of free 
fatty acids to BHB and other ketones (302). The suggested %EI from carbohydrates for GDM 
management should not be associated with elevated ketone levels in the blood, although there are 
no trials to confirm the assumption. In studies of carbohydrate reduction in GDM, only urinary ketone 
levels have been assessed (44, 190, 191).  
While there is a strong correlation between urine and blood ketone levels, blood ketone 
measurements are considered superior (130) and reflective of current ketone status in the body. 
Given the potentially serious negative effects of ketonaemia on fetal brain development (196), we 
aimed to investigate actual blood levels and risk of ketonaemia in women with GDM following a 
modestly lower carbohydrate (MLC) diet (carbohydrate target 135 g/day) versus routine care (RC) 
(180-200 g/day). Pregnancy outcomes, including birth weight and head circumference were also 
measured. We hypothesised that a modest reduction in dietary carbohydrate intake would not 
increase blood ketone levels or risk of adverse pregnancy outcomes.  
 
3.2  Methods 
The present study was a pilot 6-week, 2-arm, parallel randomised controlled trial conducted at the 
antenatal clinics of RPA Hospital (Camperdown) and Campbelltown Hospital, Australia. Recruitment 
took place between April 2016 to May 2018. All personnel and participants were blinded to the 
dietary group allocation, except for the study dietitian (J.M.). We selected the intervention period of 
6-weeks, as this timeframe was sufficient to promote changes in maternal and neonatal outcomes 
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in previous studies (303, 304). The trial was registered in the Australia and New Zealand Clinical Trials 
Register (ANZCTR): 12616000018415. Ethics approval was obtained from the South-Western Sydney 
Local Health District (HE16/367) and Human Research Ethics Committee of the Sydney South West 
Area Health Service (RPA Hospital Zone HREC/15/RPAH/397).  
 
3.2.1  Participant recruitment 
Pregnant women aged 18-45 years with a singleton pregnancy, between 24-32 weeks gestation and 
a GDM diagnosis were eligible to take part in the study (Table 3.1).  
 
Table 3.1  Participant selection criteria.  
Criteria 
Inclusion 
✓ 18-45 years old 
✓ 24-32 weeks gestation 
✓ Women diagnosed with gestational diabetes  
✓ Singleton pregnancy 
✓ Understanding the English language 
Exclusion 
X Women with special dietary requirements (e.g. vegan/vegetarian) 
X Existence of co-morbidities other than obesity, hypertension or dyslipidaemia 
X Pre-existing diabetes 
X Undesirable lifestyle habits such as smoking and alcohol consumption 
X Pregnancy achieved by assisted reproduction (in-vitro fertilisation) 
 
GDM diagnosis was based on a fasting 75 g OGTT, using the 2010 IADPSG diagnostic criteria: Fasting 
BGL ≥5.1 mmol/L, 1-hr BGL hour ≥10.0 mmol/L and 2-hr BGL ≥8.5 mmol/L (305). The hospitals 
differed in their blood glucose monitoring targets, with a fasting BGL target of ≤5.3 mmol/L and 2-hr 
post meal ≤6.8 mmol/L used by the Campbelltown Hospital, and a fasting BGL ≤5.2 mmol/L and 1-hr 
post meal ≤7.4 mmol/L used by RPA Hospital. Women were excluded if they had current alcohol or 
81 
 
smoking status, followed a gluten free or vegan/vegetarian diet, could not understand the English 
language or had major surgery (e.g. Roux-En-Y) in the past 5 years that affected nutrient absorption.  
Once deemed eligible, study procedures were explained, and willing participants completed the 
consent and enrolment forms. The enrolment form captured demographic data including age, parity, 
past and present medical conditions, self-reported pre-pregnancy weight and PA levels, and degree 
of exposure to nutrition information. Gestational age was based on last menstrual period and 
corrected if indicated otherwise by an ultrasound scan. Since weight was measured as part of usual 
care at both hospitals, we obtained participant weight from medical records at each visit.  
 
3.2.2  Baseline data collection 
Once enrolled, participants were required to complete a 3-day food diary and a 2-day blood ketone 
diary. The food diary consisted of any 2 weekdays and 1 day of the weekend to account for day-to-
day variability in dietary intake (306).  Ongoing blood glucose monitoring was required as per usual 
care. Blood finger prick glucose levels were assessed 4 times/day, with first measurement collected 
in the morning following an overnight fast and subsequent measurements taken 1-hour (RPA 
Hospital) or 2-hours (Campbelltown Hospital) after each of the 3 main meals. To ascertain baseline 
glucose management, HbA1c levels were extracted from medical records. 
Blood ketone levels in the form of BHB were determined using Optium™ meter and Optium™ β-
ketone test strips (Abbott, Macquarie Park, Australia). The ketone test strips contained 3 electrodes, 
including a fill trigger, working and a reference electrode (307). To operate, the strips required ~0.6 
μL of whole blood, which was obtained using a disposable lancet (Accu-Chek®, Roche Diagnostics 
GmbH, Mannheim, Germany). The research dietitian demonstrated how to measure blood samples, 
operate the ketone monitor and instructed participants to collect 3 blood samples per day during 
the 2-day blood ketone collection period.  The first measurement took place in the morning after an 
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overnight fast. Two other measurements were collected at noon and in the evening, both prior to a 
main meal to determine the likely highest rise in ketones. The following criteria were used to define 
safe ketone levels: normal: <0.5 mmol/L, hyperketonaemia: >1.0 mmol/L and ketoacidosis: >3.0 
mmol/L (106). All baseline measurements were cross-checked by the research dietitian. 
 
3.2.3  Randomisation and stratification 
Participants were randomly allocated to either a MLC or RC diet using block randomisation technique 
- a method which ensured a balance in participant numbers and characteristics at baseline (308, 309). 
In practice, this generated 4 boxes stratified according to age (18≤age≤30 or 30<age≤45) and BMI 
(≤27 or >27) category. Each box contained an equal number of concealed “intervention” or “control” 
cards (i.e. 8 intervention and 8 control cards). If a participant met the criteria for any of the 4 boxes, 
a card was drawn from that box by the research dietitian to achieve random assignment. Once 
assigned, the card was disposed. Aside from the research dietitian, participants and other health 
professionals were blinded to the diet allocation.  
 
3.2.4  Dietary intervention, safety and compliance 
The MLC diet aimed for an absolute target of 135 g carbohydrate/day (estimated average 
requirement (EAR)) in line with Institute of Medicine recommendation for carbohydrate that would 
meet the needs of 50% of the pregnant population  (310), without restricting overall EI. The RC diet 
aimed for an absolute target of 180-200 g carbohydrate/day. Additionally, we asked participants to 
strive for an even daily distribution of carbohydrates for both diets, as depicted in Figure 3.1. A 
sample meal plan is shown in Table 3.2a and Table 3.2b.  
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Routine care (RC) diet - control 
Breakfast Snack (AM) Lunch Snack (PM) Dinner Supper 
2-3 1-2 3-4 
1-2 
3-4 1-2 
 
Modestly lower carbohydrate (MLC) diet - intervention 
Breakfast Snack (AM) Lunch Snack (PM) Dinner Supper 
2 1 2 1 2 1 
 
Figure 3.1  Target carbohydrate distribution (as exchanges) for the control and intervention 
arms of the MAMI 1 study.   
 
To assist in achieving the set carbohydrate target, we provided a pictorial booklet to both groups. 
While the booklets contained the same content such as images of different food categories, detailing 
their carbohydrate content, number of carbohydrate exchanges as well as their GI, they emphasised 
different carbohydrate targets. Study visits were made to coincide with visits to the antenatal clinic, 
approximating every 2 weeks.  
As safety was critical, the research dietitian closely monitored patient medical symptoms and 
biochemistry, with specific focus on blood ketone levels. A strategy to avoid potential adverse effects 
was developed before the study participants commenced MLC diet. If participants were generally 
feeling unwell or dizzy, they were instructed to assess both blood ketone and glucose levels. If the 
ketone level was >0.5 mmol/L, they were advised to consume a carbohydrate containing snack and 
repeat the blood ketone measurement. If blood ketone levels remained elevated (i.e. >0.5 mmol/L) 
for more than 2 days, the patient was advised to contact the hospital to arrange an immediate clinical 
review to establish the cause of elevated blood ketones. They were also instructed to increase their 
dietary carbohydrate to 180 g/day and monitor blood ketones daily until the levels stabilised (for at 
least 48 hours). The obstetrician or materno-fetal medicine fellows reviewed both maternal and fetal 
wellbeing. If and when these events occurred, participants were excluded from the study. 
 
Versus 
84 
 
Table 3.2a  Sample meal plan for the modestly lower carbohydrate (MLC) diet group. 
Meal Meal Description Amount 
BF 
Oats (Traditional) 30 g 
Skim milk 150 mL 
Blueberries ½ cup 
AM 
Wholegrain bread 1 slice 
Avocado ¼ avocado 
Lunch 
Sandwich  
- Wholegrain bread 
 
2 slices 
- Chicken breast 40 g 
- Cheese (gouda) 20 g 
- Avocado ¼ avocado 
- Vegetables of choice (1/2 medium tomato, 
1/3 capsicum, 1/2 medium carrot, few 
leaves spinach, 2 olives) 
1 cup 
PM Medium apple  
Mixed unsalted nuts 
150 g 
30 g 
Dinner 
Basmati rice steamed ½ cup = 100 g 
Garden salad (with olive oil and balsamic dressing) 1 cup 
- Lettuce  ½ cup 
- Cucumber ¼ cucumber 
- Tomato ¼ tomato 
Roasted vegetables 
- Sweet potato 
- Pumpkin 
- Capsicum 
- Broccoli 
 
30 g 
30 g 
30 g 
30 g 
Roasted (lean beef/ chicken) >85 g 
Supper Yoghurt (Yoplait Forme, strawberry sensation) 
Mixed unsalted nuts 
150 g 
30 g 
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Table 3.2b  Sample meal plan for the routine care (RC) diet group. 
Meal Meal Description Amount 
BF 
Oats (Traditional) 45 g 
Skim milk 200-250 mL 
Blueberries ½ cup 
AM 
Wholegrain bread 1 slice 
Cheese (cheddar) 1 slice 
Apple 1 medium 
Lunch 
Sandwich  
- Wholegrain bread 
 
2 slices 
- Chicken breast 40 g 
- Cheese (gouda) 20 g 
- Avocado 5 g 
- Vegetables of choice (1/2 medium 
tomato, 1/3 capsicum, 1/2 medium 
carrot, few leaves spinach, 2 olives) 
1 cup 
PM 
Medium apple  150 g 
Wholegrain cracker (Vita-Weat™) 4 crackers 
Dinner 
Basmati rice steamed ½ cup = 100 g 
Garden salad (with olive oil and balsamic dressing) 1 cup 
- Lettuce  ½ cup 
- Cucumber ¼ cucumber 
- Tomato ¼ tomato 
Roasted vegetables 
- Sweet potato 
- Pumpkin 
- Capsicum 
- Broccoli 
 
30 g 
30 g 
30 g 
30 g 
Roasted (lean beef/ chicken) > 85 g 
Supper Yoghurt (Yoplait Forme, strawberry sensation) 150 g 
 
 
A 24-hour recall, approximately every 2 weeks or at Visits 1-3, was used to assess treatment fidelity 
with compliance to prescribed diets. On Visit 3, participants were asked to complete a 2nd 3-day food 
diary and 2-day blood ketone diary.  Overall glucose control during the intervention period was 
ascertained using HbA1c levels, which were extracted from medical records. The return of the 
booklets on their 4th Visit to the clinic marked the end of their participation in the study. An overview 
of study data collection points is shown in Table 3.3.  
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Dietary information from food diaries and 24-hour recalls were entered by the research dietitian into 
the Australian nutrition analysis computer software (FoodWorks Professional Version 8, 2015, Xyris 
Software, Brisbane, Australia), based on AUSNUT 2011-2013 database. GI values were cross checked 
and compared to the international table of GI and glycaemic load (GL) values (311). 
 
Table 3.3  MAMI 1 (Macronutrient Adjustments in Mothers to Improve GDM) study collection 
plan.   
 Consent Maternal 
anthropometry 
Blood 
ketone 
Blood 
glucose 
24-hour 
diet Recall 
3-day 
food diary 
Infant 
anthropometry 
Enrolment 
(24-32 
weeks)     
   
Baseline 
 
   
 
 
 
Follow up 1 
 
 
 
 
 
  
Follow up 2 
 
 
 
 
   
Follow up 3 
 
 
 
  
  
Final 
 
   
 
 
 
 
3.2.5  Additional outcome measures 
To determine the potential effects of MLC diet on the neonate, we obtained information on 
birthweight, length, head circumference, percent fat mass (%FM) and percent fat free mass (%FFM) 
(RPA Hospital only) from electronic medical records. We used the WHO gender specific growth charts 
(weight for gestational age) to assess birthweight. Neonates below the 10th percentile were 
categorised as small-for-gestational age (SGA) and those exceeding the 90th percentile were classed 
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as large-for-gestational age (LGA). Macrosomia was defined as birthweight >4000 g. In addition, 
birthweights were compared to the Australian national birthweight percentiles (312). Both the 
Centre for Disease Control and Prevention (CDC) growth charts and Australian birthweight database 
were used to determine head circumference percentiles (313-315), 
GWG was calculated as the difference between the last measured weight before delivery and pre-
pregnancy weight and compared to the 2009 IOM weight gain guidelines (316), specific for each BMI 
category.  Full term pregnancy was defined as ≥37 weeks gestation.  
 
3.2.6  Statistics 
Statistical analyses were conducted using SPSS (version 24, IBM Australia, St Leonards, Australia) and 
SAS Statistical Software, Version 9.4 (SAS Institute Inc., Cary, NC). Descriptive data are presented as 
mean ± SEM for continuous variables and percentages for frequency variables. For continuous 
outcomes or to assess differences between groups, we used an independent samples t-test, one-
way ANOVA or Mann-Whitney U test where appropriate. Pearson’s chi-square test of independence 
was used to compare method of delivery, induction rate, infant birthweight. 
Bivariate analyses (Pearson (rρ) or Spearman (rS) correlation coefficients where appropriate) were 
used to assess the association between selected maternal variables and infant outcomes.  
We used a crude and adjusted logistic linear regression to assess the association between dietary 
intervention and odds of having elevated blood ketone levels. Blood ketones were stratified into 3 
categories according to change from baseline, namely if there was a decrease (n = 17), an increase 
(n = 4) or no change (n = 19) in measurements.  The model adjusted for maternal age and categories 
of BMI (BMI <25 and BMI ≥25). In addition, median level of daily carbohydrate intake was used 
stratify participants into higher (≥median) or lower (<median) consumers regardless of their group 
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assignment. This allowed us to ascertain whether levels of actual carbohydrate intake affected 
ketone status (adjusting for age and categories of BMI).  
Although MLC diet and RC groups were prescribed absolute carbohydrate targets, we allowed a 20% 
deviance (MLC diet ≤162 g/day; RC >162 g/day) to account for the potential difficulty in reaching the 
target. Gestational age at delivery was stratified as <39 or ≥39 weeks gestation. 
 
3.2.7  Power calculation 
The study was designed to provide 80% statistical power to detect approximately 0.04 mmol 
difference in blood ketone levels with 25 participants required for each of the 2 study arms. 
Considering a potential dropout rate of 25%, our study required a total of 65 participants, or 
approximately 32 per study group. The calculations were based on a study by Gin et al. 2006 (317).  
 
3.3  Results  
A total of 297 pregnant women diagnosed with GDM were approached, of which 76 gave consent. 
Twenty-nine of these withdrew before randomisation (Figure 3.2), leaving 46 who were randomised 
to either MLC or RC group. One participant reported extremely low energy intake (~4500 kJ) at 
baseline and was removed from further analysis. Our intention-to-treat (ITT) analysis consisted of 45 
participants. A secondary analysis consisted of 33 participants who completed all requirements of 
the study. The most common reason for non-completion included early delivery (n = 10), followed 
by loss of interest (n = 2) and medical reasons (n = 1). The 5 women who were recruited at 
Campbelltown Hospital subsequently withdrew before randomisation and baseline data collection. 
Figure 3.3 shows the cumulative recruitment rate on a week-by-week basis.  
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Figure 3.2  Flow diagram depicting progress of a 2-group parallel randomised trial.  
 
 
Figure 3.3 Cumulative frequency of participants consenting to take part in the study at Royal 
Prince Alfred and Campbelltown Hospitals. 
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Participant characteristics at baseline are shown in Table 3.4a and Table 3.4b.  The two dietary 
groups were comparable with respect to age, mean pre-pregnancy BMI, weeks gestation at 
diagnosis, OGTT results and HbA1c at baseline. Both groups had a strong family history of T2DM and 
hypertension, and 100% pregnancy multivitamin use. MLC had a higher proportion of women in the 
obese pre-pregnancy BMI category but a lower proportion using thyroid medication. Women who 
withdrew from the study were similar to the two treatment groups.  Both groups were also 
comparable in absolute intake of nutrients and macronutrient energy distribution at baseline (Table 
3.5).   
Among the women who completed the full protocol, including 3-day food diaries (n = 33), the MLC 
group consumed less carbohydrate (165 ± 7 vs 190 ± 9 g/day, P = 0.042) as predicted, but also less 
total energy (7040 ± 240  vs 8230 ± 320 kJ/day, P = 0.006) (Table 3.6). Consequently, the MLC group 
consumed less protein (85 ± 4 vs 103 ± 4 g/day, P = 0.006), and fewer micronutrients (including 
significantly less iron and iodine). As a proportion of energy, carbohydrate was similar in both groups. 
A sub-group analysis of women (n = 23) who complied with their assigned carbohydrate target (Table 
3.7) indicated a significantly lower intake of carbohydrate in the MLC vs RC group (143 ± 4 vs 196  ± 
6 g/day, P <0.0001), as well as sugars (55 ± 4 vs 77 ± 3 g/day, P <0.0001), starch (88 ± 5 vs 117 ± 5 
g/day, P <0.0001), and glycaemic load (79 ± 10 vs 104 ± 13, P <0.0001), respectively. However, intake 
of total energy was lower still in the MLC group (6640 ± 240 vs 8040 ± 210 kJ/day, P <0.0001).  On 
average, women in the MLC group met the predicted proportion of energy as carbohydrate intake 
(36% EI), but those in the RC group consumed less than instructed (41% EI).  Both dietary groups 
exceeded the 10% EI target for saturated fat. There were no differences in intake of polyunsaturated 
fatty acids including linoleic, alpha-linolenic, eicosapentaenoic, docosapentaenoic and 
docosahexaenoic fatty acid between groups at baseline, among completers or in the compliant sub-
analysis (results not shown).  
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Table 3.4a  Baseline characteristics of participants that received education.   
 n MLC n RC P 
Age, y 24 32.5 ± 0.9 21 33.9 ± 0.9  0.281 
BMI (kg.m2) 24 25.8 ± 1.0 21 28.0 ± 1.6   0.229 
BMI category       
-          Underweight (%) 0 0 2 8.7   
-          Normal (%) 12 50.0 8 34.8   
-          Overweight (%) 8 33.3 5 21.7   
-          Obese I (%) 2 8.3 4 17.4   
-          ≥ Obese II (%) 2 8.3 2 8.7 
 
Ethnicity (Asian vs Caucasian)     0.278† 
Asian (%) 13 54.2 16 69.7  
-          East Asian (%) 1 4.2 5 21.7  
-          South Asian (%) 9 37.5 4 17.4  
-          Southeast Asian (%) 3 12.5 7 30.4  
Caucasian (%) 11 45.8 7 30.4  
Other (%) 0 0 0 0  
Nulliparous n (%) 14 58.3 10 43.5 0.472† 
Weeks at GDM diagnosis  24 20.2 ± 1.1 21 20.7 ± 1.2 0.431  
75-g OGTT results (mmol/L)   
Fasting  23 4.8 ± 0.1 20 4.7 ± 0.1  0.261 
1-hour  23 9.4 ± 0.3 19 9.9 ± 0.3  0.383 
2-hour  23 8.0 ± 0.4 19 8.3 ± 0.3  0.569 
HbA1c % 20 5.1 ± 0.1 20 5.0 ± 0.1  0.522 
Education     0.727† 
-          Secondary (%) 4 16.7 3 13.0 
 
-          Tertiary (%) 20 83.3 18 87.0 
 
Marital status       
-          Single (%)  1 4.2 1 4.3 
 
-          De-facto (%)  1 4.2 6 26.1 
 
-          Married (%)  22 91.7 16 69.6 
 
Smoking Hx (%) 5 20.8 5 21.7  0.811† 
GDM Hx 2 8.3 1 4.3 
 
Family History      
-          T2DM 18 75.0 16 69.6 0.926† 
-          HT 18 75.0 14 60.9 0.538† 
-          Ow/Ob 7 29.2 6 26.1 0.965† 
Insulin use (%) 6 25.0 6 28.6 0.787† 
Thyroid Medication (%) 6 25.0 2 9.5  
Metformin (%) 1 4.2 1 4.8  
Aspirin (%) 1 4.2 1 4.8  
Supplement use 24 100 21 100  
- Pregnancy multivitamin 24 100 21 100  
Abbreviations: GDM – gestational diabetes mellitus; HT – hypertension; Hx – history; MLC – modestly lower carbohydrate (diet) 
OGTT – oral glucose tolerance test; Ow/Ob – Overweight/Obesity; RC – routine care (diet); SEM – standard error mean; T2DM – 
type 2 diabetes mellitus; 
 
Independent samples t-test, Mann Whitney tests or Pearson’s chi-square test of independence (†) were performed. P <0.05 
deemed significant. 
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Table 3.4b  Baseline characteristics of participants who withdrew from the study prior to 
randomisation compared to women that completed the study.   
 n Withdrawn n MLC n RC PA P 
Age, y 29 31.7 ± 1.0 16 32.7 ± 1.0 17 33.9 ± 1.1 0.400 0.371 
BMI (kg.m2) 29 26.9 ± 1.0 16 27.0 ± 1.2 17 29.2 ± 1.8 0.337 0.659 
BMI category          
-          Underweight (%) 0 0 0 0 2 11.8    
-          Normal (%) 13 46.4 6 37.5 5 29.4    
-          Overweight (%) 7 25.0 6 37.5 2 11.8    
-          Obese I (%) 5 17.9 2 12.5 4 23.5    
-          ≥ Obese II (%) 3 10.7 2 12.5 4 23.5    
Ethnicity (Asian vs 
Caucasian) 
      0.881† 0.836† 
Asian (%) 13 48.1 9 56.3 10 58.8    
-          East Asian (%) 3 23.1 0 0 4 23.5    
-          South Asian (%) 5 38.5 7 43.8 3 17.6    
-          Southeast Asian (%) 5 38.5 2 12.5 3 17.6    
Caucasian (%) 13 48.1 7 43.8 7 41.2    
Other (%) 1 3.7 0 0 0 0   
Nulliparous n (%) 16 57.1 8 50.0 6 35.3 0.392† 0.424† 
Weeks at GDM diagnosis  24 20.9 ± 1.2 16 21.5 ± 1.5 17 20.4 ± 1.9 0.656 0.964 
75-g OGTT results 
(mmol/L)  
        
Fasting  24 4.9 ± 0.1 15 4.7 ± 0.1 16 4.7 ± 0.1 0.599 0.587 
1-hour  23 10.1 ± 0.3 15 9.3 ± 0.4 15 9.7 ± 0.4 0.473 0. 333 
2-hour  23 7.2 ± 0.5 15 7.9 ± 0.5 15 8.2 ± 0.3 0.713 0.156 
HbA1c %  28 5.1 ± 0.1 13 5.1 ± 0.1 16 5.0 ± 0.1 0.720 0.976 
Education (Secondary vs 
Tertiary)       0.605
† 0.711† 
-          Secondary (%) 8 28.6 4 25.0 3 17.6 
 
 
-          Tertiary (%) 20 71.4 12 75.0 14 82.4 
 
 
Marital status         
-          Single (%)  2 7.4 0 0 0 0 
 
 
-          De-facto (%)  5 18.5 1 6.3 6 35.3 
 
 
-          Married (%)  20 74.1 15 93.7 11 64.7 
 
 
Smoking Hx (%) 8 29.6 3 18.8 4 23.5 0.737† 0.801† 
GDM Hx 5 25.0 2 12.5 1 5.9   
Family History         
-          T2DM 22 81.5 12 75.0 12 70.6 0.776† 0.922† 
-          HT 15 55.6 13 81.3 10 58.8 0.161† 0.146† 
-          Ow/Ob 7 25.9 3 18.8 6 35.3 0.286† 0.533† 
Insulin use (%) 8 28.6 4 25.0 6 35.3 0.520† 0.787† 
Thyroid Medication (%) 4 14.3 6 37.5 2 11.8   
Metformin (%) 0 0 1 6.3 1 5.9   
Aspirin (%) 4 14.3 1 6.3 1 5.9   
Supplement use 29 96.6 16 100 17 100   
- Pregnancy 
multivitamin 
28 92.3 16 100 17 100   
Abbreviations: GDM – gestational diabetes mellitus; HT – hypertension; Hx – history; MLC – modestly lower carbohydrate (diet) OGTT – 
oral glucose tolerance test; Ow/Ob – Overweight/Obesity; RC – routine care (diet); SEM – standard error mean; T2DM – type 2 diabetes 
mellitus; 
Values presented as mean ± SEM. PA – Independent samples t-test (between MLC and RC) or Pearson’s chi-square test of independence 
(†), P – One-way ANOVA were performed or Pearson’s chi-square test of independence (†).  
P <0.05 deemed significant.  
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Table 3.5 Maternal baseline diet in the two intervention groups.  
 Baseline  
 MLC RC PA  
n 24 21 -  
Energy (kJ) 7480 ± 320 7510 ± 370 0.949  
Carbohydrate (g) 167 ± 6 164 ± 12 0.857  
Sugars (g) 62 ± 4 61 ± 5 0.802  
Starch (g) 104 ± 4 102 ± 9 0.844  
Dietary fibre (g) 25 ± 1 24 ± 1 0.806  
Protein (g) 100 ± 6 99 ± 5 0.882  
Total fat (g) 74 ± 5 77 ± 6 0.732  
- Saturated (g) 24 ± 2 27 ± 2 0.733  
- Long chain FA-3 (g) 0.6 ± 0.2 0.5 ± 0.1 0.682  
Carbohydrate (%EI) 38 ± 1 36 ± 2 0.529  
Protein (%EI) 23 ± 0.8 23 ± 0.9 0.964  
Total fat (%EI) 36 ± 1 37 ± 2 0.505  
- MFA (% total fat) 45 ± 1 45 ± 2 0.985  
- PFA (% total fat) 19 ± 1 18 ± 1 0.773  
- SFA (% total fat) 36 ± 1 36 ± 1 0.853  
SFA (%EI) 12 ± 1 12 ± 1 0.617  
GI 54 ± 1 52 ± 1 0.339  
GL 92 ± 3 88 ± 7 0.619  
Iron (mg) 10 ± 1 11 ± 1 0.581  
Iodine (µg) 161 ± 11 144 ± 10 0.261  
Total folate (µg) 490 ± 40 440 ± 30  0.509  
Abbreviation: GI – Glycaemic index; GL – Glycaemic load; FA – Fatty acid; MFA – monounsaturated fatty acid; MLC – modestly lower 
carbohydrate (diet); EI – energy intake; RC – routine care (diet) 
Values presented as mean ± SEM; Independent samples t-test or Mann Whitney tests were performed. P <0.05 deemed significant.  
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Table 3.6  Dietary intakes of study participants at the end of the intervention. 
 
End of intervention 
 ITT  Completers only 
 MLC RC Pꓮ 
 
MLC RC PA 
n 24 21 - 
 
16 17 - 
Energy (kJ) 7070 ± 201 7750 ± 222 0.028  7040 ± 240 8230 ± 320  0.006 
Carbohydrate (g) 164 ± 4 176 ± 8 0.199  165 ± 7 190 ± 9 0.042 
Sugars (g) 65 ± 3 70 ± 4 0.255  65 ± 4 78 ± 5 0.080 
Starch (g) 98 ± 4 105 ± 6 0.373  99 ± 7 110 ± 7 0.252 
Dietary fibre (g) 23 ± 1 24 ± 1 0.370  24 ± 1 26 ± 2 0.262 
Protein (g) 90 ± 4 100 ± 5 0.102  85 ± 4 103 ± 4 0.006 
Total fat (g) 70 ± 4 77 ± 4 0.199  71 ± 5 82 ± 5 0.136 
- Saturated (g) 24 ± 1 27 ± 4 0.101  24 ± 2 29 ± 2 0.105 
- Long chain FA-3 (g) 0.6 ± 0.2 0.3 ± 0.1 0.820  0.4 ± 0.1 0.4 ± 0.1 0.264 
Carbohydrate (%EI) 39 ± 1 38 ± 2 0.516  39 ± 2 38 ± 1 0.613 
Protein (%EI) 22 ± 1 22 ± 1 0.927  21 ± 1 21 ± 1 0.330 
Total fat (%EI) 36 ± 1 36 ± 1 0.735  37 ± 2 37 ± 1 0.996 
- MFA (% total fat) 45 ± 1 44 ± 1 0.500  46 ± 1 44 ± 1 0.240 
- PFA (% total fat) 17 ± 1 17 ± 1 0.983  17 ± 1 17 ± 1 0.836 
- SFA (% total fat) 38 ± 1 39 ± 1 0.584  37 ± 1 39 ± 1 0.294 
SFA (%EI) 12.1 ± 0.4 12.6 ± 0.6 0.454  12.3 ± 0.7 13.0 ± 0.6 0.492 
GI 53 ± 1 52 ± 1 0.982  53 ± 1 51 ± 1 0.313 
GL 87 ± 3 93 ± 5 0.241  87 ± 4 98 ± 6 0.144 
Iron (mg) 9.1 ± 0.4 10.0 ± 0.4 0.075  8.7 ± 0.4 10.6 ± 0.4 0.003 
Iodine (µg) 160 ± 9 164 ± 11 0.778  147 ± 11 196 ± 14 0.009 
Total folate (µg) 443 ± 21 467 ± 21 0.413  451 ± 25 488 ± 31 0.365 
Abbreviations: EI – energy intake; GI – Glycaemic index; GL – Glycaemic load; ITT – intention-to-treat; MFA – monounsaturated fatty acid; 
MLC – modestly lower carbohydrate (diet); PFA – polyunsaturated fatty acid; RC – routine care (diet); SEM – standard error of the mean; 
SFA – saturated fatty acid. 
Values presented as mean ± SEM; Independent samples t-test or Mann Whitney tests were performed. P <0.05 deemed significant.  
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Table 3.7  Sub-analysis of women that met their assigned carbohydrate target intake.  
 End of intervention 
 MLC RC Pꓮ 
n 10 15 - 
Energy (kJ) 6640 ± 240 8040 ± 210 <0.0001 
Carbohydrate (g) 143 ± 4 196 ± 6 <0.0001 
Sugars (g) 55 ± 4 77 ± 3 <0.0001 
Starch (g) 88 ± 5 117 ± 5 <0.0001 
Dietary fibre (g) 21 ± 1 24 ± 1 0.135 
Protein (g) 94 ± 6 97 ± 3 0.610 
Total fat (g) 66 ± 4 78 ± 5 0.082 
- Saturated (g) 22 ± 1 28 ± 2 0.063 
- Long chain FA-3 (g) 0.4 ± 0.1 0.3 ± 0.1 0.912 
Carbohydrate (%EI) 36 ± 1 41 ± 1 0.056 
Protein (%EI) 24 ± 1 21 ± 1 0.023 
Total fat (%EI) 36 ± 1 35 ± 1 0.528 
- MFA (% total fat) 46 ± 1 44 ± 1 0.408 
- PFA (% total fat) 17 ± 1 17 ± 1 0.982 
- SFA (% total fat) 37 ± 2 39 ± 2 0.542 
SFA (%EI) 12 ± 1 13 ± 1 0.737 
GI 54 ± 2 52 ± 1 0.489 
GL 79 ± 10 104 ± 13 <0.0001 
Iron (mg) 8.8 ± 0.6 9.7 ± 0.4 0.207 
Iodine (µg) 143 ± 10 175 ± 13 0.091 
Total folate (µg) 428 ± 22 480 ± 25 0.156 
Abbreviations: EI – energy intake; GI – Glycaemic index; GL – Glycaemic load; ITT – intention-to-treat; MFA – monounsaturated 
fatty acid; MLC – modestly lower carbohydrate (diet); PFA – polyunsaturated fatty acid; RC – routine care (diet); SEM – standard 
error of the mean; SFA – saturated fatty acid.  
P <0.05 deemed significant; Pꓮ - Independent samples t-test or Mann Whitney tests were performed where appropriate. 
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3.3.1  Blood ketone levels (BHB) 
There was no difference in average daily blood ketone levels between the groups at baseline (Table 
3.8).  However, closer inspection indicated higher fasting values in the MLC group (P = 0.013). At the 
end of the intervention, there was no difference in our primary outcome of blood ketone levels 
between groups and no instances of high levels (>1.5 mmol/L). One participant in the RC group 
displayed a single high blood ketone value of 0.7 mmol/L, which was normalised (<0.5 mmol/L) 
following a meal. On the whole, the MLC diet group had reduced odds (OR = 0.72, 95% CI: 0.19-2.58) 
of showing high blood ketone concentration, but the difference remained non-significant after 
adjusting for maternal age and pre-pregnancy BMI category. The model appeared to be influenced 
by maternal BMI (OR = 0.38, 95% CI:0.10 -1.30), with higher BMI associated with lower blood ketone 
levels. Even when participants were stratified into groups of higher and lower intakes of 
carbohydrates (based on the median intake), lower carbohydrate intake was still associated with 
reduced odds of having higher ketones (OR = 0.42, 95% CI: 0.11 - 1.54).  
 
3.3.2  Pregnancy outcomes  
While there were no differences in total GWG between groups, MLC group had a higher proportion 
of women meeting the IOM weight gain guidelines than RC (P = 0.039). Among different modes of 
delivery, natural birth predominated and was higher in the carbohydrate restricted group (MLC 71% 
vs RC 52%), although weighted comparison between modes of delivery revealed no statistical 
difference between the two groups (P = 0.203). We observed a trend towards higher induction rates 
in the MLC diet group (P = 0.055), which could not have been explained by gestational age at delivery 
(MLC 38.7 weeks ± 0.2 vs RC 38.6 ± 0.2 weeks, P = 0.973). Three of the 4 women induced in the MLC 
group had a BMI >30. Almost 60% of participants in both groups were using insulin. There were no 
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significant differences between groups with respect to insulin dosing and mean change in units from 
baseline (Table 3.9).   
Of 45 births obtained from medical records, 4 were born prematurely (i.e. 36-37 weeks gestation). 
There were no differences between infants with respect to length, %FM and %FFM. We observed a 
moderate correlation between maternal pre-pregnancy BMI and total GWG (rρ = -0.450, n = 45, P = 
0.002), although no correlation between total GWG or GWG category and infant birthweight (results 
not shown). Among the women randomised to the MLC diet during pregnancy, there was reduced 
odds of having a higher birthweight infant (OR = 0.49, 95% CI: 0.10 – 2.05), although this did not 
reach statistical significance. Figure 3.4 shows infant birthweight according to gender using the 
Australian National Birthweight percentile as a comparator.  
Only 15 infants (33%) had Pea Pod data collection for determination of body composition.  One-
quarter of MLC diet infants (n = 6) were classed as SGA when compared to RC (n = 3; 14%). Infants 
whose mothers followed the MLC diet had significantly smaller head circumference RC (33.9 ± 0.3 
cm versus 34.9 ± 0.3 cm; P = 0.046) (Table 3.10). The difference remained significant when the model 
was adjusted for maternal GWG, weeks gestation at delivery and infant sex (P = 0.043) (Figure 3.5b).  
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Table 3.8 Biochemistry at baseline and end of the study for ITT and participants who 
complied to the respective carbohydrate targets.  
 
 Baseline  End of Intervention  
ITT n MLC n RC P  n MLC n RC P  
HbA1c (%) 20 5.1 ± 0.1 20 5.0 ± 0.1 0.518  16 5.1 ± 0.1 15 5.3 ± 0.1 0.209  
Glucose mmol/L 
(average) 
22 6.0 ± 0.1 17 6.2 ± 0.1 0.261  13 6.1 ± 0.1 15 6.0 ± 0.1 0.307  
Ketone mmol/L 
(average) 
24 0.1 ± 0.0 21 0.2 ± 0.0 0.189  21 0.1 ± 0.0 19 0.1 ± 0.0 0.308  
Fasting  24 0.1 ± 0.0 21 0.2 ± 0.0 0.013  14 0.1 ± 0.0 18 0.1 ± 0.0 0.178  
Noon 24 0.2 ± 0.0 21 0.2 ± 0.0 0.240  15 0.1 ± 0.0 18 0.1 ± 0.0 0.770  
Evening 24 0.1 ± 0.0 21 0.2 ± 0.0 0.239  13 0.1 ± 0.0 18 0.1 ± 0.0 0.754  
Sub-group analysis of compliant participants 
HbA1c (%) 9 5.0 ± 0.1 14 5.1 ± 0.1 0.859  8 5.2 ± 0.1 12 5.3 ± 0.1 0.402  
Glucose mmol/L 
(average) 
9 5.7 ± 0.1 11 6.3 ± 0.2 0.093  6 6.2 ± 0.2 11 6.0 ± 0.1 0.318  
Ketone mmol/L 
(average) 
10 0.2 ± 0.0 15 0.2 ± 0.0 0.293  6 0.1 ± 0.0 14 0.1 ± 0.0 1.000  
Fasting  10 0.2 ± 0.0 15 0.2 ± 0.0 0.753  6 0.1 ± 0.0 14 0.1 ± 0.0 0.452  
Noon 10 0.2 ± 0.0 15 0.2 ± 0.0 0.521  6 0.2 ± 0.0 14 0.1 ± 0.0 0.141  
Evening 10 0.2 ± 0.0 15 0.2 ± 0.0 0.389  6 0.1 ± 0.0 14 0.1 ± 0.0 0.780  
Abbreviation: MLC – modestly lower carbohydrate (diet); PFA – polyunsaturated fatty acid; RC – routine care (diet) 
Values presented as mean ± SEM; P <0.05 deemed significant; P value obtained from Independent samples t-test. 
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Table 3.9  Pregnancy outcomes in the two intervention groups. 
 n MLC n RC P 
Total weight gain (kg) 24 10.9 ± 0.9 21 8.2 ± 1.5 0.209 
Meeting target vs not meeting weight gain target  24 - 21 - 0.039† 
¥Below target (%)  41.7 12 57.1  
¥Within target (%)  41.7 3 14.3  
¥Above target (%)  16.7 6 28.6  
Gestational age (weeks) 24 38.7 ± 0.2 21 38.6 ± 0.2 0.973 
Mode of delivery (Vaginal vs Caesarean) 24 - 21 - 0.203† 
Vaginal delivery (%) 24 70.8  52.4  
Normal (% Vaginal)  88.2  72.7  
Vacuum Extraction (% Vaginal)  5.9  18.2  
Forceps-Liftout (% Vaginal)  5.9  9.1  
Elected Caesarean (%)  12.5  38.1  
Emergency Caesarean (%)  16.7  9.5  
Induction (Yes, %) 16 66.7 8 38.1 0.055† 
Insulin treatment (Yes at term, %) 14 58.3 12 57.1 0.936† 
Final daily insulin dose (units) 14 14.6 ± 1.8 12 21.2 ± 3.9 0.126 
∆ Insulin from enrolment (units) 14 7.1 ± 1.8 12 8.7 ± 4.6 0.748 
Abbreviations: MLC – modestly lower carbohydrate (diet); RC – routine care (diet); LGA – large-for-gestational age; PI – Ponderal 
Index; SGA – small-for-gestational age; SEM – standard error of the mean;  
Values presented as mean ± SEM; P <0.05 deemed significant; P value obtained from Independent samples t-test; 
† Pearson’s chi-square test of independence  
 
 
 
 
 
 
 
 
 
 
  
 
100 
Table 3.10 Infant characteristics at delivery.  
 n MLC n RC P 
Sex 23  19  0.853† 
Male (%)  52.2  55.0  
Female (%)  47.8  45.0  
Birthweight (g) 24 3125 ± 101 20 3278 ± 79 0.253 
Birthweight within vs outside normal 
range 
24 - 20 -  0.408† 
SGA (%) 24 25.0 20 14.3 <0.0001 
LGA (%) 24 0 20 4.8 <0.0001 
Macrosomia (%) 24 4.2 20 4.8 <0.0001 
Length (cm) 16 47.9 ± 0.7 10 49.2 ± 0.4 0.195 
Head circumference (HC, cm) 22 33.9 ± 0.3 17 34.9 ± 0.3  0.046 
HC/length  16 0.70 ± 0.01 10 0.71 ± 0.01 0.301 
HC/birthweight  22 0.11 ± 0.00 17 0.11 ± 0.00 0.270 
PI (kg/m3) 16 2.7 ± 0.1 10 2.7 ± 0.1 0.832 
Fat Mass (%) 7 7.2 ± 2.2 8 10.1 ± 1.0 0.233 
Fat Free Mass (%) 7 92.8 ± 2.2 8 89.9 ± 1.0 0.233 
Abbreviations: MLC – modestly lower carbohydrate (diet); RC – routine care (diet); LGA – large-for-gestational age; PI – Ponderal Index; 
SGA – small-for-gestational age; SEM – standard error of the mean; Values presented as mean ± SEM; Differences between groups 
determined using Independent t-test; P <0.05 deemed significant. † Pearson’s chi-square test of independence. 
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Figure 3.4 Birthweight stratified by weeks gestation at delivery and infant gender using the 
Australian National Birthweight percentiles (1998-2007) as the comparator. MLC – 
modestly lower carbohydrate (diet); RC – routine care (diet). 
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Figure 3.5 Infant outcomes based on maternal dietary intervention group. A) There was no 
association between diet and birthweight (n = 43, P = 0.149). B) A modestly lower 
carbohydrate (MLC) diet was associated with a statistically lower head circumference in 
the infant (n = 39, P = 0.043) compared to routine care (RC) diet. C) There was no 
association between diet and fat mass (FM%), (n = 15, P = 0.264). All 3 models adjusted 
for maternal gestational weight gain and weeks gestation at delivery. Unlike A and B, 
model C did not adjust for infant sex due to small sample size.  
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3.4  Discussion  
In this pilot RCT, women with GDM who were instructed to follow a MLC diet had average blood 
ketone levels and glucose control similar to those of women assigned to routine management of diet 
in GDM.  Even after a typical overnight fast when carbohydrate stores in liver are likely to be 
depleted, there was no sign of ketonaemia in either treatment group.  Our most surprising finding, 
however, was a significantly smaller head circumference in infants born to mothers assigned to the 
MLC diet (MLC 33.9 vs RC 34.9 cm). All infants in the MLC group fell within the range of the 10-25th 
percentile, while those receiving RC fell within 25-50th percentile range. This difference was seen in 
the absence of differences in birthweight and birth length, and remained significant after adjustment 
for infant sex, weeks gestation and maternal weight gain.  In addition to lower carbohydrate intake, 
mothers assigned to the MLC diet group ingested less energy and fewer micronutrients, including 
iron and iodine.  These additional factors raise concerns and may explain the difference in head 
circumference. Given the potential of head circumference to reflect brain development (318), larger 
studies of restricted carbohydrate intake in GDM are warranted.  
There are relatively few studies in GDM with which to compare the present study, although 
carbohydrate-restricting diets often led to a reduction in energy intake (319, 320) in animal models. 
Interestingly, even with energy restriction of the order of 30-33%, there was no evidence of 
ketogenesis (321, 322). However, when energy restriction reached 50%, ketonuria increased 2 to 3-
fold (321). While energy restriction has been reported to reduce maternal weight gain (323, 324) and 
birthweight in early studies (325) in animal models, there are concerns over safety (150). In 
pregnancy, energy-restricted eating patterns are likely to negatively impact daily nutrient targets 
(326). In the present study, the MLC diet group reported significantly lower dietary absolute intakes 
of iron and iodine. Any deficiency in dietary intake may have been overcome by additional 
micronutrients derived from the pregnancy multivitamin (100% usage in our study). Even carefully 
designed low carbohydrate diet models failed to provide sufficient iron to non-pregnant women 
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(326). While others have reported no differences in micronutrients between diets containing <40% 
vs ≥40% carbohydrate (327), a recent study suggested that low carbohydrate diets, particularly 
during early pregnancy, are associated with a greater risk of neural tube defects (328), likely due to 
reduced folic acid intake. Even in the context of frequent dietetic counselling, the recommended 
daily micronutrient targets for pregnancy were not achieved from dietary intake alone. These 
findings underline the importance of vitamin and mineral supplements to complement dietary intake 
to help achieve the daily nutrient targets during pregnancy. 
The MLC diet did not appear to provide any additional benefit for glucose management.  Average 
glucose levels and HbA1c were comparable in the two treatment groups. However, a systematic 
review and meta-analysis exploring varying degrees of carbohydrate restriction, suggested that 
moderate and high carbohydrate diets were both capable of reducing HbA1c levels in non-pregnant 
populations with type 1 and type 2 diabetes (61). Indeed, Hernandez and colleagues demonstrated 
that when compared to a lower carbohydrate diet, a high carbohydrate intake in GDM pregnancy 
resulted in improvements in glycaemia (296), insulin sensitivity and a trend towards lower infant 
adiposity (329).  
The controversy surrounding the most effective therapeutic diet for GDM management continues 
unabated. On one side, a high carbohydrate diet was reported to reduce the risk of macrosomia in 
an observational study (330) or suggested greater infant thinness (331). However, other studies 
reported either no association between birthweight and carbohydrate intake (332) or suggested a 
reduced risk of LGA infants with a low carbohydrate diet (191).  The mixed findings may relate to the 
heterogeneity of carbohydrates (333) with varying effects on glycaemia, insulin resistance and health 
outcomes. At the present time, it would be unacceptable to prescribe a diet of specific carbohydrate 
quantity without consideration of its quality, including GI, dietary fibre and free sugar content.  
Carbohydrate restriction has the potential to increase dietary fat intake, including saturated fat, 
which may promote accelerated fetal growth (334). Our study, on the other hand demonstrated the 
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opposite, i.e. the relative difficulty in increasing protein and fat intake despite dietary counselling, 
resulting in an energy difference of ~1000-1500 kJ. The higher cost of meat and food safety concerns 
in pregnancy may partially explain our results (335, 336). Interestingly, with respect to fat, our study 
indicated that both groups exceeded the recommendation for saturated fat intake (<10% EI).  
Saturated fat intake has been associated with increased infant birthweight (337) and unfavourable 
effects on glycaemia (HbA1c), C-peptide and insulin sensitivity (70). However, there was no 
difference in birthweight or glycaemia in the two groups. 
Carbohydrate intake in the MLC group was approximately 3 times greater than the minimum 
suggested to induce ketosis in a non-pregnant population (338, 339). The blunting of ketosis cannot 
be attributed solely to having adequate amount of carbohydrates, as protein, although less efficient, 
was also shown to reduce ketosis  (338). A 2-week 150 g carbohydrate/day intervention in pregnant 
obese women with GDM suggested a modest rise in blood ketone levels (~0.26 mmol/L) (297), but 
lower than the threshold for ketonaemia (>0.5 mmol/L). In other LC intervention studies in GDM, 
only a small number of participants tested positive to ketonuria in either the intervention (n = 2) 
(191) or control groups (n = 1) (44). These findings suggest that ketogenesis is low when carbohydrate 
is only modestly reduced.  
Interestingly, when the statistical model in the present study was adjusted for age and pre-pregnancy 
BMI category, higher BMI appeared to offer some protection from high blood ketone levels. In non-
pregnant women, obesity is associated with significantly lower blood ketone concentration, despite 
elevated free fatty acids (FFA) (340). Since ketone production is usually strongly correlated to FFA 
concentration (341), these findings imply that obesity may impair the liver’s ability to convert FFA to 
ketones (340), potentially due to fatty liver or inflammation. In GDM pregnancies, elevated levels of 
FFA are associated with increased insulin resistance (342) and excess fetal growth (343). 
The finding of lower infant head circumference in the MLC group raises some concern because of its 
direct relationship to brain volume (344) and association with intelligence (345).  According to one 
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study, high birthweight and head circumference predicted better cognitive performance at around 
10 years of age (346). Aside from infant sex (347), covariates such as socio-economic status (348) 
and maternal dietary exposure to acrylamide (349) have been linked to infant head circumference. 
However, no association was observed with respect to maternal pre-pregnancy BMI (350) and 
maternal stress during pregnancy (351). Our finding contrasts with that of Rhodes and colleagues 
who found that obese women who followed a low GL diet (~49% energy from carbohydrates) had 
infants of significantly larger head circumference at birth when compared to a low-fat diet (~52% 
energy from carbohydrates) (352). Moses and colleagues reported no differences in infant head 
circumference in women prescribed a higher GI diet during pregnancy, although the higher GI diet 
suggested higher birthweight in infants (353). Our intervention had a much lower proportion of 
energy derived from carbohydrates and our population of pregnant women had greater metabolic 
disturbance. In the present study, there was no difference in dietary GI between the intervention 
groups.  
Our study has strengths and limitations. An important constraint was the precision of the Optium™ 
meter, which reported measurements to 1 decimal point. We were therefore unable to distinguish 
values such as 0.11 from 0.14 mmol/L. While this may have meant that we missed small differences 
in ketone concentration, the clinical significance would be uncertain.  The candidate (a graduate 
dietitian) was responsible for all aspects of the study, including screening, recruitment, 
randomisation, education, and blood ketone assays in the clinic. The lack of blinding to treatment 
may have introduced bias in interpretation of results. All neonatal outcomes including head 
circumference were obtained from the medical records and may be prone to error including but not 
limited to inexperience of data collector and infant’s hair volume (354). Our study was underpowered 
to due to slow recruitment rate at the clinic. In the last few weeks of the study, a temporary 
researcher assisted with recruitment. Dietary compliance and treatment fidelity proved to be an 
important issue as some GDM participants were already restricting their intake of carbohydrate at 
baseline.  Previous studies have suggested greater underreporting in pregnant women with higher 
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BMI (355, 356) and lower education (356).  Finally, we excluded an extreme outlier with a very low 
energy intake (>2 SD below the mean of the group).  
 
3.5  Conclusion 
Modest reductions in carbohydrate intake do not result in greater ketone concentration or improved 
glucose control in GDM. However, the lower carbohydrate dietary strategy resulted in significantly 
lower intake of energy and of important micronutrients.  Although there were no adverse pregnancy 
outcomes, the lower infant head circumference in the lower carbohydrate treatment group suggests 
that additional studies with appropriate power are warranted to further examine the suitability of 
carbohydrate restriction during pregnancy.  
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Chapter 4 
___________________________________________________ 
 
 
 
 
 
Ketone levels in women with 
gestational diabetes mellitus: a 
pilot cross-sectional study 
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Abstract 
 
Background: There are growing concerns over elevated ketone levels in pregnancy due to potential 
negative effects on fetal brain development. The increasing popularity of low carbohydrate diets 
among pregnant women with gestational diabetes mellitus (GDM) makes further research more 
urgent. 
Objective: To investigate random blood and urine samples for presence of ketones in women 
diagnosed with GDM and assess whether there is an association with the maternal diet.  Additionally, 
maternal diet was compared to infant’s body composition at birth.  
Method: A total of 161 women were recruited into a pilot cross-sectional study (MAMI 2) conducted 
at Campbelltown (n = 40) and Royal Prince Alfred (RPA) Hospitals (n = 121) in Sydney, Australia. 
Maternal anthropometry, 12-hour dietary recall and blood and urine samples were collected at 
enrolment. Neonatal anthropometry and body composition (RPA only) data were taken from medical 
records. 
Results: Participants were comparable between study sites, with the exception of age and 
carbohydrate quality, with Campbelltown women being younger and more likely to consume foods 
of a higher GI and GL. Average random blood ketone levels were similar between sites (0.1 mmol/L). 
There was a trend toward higher blood ketone in the lowest vs highest tertiles of carbohydrate (%EI) 
(OR = 2.14, 95% CI: 0.98 – 4.64, P = 0.055) after adjustment for pre-pregnancy BMI, energy intake 
and GWG (2nd – 3rd trimester). Urinalysis indicated the presence of ketones in 14% of the overall 
population with a positive correlation between urinary and blood ketone levels (n = 19, rS = 0.717, P 
<0.001).  
Conclusion: Women consuming lower levels of carbohydrate intake (%E) may have higher levels of 
blood ketones, suggesting that carbohydrate intake was not sufficient to prevent ketogenesis from 
fat stores. This difference may not be clinically significant (<0.5 mmol/L).  
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4.1  Introduction 
Pregnancy is a transient state in a woman’s life characterised by metabolic changes to support the 
normal growth and development of her fetus (150). However, women with GDM experience greater 
metabolic and oxidative stress than their non-GDM counterparts (357), and often have greater 
complications of pregnancy including macrosomia and shoulder dystocia (298). With prevalence 
reaching 30% in some regions (178), developing cost-effective GDM management strategies is an 
urgent priority.  
Diet advice and PA are often prescribed as the first line of management for women with GDM, with 
insulin and other hyperglycaemic lowering agents as secondary interventions. Self-regulated dietary 
manipulation, such as a reduction in carbohydrate intake, has been reported in an observational 
study comparing intake of pregnant women with GDM and their non-pregnant counterparts (317), 
presumably in the hope of achieving better glycaemic control. Current dietary approaches of 
mothers-to-be may be influenced by the growing popularity of LC diets, as exemplified by the 
emergence of a plethora of diet books and dietary products (37). With reductions in carbohydrate 
intake, the body shifts towards greater fat than carbohydrate oxidation (358), with ketone bodies 
produced as a by-product.  
Ketones such as BHB are part of normal fat metabolism (106) and can provide energy to the brain 
with up to 20% greater efficiency than glucose (111). However, despite this, the fetus has a greater 
preference for glucose (153). In fact, an accelerated starvation response can be observed within 16 
hours of fasting in the late stage of pregnancy (124), whereby fatty acids are mobilised for maternal 
use and glucose is diverted for fetal needs (109). While some studies are in favour of lowering 
carbohydrate intake for management of GDM pregnancies (191), others have cautioned about this 
approach due a potential link between higher ketone concentrations (Chapter 1.12) and negative 
effects on fetal brain development (194, 196).  
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In most clinical settings, pregnant women have urinalysis to test for ketones and other metabolic 
markers, including protein, glucose and leukocytes. However, blood ketone levels are deemed more 
reflective of the current ketone status in the body than urinalysis, as exemplified by a faster clearance 
of ketones in blood that in urine (359). Since ketone levels rise following a prolonged fast in 
pregnancy and are considered undesirable for fetal growth and development, our aim was to 
determine the range of ketone levels in a random blood and urine sample of women diagnosed with 
GDM. We hypothesised that blood and urine ketone levels would be higher in women who consumed 
less dietary carbohydrate in the previous 12 hours and may be associated with infant birth weight 
and body composition.  
 
4.2  Methods and materials 
MAMI 2 was a pilot cross-sectional study that emerged because of slow recruitment rate 
encountered during the main RCT, MAMI 1. MAMI 2 provided us with an opportunity to answer a 
simple question on the relationship between dietary carbohydrates and body ketones as well as 
explore pregnancy outcomes in a GDM population. The study was conducted between December 
2016 to March 2018 at Campbelltown and RPA Hospitals in Sydney, Australia.  Campbelltown is a 
socio-economically disadvantaged suburb in Greater Sydney area with a population close to 160 000 
(360). RPA Hospital is situated in the Inner West Sydney area and is a teaching hospital of the 
University of Sydney. While the number of residents in the Inner West Sydney area are similar to that 
of Campbelltown area, they generally have a higher income (361).   
Participants were approached by the research dietitian (J.M.) during GDM education sessions at the 
antenatal GDM clinic, either in the morning (RPA) or afternoon (Campbelltown). Recruitment criteria 
included pregnant women diagnosed with GDM, ≥18 years and 24-35 weeks gestation. Women were 
not excluded if they had multiple-gestation pregnancy, medication and insulin use, or current alcohol 
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or smoking status, but needed to understand the English language. The women previously 
underwent a 2-hour, 75 g OGTT using the ADIPS with either an older (1998 ADIPS) (362) or more 
recent (2013 ADIPS) (363) diagnostic criteria. Any one of the following were deemed sufficient for 
GDM diagnosis:  
1998 ADIPS  
1.) Fasting BGL ≥5.5 mmol/L; 
2.) 2-hour post 75 g oral glucose load ≥8.0 mmol/L.  
2013 ADIPS  
1.) Fasting BGL 5.1–6.9 mmol/L;  
2.) 1-hour post 75 g oral glucose load ≥10.0 mmol/L;  
3.) 2-hour post 75 g oral glucose load 8.5–11.0 mmol/L.  
 
The study was approved by the South-Western Sydney Local Health District (HE16/367) and Human 
Research Ethics Committee of the Sydney South West Area Health Service (RPA Hospital Zone 
HREC/15/RPAH/397) Ethics Committee.   
Last recorded maternal weight, mode of delivery, gestation length and neonatal anthropometry, 
including birthweight, length, head circumference and Pea Pod® data (RPA hospital only) were all 
obtained from electronic medical records. Pea Pod® employs air displacement plethysmography to 
assess infant’s body composition, including fat mass (%FM) and fat-free mass (%FFM) (364). While 
Pea Pod® data collection is part of routine care at RPA, only 59 neonates (49.1%) had their body 
composition assessed. This could be related to several reasons but not limited to mother being 
placed in a ward further away from Pea Pod® data collection site. The WHO growth charts (weight 
for gestational age, gender specific) (365, 366) and the Australian national birthweight percentiles 
(312) were used to determine whether neonates were born <10th percentile (small-for-gestational-
age, SGA) or >90th percentile (large-for-gestational-age, LGA).   
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Figure 4.1 Air displacement plethysmography (Pea Pod®) device. 
 
Consenting participants completed a 1-page form detailing their anthropometry (including self-
reported pre-pregnancy weight), self reported sleep duration, blood glucose levels, as well as a 12-
hour dietary recall, capturing food intake from dinner the previous day, to breakfast the present day. 
Twelve-hour recall was employed to ascertain the effects of acute dietary carbohydrate consumed 
in the 12 hours prior and their effects on ketone concentrations. Women were also asked to provide 
urine and blood samples for ketone analysis (Table 4.2). At RPA, urine analysis is routinely collected 
and analysed using 77 Elektronika Kft.® LabStrip U11 Plus. The urine strip tests for 11 parameters 
including presence of blood, glucose, specific gravity, bilirubin, protein, nitrite, urobilinogen, 
leucocytes, ketones, pH and ascorbic acid. At the initial visit, a nurse demonstrates to participants 
how to assess their urine sample against a standard colour chart. Upon subsequent visits, pregnant 
women were encouraged to conduct the urine analysis themselves. Since urine testing was not part 
of Campbelltown Hospital’s standard practice, urine samples were analysed by the study research 
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dietitian using SIEMENS Multistix® 10 SG. Much like LabStrip U11 Plus, Multistix also assays multiple 
parameters including ketones, glucose, bilirubin, ketone, specific gravity, presence of blood, pH, 
protein, urobilinogen, nitrite and leukocyte esterase.  A ketone conversion factor (0.17212) was used 
to convert urine results from mg/dL to a standard metric unit, mmol/L. Aside from ketone, the 
additional parameters observed in the urine included glucose, leukocytes and protein.   
 
Table 4.1 MAMI 2 study collection plan 
 Consent Maternal 
Anthropometry 
Blood and 
Urine Ketone 
Blood 
Glucose 
12-Hour Diet 
Recall 
Infant 
Anthropometry 
Enrolment 
(24-35 
weeks)      
 
Birth of 
baby 
     
 
 
Non-fasting blood ketone tests were conducted by the research dietitian using an Optium™ meter 
and Optium™ β-ketone test strips (Abbott, Macquarie Park, Australia). The monitor was designed to 
measure either blood glucose or ketone levels (in the form of BHB), provided that corresponding 
strips are inserted. Optium™ β-ketone test strips contain 3 electrodes, including a fill trigger, working 
and reference electrodes (307).  Participants were required to have clean and dry hands prior to 
every finger prick using the disposable lancets provided (Accu-Chek, Roche Diagnostics GmbH, 
Mannheim, Germany). The ketone monitor requires ~0.6 μL of blood sample on the ketone test strip 
to be able to produce a reading, often within 10 seconds. A previous report suggested that hand-
held monitors and their electrodes were accurate and comparable to the laboratory analysis of blood 
ketone (129) levels, with strip sensitivity ranging between 0.1-2.0 mmol/L (317).  
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Figure 4.2 FreeStyle Optium Neo meter and corresponding ketone strips (Abbott).  
Dietary information was entered by the research dietitian into the Australian nutrition analysis 
computer software (FoodWorks Professional Version 8, 2015, Xyris Software, Brisbane, Australia), 
based on AUSNUT 2011-2013 database.  
 
4.1.1  Statistical analysis 
 
Statistical analyses were conducted using SPSS (version 24, IBM Australia, St Leonards, Australia) and 
SAS Statistical Software, Version 9.4 (SAS Institute Inc., Cary, NC). Descriptive data are presented as 
mean ± SEM for continuous variables and numbers (n) and percentages (%) for frequency variables. 
Variables were checked for normality. For categorical outcomes, comparisons between groups were 
conducted using either the chi square or Fisher’s exact test. For continuous outcomes or differences 
between 2 study sites in terms of dietary intake, we used an independent samples t-test or Mann-
Whitney U test. Associations between maternal variables (including age, dietary intake and 
anthropometry) and infant body composition were calculated using bivariate analysis, with either 
Pearson (rρ) or Spearman (rS) correlation coefficients, where it was deemed appropriate. A 
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participant with twins was excluded from further analysis, thereby bringing the final number of 
participants to 160.  
Data were transformed if non-normal to meet the assumptions for linear regression. We used crude 
and adjusted logistic linear regression to assess the association between varying amounts of 
carbohydrate intake on odds of developing elevated blood ketone levels. Ketone levels were 
stratified into 3 categories, namely 1) <0.1 mmol/L (n = 28), 2) 0.1 mmol/L (n = 92) and 3) ≥0.2 mmol/L 
(n = 41). The latter logistic linear regression model adjusted for maternal pre-pregnancy body mass 
index (BMI), age and GWG at enrolment. Carbohydrates, GI and GL were split into their respective 
tertiles based on 12-hour maternal distribution of food intake.  
Firth corrected logistic regression was used to assess the association between GWG and infant 
outcomes (birthweight and body composition), while adjusting for maternal pre-pregnancy BMI 
(continuous), age (continuous), weeks gestation at delivery, infant gender and maternal percent (%) 
glycosylated haemoglobin (HbA1c) levels (high vs low). The Firth method assists in eliminating bias 
associated with small sample sizes (<50 people) (367). Infants’ birth weights were stratified into 
either a lower (≤3230g, n = 77) or a higher range (≥3235, n = 76) based on the median value. Total 
and 3rd trimester GWG were compared against IOM weight gain guidelines for each BMI category.  
Since the study participants varied in their gestational age at enrolment (25-35 weeks), we defined 
3rd trimester as 10-13 weeks duration, i.e. from 27 weeks onwards (n = 37). Odds Ratios (OR) and 
95% confidence intervals (CIs) were calculated and a P-value <0.05 was used to define statistical 
significance. 
 
4.3  Results  
A total of 204 women were approached at RPA and 110 at Campbelltown Hospital, of which 121 
(59%, with 1 later excluded) and 40 (36%) consented to take part in the study, respectively (Total n 
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= 160). Cumulative recruitment rate of study participants is shown in Figure 4.3. Key screening 
outcomes were obtained for most participants and their offspring, including maternal blood ketone 
(100%) and glucose (99%) levels, urine analyses (91%), Pea Pod® data (47%, RPA only), birthweight 
(96%), baby length (71%), head circumference (89%) and dietary intake (100%).  
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Cumulative recruitment of participants at Royal Prince Alfred (RPA) 
and Campbelltown Hospitals. 
 
On average, participants from Campbelltown had comparable BMI, total and GWG at enrolment to 
women at RPA, however they were slightly younger and had higher HbA1c (Table 4.2).  Blood ketone 
levels were similar at both study sites (mean ± SEM mmol/L, RPA 0.1 ± 0.0 versus Campbelltown 0.1 
± 0.0) and well below the threshold for ketonaemia (>0.5 mmol/L). Based on the 12-hour recall, 
maternal diet was generally comparable between the study sites. The exception was GI and GL, which 
were statistically lower in the RPA group (Table 4.3). 
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We observed a time-gap ~1.4 weeks between delivery and date of last recorded maternal weight. 
When stratified according study site, the gap was larger at Campbelltown Hospital (P = 0.002). When 
the rate of weight gain for the 3rd trimester (10-13 weeks until delivery) was stratified according to 
BMI category and compared to IOM recommended rate of GWG, we found that 59% of women were 
below the target, ~24% were above and only 15% met the target rate. Third trimester rate of GWG 
was not associated with increased odds of having a larger infant birthweight (results not shown).      
When total GWG was compared to IOM’s guidelines, 38% of women did not gain sufficient weight, 
31% exceeded and 31% met the weight criteria for their respective BMI category. Using alternate 
weight gain recommendations suggested by Faucher et al. (368), 36% of women did not gain 
sufficient weight, 34% exceeded and 30% met the weight criteria (results not shown). We also 
observed weight loss in some obese women, reaching up to -15 kg by end of pregnancy.  
Maternal age was strongly and positively correlated to pre-pregnancy BMI (rS = 0.254, P = 0.001), 
however BMI was negatively associated with 2nd-3rd trimester weight gain (rS = -0.256, P = 0.001) 
(Figure 4.4). The relationship was also significant when total GWG was compared to maternal pre-
pregnancy BMI (results not shown, n =152, rS = -0.252, P = 0.002). We found no association either 
between sleep and blood ketone levels, or between sleep and blood glucose levels. 
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Table 4.2 Maternal characteristics combined or stratified according to their research sites.   
 Overall  
(n = 160) 
RPA  
(n = 120) 
Campbelltown  
(n = 40) 
P 
Age (years)  32.9 ± 0.4 33.3 ± 0.5 31.5 ± 0.8  0.019 
Pre-pregnancy BMI 26.3 ± 0.5 25.5 ± 0.5 28.8 ± 1.4 0.060 
Underweight n (%) 8 (5.0) 5 (4.1) 3 (7.5)  
Normal n (%) 79 (49.1) 66 (54.5) 13 (32.5)  
Overweight n (%) 37 (22.3) 27 (22.3) 10 (25.0)  
Obese n (%) 37 (22.3) 23 (19.0) 14 (35.0)  
Weeks gestation (enrolment) 30.9 ± 0.2 31.0 ± 0.3 30.7 ± 0.5  0.617 
Weeks gestation (delivery) 38.7 ± 0.2 38.7 ± 0.1 38.6 ± 0.2 0.340 
Weight gain (enrolment) (kg) 8.6 ± 0.4 8.3 ± 0.5 9.6 ± 0.9 0.364 
Total weight gain (kg) 10.8 ± 0.5 10.7 ± 0.6 11.5 ± 1.0 0.435 
¥Below target n (%) 58 (38.2) 47 (40.5) 10 (27.8)  
¥Within target n (%) 47 (30.9) 34 (29.3) 14 (38.9)  
¥Above target n (%) 47 (30.9) 35 (30.2) 12 (33.3)  
Rate of weight gain (3rd trimester, n = 34) 
¥Below target n (%) 20 (58.8) 15 (55.5) 5 (71.4)  
¥Within target n (%) 6 (14.7) 5 (18.5) 1 (14.3)  
¥Above target n (%) 8 (23.5) 7 (25.9) 1 (14.3)  
Ketone (mmol/L) 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0  0.885 
BGL (mmol/L)  5.9 ± 0.1 6.0 ± 0.1 5.4 ± 0.1 0.007 
HbA1c (%) 5.1 ± 0.0 5.1 ± 0.1 5.4 ± 0.0 <0.0001 
Mode of delivery 
Vaginal delivery n (%) 105 (67.3) 76 (65.5) 29 (72.5)  
Normal n (%) 75 (71.4) 53 (69.7) 22 (75.9)  
Vacuum Extraction n (%) 15 (14.3) 8 (10.5) 7 (24.1)  
Forceps-Liftout n (%) 15 (14.3) 15 (19.7) 0 (0)  
Elected caesarean n (%) 30 (19.2) 19 (16.4) 11 (27.5)  
Emergency caesarean n (%) 21 (13.5) 21 (18.1) 0 (0)  
Abbreviations: BGL – blood glucose levels; RPA – Royal Prince Alfred (Hospital) 
¥ Institute of Medicine gestational weight gain criteria; 
Values presented as mean ± SEM; Differences between groups determined using Independent t-test, P <0.05 deemed significant. 
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Table 4.3 Maternal dietary characteristics based on the 12-hour recall, combined or stratified 
according to the research sites.   
 
 
Overall  
(n = 160) 
RPA  
(n = 120) 
Campbelltown  
(n = 40) 
P 
Energy (kJ) 3890 ± 90 3870 ± 100 3940 ± 190 0.724 
Protein (g) 52.6 ± 1.6 52.9 ± 2.0 51.8 ± 2.9 0.918 
Total fat (g) 38.1 ± 1.4 37.9 ± 1.7 38.7 ± 1.1 0.820 
Saturated fat (g) 13.4 ± 0.6 13.1 ± 0.6 14.5 ± 1.1 0.295 
Carbohydrate (g) 87.2 ± 2.2 86.0 ± 2.5 90.6 ± 5.2 0.375 
Sugars (g) 30.8 ± 1.3 30.5 ± 1.4 31.6 ± 2.8 0.720 
Starch (g) 56.0 ± 1.7 55.1 ± 1.9 58.7 ± 3.7 0.356 
Dietary fibre (g) 12.3 ± 0.5 12.4 ± 0.5 12.0 ± 1.1 0.466 
GI 52 ± 1 51 ± 1 55 ± 1 0.008 
GL 46 ± 1 44 ± 2 50 ± 3 0.050 
Protein (%EI) 23.1 ± 0.5 23.3 ± 0.6 22.7 ± 0.9 0.720 
Carbohydrates (%EI) 38.4 ± 0.9 38.3 ± 1.0 38.7 ± 1.7 0.816 
Total fat (%EI) 35.0 ± 0.7 34.8 ± 0.9 35.4 ± 1.4 0.730 
Saturated fat (%EI) 12.4 ± 0.3 12.1 ± 0.4 13.4 ± 0.7 0.163 
Abbreviations: EI – Energy intake; GI – Glycaemic index; GL – Glycaemic load; RPAH – Royal Prince Alfred (Hospital).  
Values presented as mean ± SEM; Differences between groups determined using Independent t-test, P <0.05 deemed significant. 
 
 
 
 
 
 
 
 
 
 
 
  
 
121 
Figure 4.4  Association between maternal pre-pregnancy BMI and age. Bivariate analysis 
conducted using a Spearman correlation (rS = 0.254, P = 0.001).  
 
 
Figure 4.5 Correlation of maternal weight gain at enrolment and maternal pre-
pregnancy BMI. Grey areas indicate Institute of Medicine (IOM) 
gestational weight gain recommendations by BMI category.  Bivariate 
analysis conducted using Spearman correlation (n = 157, rS = -0.255, P = 
0.001).  
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4.3.1  Neonatal characteristics and anthropometry  
Of 159 births with information from medical records, 5 were born prematurely (<37 weeks 
gestation). Overall, there were more male than female neonates at both sites and no differences in 
their birthweights (Table 4.4). Based on the WHO birthweight-for-age growth chart, approximately 
11% of all birthweights met the SGA criteria, 4% were LGA. Using the Australian National birthweight 
percentiles, proportions of neonates deemed SGA were higher (14%) and comparable for LGA (5%). 
When compared to RPAH, Campbelltown site had higher rates of LGA regardless of which criteria 
was used to ascertain birthweight percentile.   
Infants from Campbelltown Hospital had greater birth length (P = 0.020) and subsequently lower 
ponderal index (PI) (P = 0.006) than infants from RPA Hospital. Higher maternal pre-pregnancy BMI 
was a predictor of greater birthweight (rS = 0.304, P <0.0001), infant head circumference (rS = 0.301, 
P <0.0001) and birth length (rS = 0.235, P <0.011). Maternal GWG at enrolment (24-35 weeks 
gestation) was positively correlated with birthweight (rS = 0.170, P = 0.036). When compared to 
women meeting the total gestational weight gain guidelines, those exceeding them had 3.4-fold 
increased odds of having an infant of higher birthweight (OR = 3.40, 95% CI:1.26 - 9.74, P = 0.007) 
(Figure 4.6). This model was strongly and significantly influenced by maternal age and gestational 
age at delivery.  
Body composition data were available for 59 neonates at the RPA Hospital.  Female neonates had a 
significantly higher %FM than their male counterparts (P <0.0001). Infant %FM was positively 
correlated with birthweight (rρ = 0.424, P = 0.003) and infant length (rρ = 0.399, P = 0.001).  In 
addition, we found no increased odds of having an infant with higher %FM at birth in women who 
exceeded total GWG guidelines (OR = 1.04, 95% CI: 0.20 - 5.25, P = 0.869) (Figure 4.6). In addition, 
we found no association with maternal dietary intake and any infant outcome (data not shown).  
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Table 4.4 Infant anthropometry outcomes combined or stratified according to their research 
sites, where possible.  
 
 Overall (n = 160) RPA (n = 120) Campbelltown (n = 40) P 
Male n (%) 84 (56.0) 65 (57.5) 19 (51.4)  
Female n (%) 66 (44.0) 48 (42.5) 18 (48.6)  
Birthweight (kg) 3250 ± 40 3250 ± 40 3250 ± 90 0.952 
Male mean (kg) 3260 ± 50   
0.922 
Female mean (kg) 3270 ± 50   
WHO criteria SGA n (%) 17 (11.3) 12 (10.0) 5 (12.5)  
WHO criteria LGA n (%) 6 (4.0) 2 (1.7) 4 (10.0)  
ANBP SGA n (%) 21 (13.9) 14 (12.3) 7 (18.9)  
ANBP LGA n (%) 7 (4.6) 2 (1.8) 5 (13.5)  
Length (cm) 50 ± 0.2 49 ± 0.2 51 ± 0.5 0.020 
HC (cm) 34.4 ± 0.1 34.4 ± 0.1 34.5 ± 0.3 0.842 
PI (kg/m3) 2.7 ± 0.0 2.7 ± 0.0 2.5 ± 0.1 0.006 
Fat Mass (%)  10.1 ± 0.6   
Male (%)   9.3 ± 0.9   
0.044 
Female (%)  11.8 ± 0.7  
¥Male (%)   8.6 ± 0.5   
<0.0001 ¥Female (%)  11.8 ± 0.7  
Fat Free Mass (%)  89.9 ± 0.6   
Abbreviations: ANBP - Australian National birthweight percentiles (312); %FFM/FM – Percent fat free mass/fat mass; 
HC - Head circumference; LGA – large-for-gestational age; SD – standard deviation; SGA – small-for-gestational age; 
Ponderal index – PI; WHO criteria – World Health Organization criteria (365, 366).   
 
¥ Comparing mean of %FM between male and female neonates, after removal of an extreme outlier.  
Values presented as mean ± SEM; Differences between groups determined using Independent t-test, P <0.05 deemed significant. 
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Figure 4.6  Odds ratios (OR) of higher birthweight or percent Fat Free Mass when Institute of 
Medicine’s (IOM) weight gain guidelines are exceeded. Multivariable models adjusted 
for BMI, maternal age, weeks gestation at delivery, baby gender and Hba1c category.  
 
4.3.2  Blood ketone and carbohydrate intake 
 
Tertiles of carbohydrate intake (%EI) are shown in Table 4.5.  Compared to the highest tertile, the 
lowest tertile had a 2-fold increased odds of having higher blood ketone levels, although the increase 
was not statistically significant at the 5% level (OR = 2.05, 95% CI: 0.97 – 4.34, P = 0.060) (Table 4.6). 
When the model was adjusted for pre-pregnancy BMI, energy intake and GWG at the time of 
enrolment, we observed similar findings (OR = 2.14, 95% CI: 0.98 – 4.64, P = 0.055).  
However, we found no relationship between highest vs lowest tertile of GI or GL and blood ketone 
levels (crude GI OR = 0.67, 95% CI: 0.32 – 1.41, P = 0.300; crude GL OR = 1.08, 95% CI: 0.52 - 2.26, P 
= 0.832). Further adjustment for pre-pregnancy BMI, energy intake and GWG at the time of 
enrolment yielded similar results (GI OR = 0.68, 95% CI: 0.32 - 1.44, P = 0.315; GL OR = 1.11, 95% CI: 
0.53 - 2.34, P = 0.776).  
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Table 4.5  Tertiles of carbohydrate intake (%EI) from the 12-hour recall.  
Percent (%EI) kJ Carbohydrate Mean Min Max  
Tertile 1 26.4 4.3 33.4  
Tertile 2 38.5 33.5 43.6  
Tertile 3 50.0 43.7 63.2  
 
 
Table 4.6  Carbohydrate content and odds of developing elevated ketones.  
 OR 95% CI Upper 95% CI 
Lower 
P 
Model 1† Tertile 3 versus 1 2.05 0.97 4.34 0.060 
 Tertile 3 versus 2 0.75 0.36 1.58 0.448 
Model 2‡ Tertile 3 versus 1 2.14 0.98 4.64 0.055 
 Tertile 3 versus 2 0.77 0.37 1.63 0.500 
Abbreviations: CI - confidence intervals; OR = Odds Ratio;  
P <0.05 deemed statistically significant  
†            Model 1 - Crude logistic regression model 
‡            Model 2 - adjusted for pre-pregnancy body mass index (BMI), age and gestational weight gain at enrolment. Carbohydrates 
tertiles based on the distribution of intake from the 12-hour diet recall.  
 
 
 
 
 
 
 
 
  
 
126 
4.3.3  Blood ketone and urine ketone 
Random urinalysis suggested presence of ketone (14%), glucose (7%), protein (29%) and leukocytes 
(40%) in a proportion of women at both study sites (Figure 4.7). Compared with RPA, Campbelltown 
Hospital had a greater proportion of women testing positive for protein and ketone in their urine 
(protein P  = 0.026; ketone P <0.0001). In women that tested positive for ketones in urine, their 
values were strongly and positively correlated with blood ketone levels (n = 19, R² = 0.37, rS = 0.717, 
P <0.001) (Figure 4.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Urinalysis of pregnant women with gestational diabetes mellitus 
(GDM). Blue represents the Royal Prince Alfred (RPA) and green 
represents the Campbelltown hospital. Chi square test and Fisher’s 
test were used to ascertain statistical difference, with P <0.05 (*) and 
P <0.001 (***) deemed as statistically significant.  
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Figure 4.8 Correlation between urine samples testing positive for ketone and their 
corresponding blood ketone levels. Bivariate analysis conducted using 
Spearman correlation (n = 19, rS = 0.717, P = 0.001).  
 
 
 
 
 
 
 
 
 
 
 
-5
0
5
10
15
20
25
30
0.0 0.1 0.2 0.3 0.4 0.5
U
ri
n
e 
K
e
to
n
e 
(m
m
o
l/
L)
Blood Ketone (mmol/L)
n = 19 
rS = 0.717 
P = 0.001 
  
 
128 
4.4  Discussion 
Our pilot cross-sectional study suggested a trend of increased (non-fasting) blood ketone levels when 
lowest tertile of carbohydrate intake in the previous 12 hours (~40% EI) was compared to highest in 
women with GDM, although non-significant. In another study of similar design and population, 
consumption of carbohydrates at bedtime resulted in lower fasting ketone concentrations (369).  
Approximately 40% of participants at Campbelltown Hospital had ketonuria (vs 3% at RPAH). Given 
that urinalysis was self-reported at RPAH and assessed by the researcher at Campbelltown Hospital, 
the difference could be attributed to observer bias (133) as well as sample collection at different 
time of day (morning vs afternoon). In a study by Robinson et al. 2018 ~22% of women between 16 
to 28 weeks gestation demonstrated detectable ketones, which subsequently dropped to 8% at 36 
weeks gestation (370).  
Our findings contrast with an observational study by Gin and colleagues (317), which found no 
correlation between dietary variables and ketonaemia. This could be explained in part by the 
relatively high intake (>200 g) of carbohydrate per day in their cohort of women, a level which may 
have been insufficiently low to induce higher level of ketones in blood. We also demonstrated a 
strong correlation between urine and blood ketone levels, which is in agreement with previous 
studies (130, 369).   
We found a negative correlation between maternal pre-pregnancy BMI and GWG.  However, ~70% 
of pregnancies still did not meet total GWG guidelines. While the current IOM’s GWG 
recommendation is fixed for all classes of obesity (5-9 kg), evidence from a comprehensive 
systematic review suggested ideal GWG should differ according to classes of obesity (Class I: 5-9 kg, 
Class II: 1 to <5 kg, Class III: no weight gain) as well as ethnicity (368).  In fact, when different classes 
of obesity were taken into consideration and then compared to IOM guidelines, 3% (IOM 31% vs 
Faucher et al. 34%) more women exceeded weight gain recommendations.  
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Our study did not find any association between rate of GWG in the 3rd trimester and infant 
birthweight.  Sridhar and colleagues (371) reported similar findings. However, their study suggested 
that GWG below IOM’s guidelines in the 2nd trimester generally increased the risk of having a SGA 
infant, but not among overweight or obese mothers (371). Excess weight gain in women of normal 
BMI in all trimesters increased the risk of LGA infant, but only 3rd trimester weight gain for overweight 
or obese women increased the risk (371). This suggests that there is still an opportunity to intervene 
and control the rate of GWG in GDM pregnancy (diagnosis 24-28 weeks gestation) and influence 
infant birthweight.  
While our study observed a weight loss of up to 15 kg among obese pregnant women, a retrospective 
study consisting of ~26,000 participants suggested that 3rd trimester weight loss in overweight and 
obese women with GDM improved maternal and neonatal outcomes (372). However, this was at the 
expense of increased odds of preterm delivery and having a SGA infant (372). With overweight and 
obesity on the rise (25) and women entering pregnancy with the excessive weight (373), more 
research on weight management and weight loss in overweight and obese women prior to 
conception is warranted.    
Despite being part of RPA Hospital’s routine care to collect Pea Pod® values at birth, only 49% of 
infants had their body composition measured. Female infants had higher %FM when compared to 
males, a finding supported by other studies (374, 375). When Pea Pod® measurement was compared 
to maternal dietary intake on previous 12 hours, we found no observable association with either 
%FM or FFM. In contrast, Kizirian and colleagues reported that higher maternal GI and carbohydrate 
intake during the 3rd trimester of pregnancy were associated with lower FFM and FM index, 
respectively (303). The lack of correlation in the present study could partially be attributed to our 
dietary collection tool, which did not capture a full day’s worth of food intake. While the relative 
validity of an electronic 12-hour dietary recall was in good agreement with a food frequency 
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questionnaire and four dietary records (376), a 3-day food diary capturing maternal weekday and 
weekend dietary intake would have provided a better insight into a participant’s typical diet (377).  
Although the present study found no association between sleep duration and blood glucose values, 
others have reported that lack of sleep could impair glucose metabolism (378, 379). Since sleep was 
self-reported, it may not be reflective of participant’s actual sleep duration, nor could it take into 
account periods of sleep disturbances, a common occurrence (~46%) among expectant mothers 
(380). While Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study suggested a 
moderate correlation between self-reported and objectively measured sleep, the mean of self-
reported sleep duration was 1-hr longer than mean of objectively measured sleep (381). Since sleep 
has clinical implications for blood glucose levels, this raises the importance of establishing sleep 
patterns, particularly in individuals with elevated blood glucose levels. 
Our study had strengths and limitations. We were limited in the reporting of blood ketone levels due 
to the narrow working range of Optium™ ketone monitors. This meant that values such as 0.11 vs 
0.14 mmol/L were not different (i.e. 0.1 mmol/L) and a 0.0 mmol/L reading could mislead the 
observer because under normal living conditions ketones are always present in the blood (106). 
Interestingly, Gin and colleagues measured blood ketone levels using the same device, but reported 
their measurements with up to 2 decimal places (317). Considering the device’s working range 
limitations, we resorted to using a categorical logistic regression analysis when determining the 
relationship to maternal carbohydrate intake. While this may have been the better option in terms 
of analysis, we still had an imbalance within the 3 categories of ketones, which could have influenced 
our results. Since we investigated non-fasting blood ketones, their levels could have declined due to 
a surplus of carbohydrates following breakfast, thereby preventing us from determining the true 
extent of their rise in the morning. We believe that future studies, which specifically assess fasting 
blood ketone levels using a device with greater precision will demonstrate greater odds of having a 
rise in blood ketones levels due to lower consumption of carbohydrate (%EI). In addition, due to 
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time-restraint, the study did not capture data on ethnicity, which could have potentially explained 
the differences in blood glucose concentrations between the sites. 
 
4.5  Conclusion  
Under standard living conditions in GDM population, we did not find extreme high blood ketone 
levels. Our study, however, suggested a trend between lower compared to higher tertiles of 
carbohydrate intake and rise in blood ketone levels, although non-significant and below the 
threshold for ketonaemia (<0.5 mmol/L).   
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Discussion of main findings and future directions  
Overweight and obesity, delayed age of motherhood and adoption of the new GDM diagnostic 
criteria are just some of the factors driving an increase in the rates of GDM (160, 176, 177). GDM is 
associated with numerous complications in pregnancy as well as epigenetic changes in the offspring, 
instigating a vicious cycle of metabolic diseases for many generations to come (165). In Chapter 1, 
we summarised current evidence supporting the use of LC diets to normalise blood glucose 
concentrations within the accepted ranges for GDM.  Unfortunately, there were only a handful of 
studies available (44, 190, 191, 295). On closer inspection of the literature, studies on LC diets in non-
pregnant populations indicated conflicting evidence with respect to their effects on weight loss, 
serum glucose, insulin, cholesterol (LDL-C and HDL-C) and triglyceride concentrations. Inconclusive 
findings were largely attributed to heterogeneity in study design, duration and differences in target 
populations (e.g. obesity, T2DM).  
In Chapter 2, a systematic review and meta-analysis was conducted specifically targeting prospective 
observational studies that reported on dietary intake and PA levels before and in early pregnancy on 
the risk of developing GDM. With respect to dietary studies, frequent consumption of potato and 
protein (% energy) derived from animal sources, particularly processed meats, suggested a higher 
risk of GDM. On the other hand, the Mediterranean diet (MedDiet), dietary approaches to stop 
hypertension (DASH) diet and  higher alternate healthy eating index (AHEI) reduced the risk by ~15-
38% (182). While engagement in PA has been previously shown to improve insulin sensitivity (382), 
our meta-analysis suggested for the first time that engagement in leisure time PA before and in early 
pregnancy above >90 min/week, may reduce the odds of GDM by 46% (182). These findings raise the 
importance of modifiable lifestyle factors in disease prevention and provide hope and possible 
direction for future management of GDM.   
While there is no consensus at present on the most effective diet for GDM treatment (185), certain 
endocrine societies recommend a LC diet to achieve normoglycaemia (188, 383), despite the lack of  
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evidence for their safety in pregnancy. In Chapter 1, we established that LC diets can augment 
enhanced FAO to BHB and that this metabolic parameter has been inversely correlated to child’s 
intelligence (196). The implication is that LC diets in pregnancy might reduce child IQ by increasing 
the concentration of maternal blood ketones. Therefore, MAMI 1 RCT was a pilot study undertaken 
to investigate the safety of LC diets (Chapter 3) and MAMI 2 explored the association of carbohydrate 
intake in the previous 12 hours with BHB levels (Chapter 4). To our knowledge, the RCT is the longest 
(6 weeks) intervention study which compared the effects of modestly lower carbohydrate diets and 
conventional healthy diets (135 vs 180-200 g/day carbohydrate) on blood BHB levels in GDM. While 
there were no observed differences in BHB levels following a reduction in absolute carbohydrate 
intake, there were also no apparent benefits for glycaemia and insulin dosing. Certainly, the most 
surprising finding was a statistically smaller (~1cm) head circumference in the treatment group when 
compared to routine dietary advice. According to the Australian birthweight database and Centre for 
Disease Control and Prevention (CDC) growth charts (313-315), this meant that the head 
measurements were either within the 10th to 25th percentile, or between 25th to 50th percentile for 
MLC and RC diets, respectively. Because there is a strong correlation between head circumference 
and brain volume (344), as well as brain volume and intelligence (345), this raises questions of safety 
or negative long-term effects on offspring brain development. However, in the context of GDM, it 
could also be suggested that a smaller head circumference may be beneficial in promoting more 
vaginal deliveries, however we found no statistical difference between modes of delivery between 2 
study arms of MAMI 1 study (P = 0.203).  
A follow up study on MAMI 1 offspring could be useful in determining whether differences in head 
circumference persist into childhood and whether there are any implications for their psychomotor 
performance. However, factoring in the limited number of participants who completed MAMI 1 
study (n = 33), the sample size may be too low. To help address this issue and to further investigate 
the relationship between carbohydrate restriction and infant head circumference, there are 3 
possible paths to undertake (Figure 5.1). Firstly, we could explore the published literature on dietary 
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intake in pregnancy and neonatal measurements, in the hope of obtaining not just carbohydrate 
intake and head circumference, but also other metabolic parameters of interest (e.g. glycaemia, 
BHB). According to a recent study exploring the effects of western, healthy and traditional dietary 
patterns in early pregnancy, there were no reported differences in infant head circumference 
between the study groups. However, in all these groups, carbohydrate intake (210-341 g/day) 
exceeded the amount prescribed in the MAMI 1 study (384). On the other hand, a cross sectional 
study suggested that higher %EI from carbohydrate was associated with lower infant head 
circumference (385). The authors, however, noted that the study effect size estimate was reasonably 
small (β ≤−0.01), thereby limiting generalisability of their findings (385). Since neither study 
investigated serum BHB concentrations in a GDM population, it may be difficult to collate evidence 
from studies which have been designed to test a different hypothesis.   
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Figure 5.1 Framework for further investigation of the possible relationship between 
modestly lower carbohydrate (MLC) diet or energy restriction and infant head 
circumference.  
 
Secondly, we could use animal models comparing low and high carbohydrate diets as this has been 
a relatively popular focus of study. In one study, a ketogenic diet in mice resulted in embryonic brain 
growth deviating from the established norm, suggesting possible behavioural changes after birth 
(198). According to another rodent model, carbohydrate quantity rather than type and quality 
influenced fetal brain mass, with lower intake associated with a reduction in brain mass (386). 
Restriction of maternal carbohydrates was also reported to lower concentrations of an important 
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neurotransmitter (5-hydroxytryptamine) for brain development (386). These findings could explain 
the mechanism behind lower head circumference observed in the MLC group of our MAMI 1 study.  
Clearly, animal studies provide sufficient reason to undertake human studies of larger sample size. 
Lastly, we propose that the MAMI 1 study is conducted on a larger scale to confirm findings reported 
in our pilot study. Apart from simply increasing participant numbers, incorporating a control group 
of healthy pregnant women without GDM could assist in establishing whether the head 
circumference phenomenon was mediated by differences in glycaemia, insulinaemia, or ketonaemia. 
The pilot study also demonstrated the relative difficulty in increasing protein and fat intake without 
producing an energy deficit (~1000-1500 kJ), despite dietary counselling. We speculate that the 
relatively high cost of meat (336) and advice to restrict intake of fish, processed or deli-style cold 
meats due to food safety concerns (335), may be partly to blame. The protein leverage hypothesis is 
also relevant.  It proposes that individuals have a protein target that must be reached each day 
irrespective of carbohydrate and fat intake. Thus higher intake of high-protein foods brings about a 
reduction in intake of carbohydrate and fat, and therefore energy (387). On the other hand, advice 
to consume a high carbohydrate (or a high fat diet) may inadvertently increase total energy intake in 
order to reach the protein target. In the scientific literature, high protein intake is positively 
associated with neonatal head circumference (388), but this is largely driven by the adverse effects 
of very low protein diets.   
High fat diets have also been recommended to bring about reductions in carbohydrate intake 
without increasing protein.  However, in GDM, this may be a cause for concern. High-fat diets during 
pregnancy have been associated with an increase in insulin resistance in rodents (389), fetal 
overgrowth, particularly if maternal FFAs were high (343, 390), and effects on child neurobehavioral 
development (391).  In future studies, it may therefore be helpful to compare 3 diets in one RCT, 
wherein the third diet achieves a low carbohydrate intake by increasing the intake of beneficial fats 
(Mediterranean-style diet).  It would also be informative to assess neonatal biochemical and 
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behavioural parameters. Altered maternal glucose metabolism in diabetes can cause neonatal 
hypoglycaemia, hyperbilirubinaemia and hypocalcaemia, which in turn have been associated with 
fetal congenital malformations (392).  At present, we have little understanding of whether these 
biochemical markers improve (or not) when the mother consumes a MLC diet.  
Aside from an energy deficit, the intervention resulted in a decreased intake of carbohydrate-rich 
foods, such as breads.  In Australia, most breads are fortified with iodised salt (by law) and are a 
major source of iodine. Recent studies suggest that many Australian women do not ingest enough 
iodine to satisfy the increased requirements during pregnancy, and this is associated with deficits in 
scores for numeracy and literacy (393). While iodine undoubtedly plays an important role in fetal 
neurological development and fetal thyroid function (394), women ingesting LC and MLC diets should 
be closely monitored for iodine, particularly in participants that do not take pregnancy supplements.  
Improved methods of tracking ketones are also needed in future studies. The typical pregnant 
woman is diagnosed with GDM at ~24 weeks gestation and delivers at ~40 weeks. During that time, 
she will have performed ~450 finger prick tests to ascertain fasting and postprandial glucose 
concentrations. In the MAMI 1 study, the mother was expected to perform additional finger prick 
tests, involving more time, pain and discomfort. To overcome the barrier and promote more 
frequent measurements, non-invasive devices will be appealing (395).  ‘Flash’ glucose testing and 
other new devices should be considered in the planning of future studies. GlucoTrack is one such 
non-invasive device, which can determine glucose fluctuations using a clip which attaches to the 
earlobe and has a cable extending to a reader. According to a recent study in a T2DM population, 
GlucoTrack was reasonably accurate, regardless of individual’s duration of diabetes, %HbA1c and 
smoking history (396).   
Unfortunately, with regards to ketone assessment, there are no real-time devices on the market to 
assess blood BHB concentration. Current ketone detectors are more suitable for detecting 
ketoacidosis in individuals with T1DM or poorly management of T2DM (397). There may be a market 
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for continuous ketone readings in people following LC diets as well as GDM pregnancy.  This would 
potentially map out important periods of BHB spikes. This information could be useful for dietary 
counselling and meal timing to prevent further BHB peaks and potential undesirable effects on fetal 
brain development.   
Given the limited and often conflicting evidence in the scientific literature, it is not surprising that 
there is lack of consensus regarding dietary management of GDM. The studies described in this thesis 
indicate that it is critical that the potential unintended consequences of well-meaning dietary advice 
be considered. There is room for improvement in the usual nutrition advice given to women with 
GDM. It should not be acceptable for advice in GDM to be based on ‘intuition’ and anecdontal 
evidence. Rather, dietary advice backed by strong scientific evidence is likely to promote better 
outcomes for the mother and her offspring. Taken together, our findings provide a rational basis for 
appropriately powered studies investigating the safety of LC diets in pregnancy.   
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Appendices 
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Figure A1: Assessing the risk of publication bias using funnel plots for different meta-analyses. lnOR, 
natural log odds ratio 
 
 
 
 
 
 
 
 
 
Figure A1a. Any type of PA in early pregnancy versus none (n studies = 9, z = -0.65, p = 0.52). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1b. Pre-pregnancy LTPA high versus none reported in MET.hr/week (n studies = 6, z = -2.96, 
p = 0.003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1c. Pre-pregnancy LTPA high versus none levels reported in hr/week, (n studies = 4, z = -
2.34, p = 0.02). Due to insufficient number of studies reporting on early pregnancy.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A1.   Natural odds ratio (lnOR) values before back-transformation correspond to Figures 3A, 3B, 4A, 4B, 5 
and 6.  
 
 
 
Study lnOR 
95 % Confidence Intervals 
Lower Upper 
Fi
gu
re
 3
A
 
Badon et al. 2016 (234) -0.64 -1.18 -0.11 
Chasan-Taber et al. 2008 (251) -0.22 -1.43 0.99 
Chasan-Taber et al. 2014 (250) -0.24 -1.12 0.65 
Currie et al. 2014 (254) -0.51 -1.37 0.35 
Dempsey et al. 2004 (235) -1.76 -2.69 -0.83 
Morkrid et al. 2014 (256) -0.37 -0.70 -0.05 
Solomon et al. 1997 (217) -0.04 -0.30 0.21 
Van der Ploeg et al. 2011 (233) 0.08 -0.35 0.50 
Zhang et al. 2006 (221) -0.36 -0.54 -0.19 
Oken et al. 2006 (234) -0.58 -1.12 -0.04 
Rudra et al. 2006 (229) -0.46 -1.34 0.42 
OVERALL -0.36 -0.57 -0.16 
Fi
gu
re
 3
B
 
Badon et al. 2016 (224) -0.56 -1.04 -0.08 
Chasan-Taber et al. 2008 (241) -0.36 -1.33 0.61 
Chasan-Taber et al. 2014 (240) -0.37 -1.26 0.52 
Currie et al. 2014 (244) -0.58 -1.49 0.33 
Dempsey et al. 2004 (225) -0.35 -1.04 0.35 
Dye et al. 1997 (237) 0.00 -0.22 0.22 
Morkrid et al. 2014 (246) -0.30 -0.67 0.07 
Oken et al. 2006 (234) -0.11 -0.70 0.49 
OVERALL -0.24 -0.45 -0.03 
Fi
gu
re
 4
A
 
Badon et al. 2016 (224) -0.64 -1.18 -0.11 
Chasan-Taber et al. 2008 (241) 0.74 -0.43 1.92 
Chasan-Taber et al. 2014 (240) 0.23 -0.63 1.09 
Rudra et al. 2006 (229) -1.71 -2.64 -0.77 
Dempsey et al. 2004 (225) -0.37 -0.70 -0.05 
Morkrid et al. 2014 (246) -1.97 -2.86 -1.07 
Solomon et al. 1997 (217) -0.04 -0.30 0.21 
Van der Ploeg et al. 2011 (233) 0.20 -0.22 0.62 
Zhang et al. 2006 (221) -0.36 -0.53 -0.19 
Oken et al. 2006 (234) -0.58 -1.12 -0.04 
OVERALL -0.43 -0.86 0.00 
 
 
 
 
 
 
 
 
 
 
 
Study 
 
lnOR 
 
95 % Confidence Intervals 
Lower Upper 
Fi
gu
re
 4
B
 
Badon et al. 2016 (224) -0.67 -1.16 -0.18 
Chasan-Taber et al. 2008 (241) -0.36 -1.50 0.79 
Chasan-Taber et al. 2014 (240) 0.07 -0.68 0.82 
Dempsey et al. 2004 (225) -0.63 -1.39 0.13 
Oken et al. 2006 (234) -0.11 -0.70 0.49 
OVERALL -0.37 -0.70 -0.04 
Fi
gu
re
 5
 
Badon et al. 2014 (224) -0.64 -1.18 -0.11 
Dempsey et al. 2004 (225) -1.71 -2.64 -0.77 
Rudra et al. 2006 (229) -1.97 -2.86 -1.07 
Solomon et al. 1997 (217) -0.04 -0.30 0.21 
Van der Ploeg et al. 2011 (233) 0.20 -0.22 0.62 
Zhang et al. 2006 (221) -0.36 -0.53 -0.19 
OVERALL -0.66 -1.32 -0.00 
Fi
gu
re
 6
 
Badon et al. 2014 (224) -0.64 -1.18 -0.11 
Dempsey et al. 2004 (225) -1.71 -2.64 -0.77 
Morkrid et al. 2014 (246) -0.37 -0.70 -0.05 
Solomon et al. 1997 (217) -0.27 -0.76 0.22 
OVERALL -0.62 -1.09 -0.14 
